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In this thesis I have studied the natural course, 
outcome and management of patients who developed a 
pancreatic pseudocyst following an episode of acute 
pancreatitis. The clinical information for this work 
originated in 2 studies involving a total of 129 patients 
with a pseudocyst. This represents one of the largest 
reports of such patients in medical literature.
One study was of 100 patients with a pseudocyst 
presenting to G l a sgow Royal Infirmary, over a period of 23 
years (1962 - 1984 ) (Chapter 3 ) (Imr ie et al 1988 . Appendix
1). The second study was of 29 similar patients (Chapter
4) doc ume nted during a prospective trial of therapeutic 
peritoneal lavage in patients with severe acute 
pancreatitis recorded in Leeds, Bristol and Glasgow 
(1982 - 1984) (Co rfield et al 1985, Ma yer et al 1985.
Ap pendix 1).
Using the information derived from these studies, I 
have formulated an assessment system for predicting the 
likelihood of spontaneous resolution of a pseudocyst 
(Ch apter 8). With the addition of results obtained fr om 
an analysis of percutaneous needle aspiration (Chapter 6) 
and analysis of acute phase reactant proteins within 
pseudocyst fluid (Chapter 7) I propose a new plan of 
management for patients with acute pancreatic pseudocysts.
2 3
The important findings of this thesis are summarised 
as f o i l o w s :-
1. The "waiting time" for conservative management of a 
pancreatic pseudocyst could safely be extended to 12 
weeks.
Bradley et al (1979) have suggested that a period of 
6_weekjs from the time of pseudocyst formation should be 
regarded as both the m a x i m u m  time to wait for spontaneous 
resolution of a pseudocyst and the optimum time to 
consider some form of drainage procedure. A  pseudocyst 
was drained surgically in 78 (%) of the 100 patients from
Gl a s g o w  Royal Infirmary and resolved spontaneously in the 
other 22 (%). The median time from diagnosis to drainage
by cys togas t r os t omy was \2_ weeks (range 2 - 69 weeks). The 
median time to complete spontaneous resolution was also 1__2 
weeks (range 2 - 104 weeks). Of the 29 patients from
Leeds, Bristol and Glasgow surgical drainage was performed 
in 11 (38%) at a median time of 7 weeks (range 3 - 3 8
weeks) and spontaneous resolution occurred in 15 (52%) at
a median time of 7 weeks (range 2 - 2 0  weeks).
Bradley et al (1979) also found an increasing 
proportion of patients developed c omp lications the greater 
the time a pseudocyst was left untreated. Only 6 (5%) of
all 129 patients studied suffered c omp lications as a 
result of an undrained pseudocyst.
Based on the above results I suggest that 6 weeks is 
too short a period and 1^ 2 weeks is a more appropriate time 
to wait for spontaneous resolution to occur provided the
R£*.l.SiIll. i£ ££R££Jl£^..LZ by cJ_J_nj_caJ_ examination and
u 1 t r asound £cann j_ng t_o confirm t_ha t^ phe dpameter of the
RfLRH.SL2.RXEl. L — E2.1 A.E2E2EE.LR.S. ILH.SL LlLLH.1. phe clinical state 
of t_h e £a t_j_en t_ i_s_ not de t_e r i opa ting.
2. No single factor causing acute pancreatitis
predisposes to pseudocyst formation.
Of the 100 patients from G l a s g o w  Royal Infirmary
a_l^ £ o h op wa s the cause of acute pancreatitis in 59%,
galls ton e s in 27% and the aetiology was i_d po pa p h i c in 9%. 
In contrast, of the 29 patients from Leeds, Bristol and 
G l a s g o w  a_J_c^ o h o J_ was the aetiological factor in 23%,
£LE.l.L£l.2E.2£ in 4 8% and it was i d^opa t^ h j_c in PP%- This 
distribution was very similar to that of a total of 418 
patients with acute pancreatitis studied in the three 
cities (Chapter 4)(g a 11stones 54%: alcohol 20%: idiopathic
21%). Th pp puggep^t £ t^ ha t^ no £ j_ng a e^ t a j_ factor o_f
acute REEEEEE1..L1..LE EE mope j_pke po cause pseudocy s t 
f o rma t i o n .
25
3. The aetiology of the preceding acute pancreatitis is
an important factor in determining the outcome of
patients with a pseudocyst.
The m o rta J_p£y HEEES.EJL EfLli® IEEE? 9 J_E£§°w  Royal
i.Ei.i.£0E.£.Z w ££_L_L£Jl£E£ J_nduced pancreatitis and
££££^££££1. £E£E}£li£E w a £  s i gn i f i cant 1 y greater than
that of E££i_£E££ wj_ph a j_£oho i nd uced disease (5%
£}o ppa p p p y P . The majority of patients who died as a result
of gallstone induced disease did so because of sepsis 
and/or haemorrhage. The pmppication from this is that, if 
p o s s i b 1 e , pn order po de££eape the poss i b i l i t y  of 
i£l££ii££-L £he bpPpapy ppa£p phoupd be c Reaped of stones 
at phe ppme oT d e f in itive pseudocyst surgery.
4. Spontaneous resolution of a pseudocyst can be 
predicted using a multi-factor assessment system.
A pseudocyst resolved spontaneously in 22 (%) of the
100 Glasgow Royal Infirmary patients and 15 (52%) of those
from Leeds, Bristol and Glasgow. Differences in clinical,
laboratory and radiological findings in these patients
were compared with those of patients whose pseudocyst
needed drainage. The proportion of patients with a
p a l p a b l e  ^ b d o m p n a p  m a s s  w a s  s i g n i f i c a n t l y  g r e a t e r  in t h o s e
who required surgery in both groups of patients. The
results for the patients from Leeds, Bristol and Glasgow
also showed a significantly higher proportion with
9
a b d o m i n a l  d i s t e n s i o n  a n d  a peuk_o£y p o p p y  p > p p x p £  ££j_J_£Zi.) 
a m o n g s t  t h o s e  w h o  u n d e r w e n t  s u r g e r y .
A  pseudocyst di ame ter of 6.££} wa s found to provide a 
valuable discriminating level between those pseudocysts 
resolving spontaneously and those requiring drainage. Only 
1 of 7 (14%) pseudocysts (Leeds, Bristol, Glasgow
patients) with a di ame ter greater than 6 cm resolved 
spontaneously compared to 9 of 11 (82%) with a size of 6cm
or less.
The features noted above have been incorporated into 
a 5 factor scoring system for predicting the outcome of a 
pancreatic pseudocyst. The 5 criteria are:-
1) a m a x i m u m  pseudocyst diameter of greater than 6cm
2) a serum amylase at the time of pseudocyst
diagnosis of 450 IU/1 or greater
9
3) a leukocytosis of 12x10 cells/1 or greater
4) the presence of an abdominal mass
5) the presence of abd om inal distension.
If 3 or more of these criteria are positive then 
spontaneous resolution is unlikely. When this scoring 
system is applied to the results from Leeds, Bristol and 
Glasgow, 12 of the 15 patients whose pseudocyst resolved 
had less than 3 criteria positive (80% sensitivity) and 10 
of 11 patients whose pseudocyst was drained had 3 or more 
positive (92% specificity).
It had been hoped that analysis of acute phase 
proteins within pseudocyst fluid (Chapter 7) would have 
provided a useful marker in addition to the criteria noted 
above but this was not the case.
27
5. A new plan of management for patients with a 
pancreatic pseudocyst is proposed.
Having developed a m e t h o d  for assessing outcome I 
considered the place of percutaneous needle aspiration and 
catheter drainage in the ma  nag erne nt of patients with a 
pseudocys t .
Percutaneous needle aspiration was successful in only 
6 (29%) of 21 patients studied. The use of p e r c u t a n e o u s 1y
placed long term catheters is mor e  successful (Chapter 6 ) 
and there is a limited place for this type of treatment in 
selected patients.
I propose that the management for patients who form a 
pseudocyst because of acute pancreatitis (Chapter 8) 
should now include:-
1 ) asses sme nt of outc ome b y mu ltifactor scoring 
s y s t e m .
2) repeated assessment of the patient with clinical 
examination, ultrasonic scanning and estimation of 
C  reactive protein for a jt J_ea£t_ .12^ weeks f r om the 
time of pseudocyst diagnosis ££0 v^d j_ng t^ ha t_ _t he 
g.££££_£j_ condi^_t jj_on of_ t_he £a t_j_en not d e£e£j_o^a£j_ng
and _the size of_ the ££_|_J_£C £j_££ ££ not _L££££££_L££•
3) consideration oi_ £££££*.££££££ ££ £he t_e£ dr_a_i_n age if 
the d i ame ter of the pseudocyst is not decreasing. 
This may help to prevent late complications e.g. 
rupture and ha emo r r h a g e .
CHAPTER 1 
INTRODUCTION
The principle aims of this thesis are directed 
t o w a r d s :-
1) establishing the natural history of patients 
developing pseudocysts as a complication of 
pancreatitis. In particular, it considers whether the 
m a x i m s  of "6 weeks" and "6 centimetres" relating to 
the critical "age" and size of a pseudocyst are valid 
parameters for determining the necessity and timing 
of some form of intervention to drain a pseudocyst.
2) determining important and significant differences 
in the clinical course of patients in w h o m  a 
pseudocyst resolved spontaneously as compared with 
those in w h o m  a pseudocyst required surgical 
drainage. The information from this part of the 
thesis was used to formulate a set of criteria into a 
system for predicting the outcome in patients who 
develop a pseudocyst after an episode of acute 
pancrea t i t i s .
3) assessing the place of percutaneous aspiration in 
the management and treatment of pancreatic 
pseudocys t s .
4) evaluating analysis of acute phase reactants in 
pseudocyst fluid with a view to finding a factor for 
predicting outc ome .
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D E F I N I T I O N  OF PANCREATITIS
Since 1963 there have been three me etings of 
international experts with a particular interest in the 
pancreas specifically convened to establish a practical, 
international classification of acute and chronic 
pancreatitis. The meetings took place Marseilles in 1963 
(Sarles 1965) and 1984 (Singer et al 1985), and in
C a m b ridge in 1983 (Sarner and Cotton 1984). The definition 
finally produced fr om  the mo st recent Ma rseilles me e t i n g 
is as follows:- "Clinically, acute pancreatitis is
characterised by acute abdominal pain accompanied by
increased pancreatic enzymes in blood or urine, or both. 
Though it usually runs a benign course, severe attacks may 
lead to shock with renal and pulmonary insufficiency that 
ma y prove fatal. Ac ute pancreatitis ma y be a single 
episode or it may recur.
Morphologically, there is a gradation of lesions seen 
in acute pancreatitis. In the mild form, peripanereatic 
fat necrosis and interstitial oed ema can be recognised, 
but as a rule pancreatic necrosis is absent. The mild form 
may develop into a severe form with extensive 
peripancreatic and intrapancreatic fat necrosis, 
parenchymal necrosis and haemorrhage. The lesions may be
either localised or diffuse. Occasionally, there may be
little correlation between the severity of the clinical 
features and the mo rphologic findings." (Singer et al 
1985 )
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This definition has been quoted in full because it 
was an attempt to encompass both clinical and pathological 
aspects of the disease. However, it made no me n t i o n  of 
specific complications relating to acute or chronic 
pancreatitis. There was no specific definition for 
pseudocysts, pancreatic abscess or infected pancreatic 
necrosis and unfortunately, the repeated defining of a 
condition often only serves to add to the confusion 
p articularly when discussing patients with these 
c omp lications.
There is, as yet, no reliable method of determining 
which patients will develop pseudocysts and, in 
consequence, no effective prophylactic therapy.
There have been very few prospective studies 
concentrating on patients who develop a pseudocyst 
following an episode of acute pancreatitis. The present 
wo rk is an att emp t t o r  erne dy this situation.
H I S T O R I C A L  B A C K GROUND
Mo rgagni (1761) is quoted by Judd et al (1931) as 
being the first observer to describe a cystic lesion of 
the pancreas in a cadaver. Claessen (1842) reviewed 
several reports of pseudocysts from the existing 
literature and Friedrich (1875) wrote the first major 
review on the subject. By that time, the pathology of the 
disease had been described in detail, and the term 
pseudocyst was employed because of the fibrous wall and 
lack of an epithelial lining around the cavity.
Between 1888 and 1910 numerous individual reports of 
patients with a pseudocyst were published and further 
reviews of the condition were written by Korte (1898), 
Lazarus (1904) and Oser (1903).
Most of the literature ad-dressed the problems of the 
anatomical and pathological detail of pseudocysts. The 
association between such collections and acute 
pancreatitis was recognised by these early authors.
Op i e (1903) suggested that pseudocysts formed as a 
result of rupture of a small branch of the pancreatic 
duct system allowing leakage of the exocrine secretions 
into the surrounding tissue and subsequent activation of 
pancreatic enzymes. He postulated that this produced 
necrosis and inflammation within the lesser peritoneal sac 
and around the pancreas. This hypothesis, suggesting a 
direct communication between duct and pseudocyst, was not 
readily accepted because of failure to confirm a fistula 
in many of the early specimens.
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P A N C R E A T I C  PSEUDOCYSTS AS A  CONS E Q U E N C E  OF PANCREATITIS
De£i_n i__t i_on o_f a £ £ e u d o c p  t
A  pancreatic pseudocyst is defined as:-
a localised fluid collection of pancreatic origin in, 
or around the pancreas confined by a fibrous lining 
devoid of an epithelium. As a result of the
i n f 1amma tory reaction of pancreatitis, especially 
following acute pancreatitis, there is frequently 
rupture of a pancreatic duct leading to a persistent
corrmun i ca t i on between the duct system and the
collection. The fluid is therefore rich in pancreatic 
e n z yme s .
On histological examination a pseudocyst has a wall 
of fibrous granulation tissue with fibroblasts and chronic 
i n f 1 amma tory cells surrounding a fluid filled cavity 
(Figure 1). In order to confirm completely that a fluid
collection forming around the pancreas following acute 
pancreatitis is a true pseudocyst it would be necessary to 
analyse the fluid, demonstrate a fistula between a 
pancreatic duct and the collection, and biopsy the wall to 
d emo nstrate the fibrous tissue. Such c omp lete analysis can 
occasionally be achieved, particularly in patients who 
ultimately undergo surgery but is inappropriate in 
patients in w h o m  a collection resolves spontaneously.
FIGURE 1
LUMEN
r,i», ^ V  *f
Histology of pseudocyst wall showing 
dense fibrous tissue devoid of an
epithelial lining.
Lumen marked. The tissue bordering the 
pseudocyst consists of fibrosing
granulation tissue.
Haemotoxylin and eosin xlOO
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With the develo pme nt of contrast radiography and 
techniques of performing pancreatograms during surgery, a 
communication between the duct system and a pseudocyst 
cavity has been reported in 70% of patients with 
pseudocysts (Kaiser et al 1964). Following the 
introduction of pancreatograms performed via an endoscope, 
these findings have been confirmed (Silvis et al 1974) and 
it is clear that Op ie's (1903) hypothesis has been 
substantiated (Frey et al 1988).
E x £ e r imen t_a J_ S t u d i es
There are only 7 reports of experimental attempts 
at producing pancreatic pseudocysts. The most frequently 
quoted has been the work of Warren et al (1957 ). Using 
dogs, these authors inserted a sponge filled plastic bag 
into the lesser peritoneal sac in order to create a cavity 
lined with fibrous, granulation tissue. Four to 6 weeks 
later a second operation was performed to transpose the 
transected end of the pancreatic duct into the cavity in 
order to fill it with pancreatic juice. Wh en the second 
stage of this experiment was performed the majority (66%) 
of the animals had died. In the remaining dogs the authors 
noted that the pseudocyst wall was lined with granulation 
and fibrous tissue similar to the histological changes 
found in the human. There was no record of sequential 
studies of the development of the wall but based on 
histological appearances at 4-6 weeks it was regarded that 
the fibrous tissue was mature.
Following this work and based on clinical experience, it 
was deduced that a period of 6 weeks was sufficient time 
to allow matu r e  pseudocyst wall fibrosis to occur in
humans (Bradley et al 1976; Cerilli and Faris 1967; 
Ephgrave 1986).
Prior to 1957 only three attempts at creating
pseudocysts had been documented and none was particularly 
successful (Lazarus 1903: Senn 1886; Thiroloix 1903).
Subsequently there have been three other experimental 
studies. Karlan et al (1958) implanted the distal
transected pancreas into an ome ntal sac but this caused 
atrophy of the pancreas and only small pseudocysts formed. 
Rosello and Novoa (1978) used a similar first stage to 
Warren and then, like Karlan, implanted the distal
pancreas into this cavity. Again the distal portion 
degenerated and failed to produce pancreatic secretion.
Mo re recently Salinas et al (1985), has further 
mo d ified the Warren technique. The cavity was created as 
formerly and 6 weeks later the pancreatic duct was 
transected and both ends implanted into the cavity. These 
authors subsequently administered secretin intravenously 
in order to stimulate enzyme production from the pancreas. 
In three animals they also partially ligated the 
pancreatic duct. A  cavity developed in all ani ma Is but 
only those with the ligated ducts produced a fluid filled 
pseudocys t .
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These authors suggested that an obstructive element 
ma y be critical in the develo pme nt of a pseudocyst in 
humans. These aforementioned, complex experimental studies 
are not strictly analogous to the human clinical situation 
(Kane and Krejs 1984) and no experimental model developed 
to date has been able to demonstrate sequential formation 
of a pancreatic pseudocyst
After consideration and discussion with several 
authorities viz: my supervisor, Mr C  W  Imr i e , Dr A  Foul is, 
Pathologist with a special interest in the pancreas; 
Professor E Bradley, Atlanta, U.S.A., Professor D  Carter, 
Glasgow, it was decided that none of the previously 
described experimental models of pancreatic pseudocyst 
adequately reflected the situation in humans and no new 
model could be envisaged. Therefore, considering the 
advice given, no att emp t wa s ma de to create such a mo del.
Pa thogenes i s
The factors involved in the pathogenesis of 
pseudocysts have been deduced fr om consideration of the 
available evidence. The pathological features necessary 
for the production of a pseudocyst are (Figure 2):
1) pancreatic duct rupture, either as a result of 
pancreatitis or trauma (Erb and Grime I960 ; Kane and 
Krejs 1984; Opie 1903)
2) continued secretory function of at least part of 
the gland (Elliot 1975; Winship et al 1977).
3) obstruction, partial or complete, of normal 
pancreatic duct drainage (Bradley 1982; Do ubilet and 
Mu lholland 1953)
DUCTAL COMMUNICATION 
WITH SURFACE OF THE GLAND 
THROUGH AREAS OF NECROSIS
FUNCTIONING GLAND
OBSTRUCTION OF THE PANCREATIC DUCT
GALLSTONE
OEDEMA
PROTEIN PLUG
PANCREATIC DUCT STONE
FIBROSIS
FIGURE 2 Illustration of factors necessary for
formation of a pancreatic pseudocyst.
the
The duct obstruction occurring in a pseudocyst which 
develops as a result of chronic pancreatitis may be caused 
by protein plugs, pancreatic stones or fibrosis (Sarles et 
al 1965), whereas the obstruction in those forming after 
acute pancreatitis most likely results from oedema around 
the proximal pancreatic duct or the presence of a
gallstone impacted just proximal to the ampulla of Vater 
(Acosta and Ledesma 1974). Other less common causes of 
duct obstruction, for ex amp le carcin o m a , can also cause
pancreat i t i s .
The most common site for a pancreatic pseudocyst is 
within the lesser peritoneal sac, and for a collection to 
be contained within this space the entrance to the sac 
(the foramen of Winslow) has to be temporarily occluded 
(Bradley and Klein 1956).
The size to which a pseudocyst will develop is, in
part, determined by the duration of obstruction to normal 
duct drainage. It has been postulated that a pseudocyst 
will increase in size until the pressure exerted by the
surrounding tissues exceeds that of the secretory pressure 
within the pancreatic duct (White and Bourde 1970).
The fluid within a pseudocyst has a high protein 
content and, once localised, further tissue fluid is 
attracted into the cyst by osmosis (Elliot 1975), 
resulting in further expansion of the collection. On c e 
released, the activated pancreatic juice stimulates a 
considerable tissue reaction leading to the formation of 
fibrous, granulation tissue.
The diagnosis of a pseudocyst must be based on a 
combination of » biochemical and imaging
information but early studies relied solely on clinical 
evidence with the presence of an abdominal mass being 
par amo unt. Judd et al (1931) reported the Ma yo clinic 
experience of 44 patients with pseudocysts. The authors 
noted a high incidence of abdominal pain, a palpable mass 
and persistent nausea and vomiting following an episode of 
acute pancreatitis as being the most important clinical 
features. The m a j ority of the pseudocysts which these 
authors reported were of considerable size. At the time of 
their review, serum amylase estimation was not generally 
available despite being introduced as a diagnostic test 
for pancreatitis in 1927 (Elman and M c C a u g h a m  1927). 
P i n kham (1945) noted that a sustained elevation of serum 
amylase following acute pancreatitis was suggestive of a 
p s e u d o c y s t . An elevated level of the enz yme is a useful 
indicator and is still the mainstay of biochemical 
d i agnos i s .
In a review of 12 studies, the incidence of a raised 
s e r um amylase in patients with proven pseudocysts varies 
from 11-100% (Median value 7 0%). (Becker et al 1968; 
Brilhart and Priestley 1951; Caravati et al 1966; Folk and 
Freeark 1970; Frey 1978; Gonzalez et al 1976; Grace and 
Jordan 1976; Kaiser et al 1964; Sankaran and Walt 1975; 
Scharplatz and White 1972; Thomford and Jesseph 1969; 
Tucker and Webster 1972). At present there are no other 
sgeci_fj_c biochemical markers for pseudocysts.
Perhaps the most significant advance in establishing 
a positive diagnosis of a pancreatic pseudocyst in the 
past 20 years has been the use of ultrasonic scanning of 
the pancreas (Filly and Freimanis 1970). Prior to this, a 
b a r i u m  meal with lateral erect views to demonstrate 
d i s p 1 a c erne nt of the st oma ch or duoden um by the pseudocyst, 
was the most sensitive radiological investigation (Figure
3). A  diagnosis was only possible in those collections 
which were of sufficient size to distort the stomach or 
d u o d e n u m  and it was not until ultrasonic scanning was 
introduced, that pseudocysts were more readily identified 
and their natural course revealed.
Filly and Freimanis (1970) reported the ultrasonic 
characteristics of various pancreatic diseases, but the 
first i mp  ortant study specifically related to cystic 
collections was performed by Bradley and Clements (1974). 
They provided a detailed analysis of the ultrasonic 
appearances and characteristics of pseudocysts. Since this 
report, technical improvements in ultrasonic equipment 
have resulted in improved definition and it has become 
possible to characterise the natural history of 
pseudocysts particularly when these are associated with 
acute pancreatitis (Bradley 1982).
Bradley et al (1976) established that fluid 
collections in the vicinity of the pancreas following 
acute pancreatitis were more conmon than had been 
previously imagined.
FIGURE 3 Radiograph of a lateral erect view of a 
b a r i um me al in a patient with a large 
pseudocys t .
The stomach and o e s o p h a g o -gastric junction 
are displaced anteriorly by the pseudocyst.
PC = pseudocyst 
O  = oesophagus 
S = s t oma c h
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Some of these collections represented local loculi of 
peritoneal exudate released fr om the d ama ged gland but 
such collections frequently resolved spontaneously within 
2 to 3 weeks of the episode of acute pancreatitis. These 
authors also demonstrated that a proportion of the 
collections which they assessed as true pseudocysts 
resolved spontaneously. This observation resulted in a 
considered reappraisal of pseudocyst ma nag erne nt and led to 
a policy of continued conservative observation being 
advocated (Czaja et al 1975; Duncan et al 1976; Poliak et 
al 19 78 ). The ability to repeatedly monitor the size of 
collections is of paramount importance in adopting such a 
ma nag erne nt policy and clearly, wo uld not have been 
possible without the advent of ultrasonic techniques.
Technical improvements in ultrasonic machines have 
led to improved definition of the images such that a 
pseudocyst and the surrounding tissues can be clearly 
identified (Figure 4).
In more recent years computerised tomography (CT 
scanning) has also been used to delineate pancreatic 
m orphology and * is now being used with
increasing frequency in patients with pancreatitis (Hill 
et al 1982 ; Siegelman et al 1980 ). High resolution 
scanners and contrast enhanced dyn am ic scanning have 
increased the diagnostic capabilities of these techniques 
(Figure 5). Both ultrasound and CT scanners are now 
capable of defining the thickness of the wall of a 
pseudocyst and, with the appropriate appearances of a 
fluid collection surround by a thick wall, are frequently 
regarded as sufficient to substantiate the diagnosis.
FIGURE 4 Ultrasound scan of a large pseudocyst
showing a large fluid filled cavity 
overlying the pancreas.
PC = echolucent fluid filled cavity 
WALL = echo dense wall of pseudocyst 
P = pancreas
FIGURE 5 Comp uterised t omo graphic scan of large
pseudocys t .
The uniform density of the fluid within the 
pseudocyst and the thick surrounding wall 
are both clearly d emo nstrated.
PC = pseudocyst
WALL = thick fibrous w a 11
S = stomach compressed by pseudocyst
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The other important diagnostic technique which has 
been employed is endoscopic retrograde pancreatography. 
This permits assessment of the pancreatic ducts and can 
c o n f i r m  the presence of a fistula from the ducts into the 
c o l l ection (Figure 6). Th is technique is clearly mo r e
invasive than ultrasound or CT scanning and can introduce 
infection into a previously sterile collection.
Ae t^ i o 1 ogy_
A  pseudocyst can develop in any patient suffering 
f r om  acute or chronic pancreatitis irrespective of the 
aetiology of the acute pancreatitis. The majority of
studies relating to pseuddcysts have comprised patients 
with alcohol induced pancreatitis. A  review of
retrospective reports of pseudocysts covering the period 
from 1921 until 1982 encompasses 1124 patients of who m  ^ 6ja 
had alcohol induced pancreatitis; ^3^% ga one
associated disease; 11%. developed pseudocysts following 
trauma ; in 7% the aetiology remained un known and the 
remaining 3% had mi scel_l_aneous causes for their disease. 
(Anderson 1972; Aranha et al 1983; Becker et al 1968;
Bradley et al 1976 ; Caravati et al 1966 ; Crass and Way 
1981; Erb and Grimes I960 ; Folk and Freeark 1 970 ; Frey 
1978; Gonzalez et al 1976; Grace and Jordan 1976; Hastings 
et al 1975; Judd et al 1931; Kaiser et al 1964; McConnell 
et al 1982 ; Sankaran and Walt 1 975 ; Scharplatz and White 
1972; Thomford and Jesseph 1969; Tucker and Webster 1972). 
Many of these studies emanated from areas where alcohol 
was the predominant cause of pancreatitis and the results 
were undoubtedly biased towards this aetiology.
FIGURE 6 Radiograph taken during an ERCP. Contrast
is seen leaking from the pancreatic duct 
into a large cavity.
CBD = c orrrno n bile duct 
PD = pancreatic duct
PC = pseudocyst with leak of contrast
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As a result, pseudocysts have become associated with 
alcohol induced pancreatitis but ma ny of the reports 
failed to differentiate between collections forming after 
acute pancreatitis and those which were associated with 
chronic pancreatitis.
Outcome
Because detection of a pseudocyst was based on 
clinical ex am ination and relatively insensitive 
radiological techniques, prior to the introduction of 
ultrasonic scanning, most pseudocysts were treated by some 
form of surgical drainage (Warren et al 1958). Spontaneous 
resolution was regarded as rare and possibly related to 
rupture into a hollow viscus or peritoneal cavity (Becker 
et al 1968; Hanna I960; Kaiser et al 1964). The ability to 
repeat a scan of a collection has confirmed spontaneous 
resolution in as ma ny as one third of pseudocysts.
S£ontaneous resolu t ion o f_ £ancreat i_c
The advent of ultrasonic scanning has greatly 
enhanced the understanding of the natural history of 
pseudocyst formation and there is no doubt that 
pseudocysts associated with acute or chronic pancreatitis 
can resolve spontaneously. The seminal literature on this 
subject has come from Atlanta, Georgia, U.S.A. (Bradley 
and Clements 1974; Bradley and Clements 1975; Gonzalez et 
al 1976; Bradley et al 1976; Bradley et al 1979). In this 
series of papers, the authors described in detail the use 
and application of ultrasound scanning in assessing and 
following the natural history of pancreatic pseudocysts.
The authors observed that fluid collections around the 
pancreas in response to acute pancreatitis were more 
frequent than had been previously thought, and they 
demonstrated that between 2 5 and 50% of these collections 
would resolve spontaneously within 6 weeks of onset.
In their study of 93 patients with a pseudocyst 
(Bradley et al 1976), 11 were subjected to emergency
surgical drainage of their collections, 28 others had what 
was referred to as "elective" operative drainage and the 
remaining 54 patients were managed with repeated clinical 
and ultrasound examination. Spontaneous resolution 
occurred in 11 (20%) of these 54 patients, 10 within 6
weeks of formation. The authors also found an increasing 
incidence of complications in the other patients with 
pseudocysts older than 6 weeks. The mean time from 
the develo pme nt of a pseudocyst until a c o m p 1i c a t i o n 
supervened was 13.5 +/- 6 weeks. Seven (13%) of the 54
patients died. In contrast, there were no deaths amongst 
the 28 patients who underwent elective surgery.
On the basis of these results Bradley et al (1979) 
concluded that if a pseudocyst had not resolved within 6 
weeks from formation elective drainage surgery should be 
p e r f o rme d .
A  number of authors (Table 1) have also referred to a 
period of six weeks in relation to the "age" of a 
pseudocyst and the likelihood of spontaneous resolution.
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PSEUDOCYSTS SPONTANEOUS RESOLUTION
AUTHOR NUMBER NUMBER % <6 WEEKS
Agha (1984) 20 5 25% 5
Aranha et al (1983) 105 29 28% 19
Bradley et al (1979) 54 11 20% 10
Crass et al (1981) 22 3 14% 3
W a r shaw et al (1985) 42 3 7% 3
To t a 1 243 51 21% 40
TABLE 1 Reports in relevant literature in which a period
of 6 weeks is mentioned in relation to the time 
to comp lete spontaneous resolution of pancreatic 
pseudocys t s .
On ly 11 of 51 pseudocysts did not resolve within 
6 weeks and 10 of these were reported by Arahna 
et al (1983).
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Not all authors regard it as a critical time and, in 
particular, the high incidence of complications in 
untreated pseudocysts after this time, noted by Bradley et 
al 1979, has not been consistently supported by others 
(Agha 1984; Aranha et al 1983; Beebe et al 1984; Lasson et 
al 1988; O'Malley et al 1985; Wade 1985).
In addition, this time of 6 weeks has been discussed 
with reference to the timing of surgical drainage but 
without supporting data to confirm it as the optimal 
period at which to instigate surgical intervention (Beebe 
et al 1984; Cerilli and Faris 1967; Wade 1985).
A  second feature of importance in the assessment of 
pseudocysts is the m a x i m u m  size of the collection. Until 
1985 (the time of the end of the patient data collection 
in the current study) there were only 4 reports (Table 2) 
detailing pseudocyst diameter (on ultrasound examination) 
in pseudocyst resolved spontaneously and those in w h o m  
surgical drainage was performed. Aranha et al (1983) noted 
that only 4 (15%) of 26 pseudocysts greater than 6 cm i n
diameter resolved spontaneously. The relevance of this 
size as a useful gauge as to whether a pseudocyst will 
resolve or not is discussed in Chapter 5.
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The incidence of spontaneous resolution of 
pseudocysts recorded in the literature varies from 8 - 84%
(Table 3. Agha et al 1984; Aranha et al 1983; Beebe et al
1984 ; Bradley and Clements 1975 ; Bradley et al 1976 , 
Bradley et al 1979 ; Crass and Way 1975 ; Czaja 1975 ; 
Gonzalez et al 1976; McConnell et al 19 82; O'Malley et al 
1985; Poliak et al 1978; Sandy et al 1981; Sankaran and 
Walt 1975; Vajcner and Nicoloff 1969; Wade 1985; W a r shaw  
and Rattner 1985).
Many of the above reports were retrospective reviews 
of patients, the majority of w h o m  had alcohol induced 
pancreatitis. Few of the studies documented the number of 
pseudocysts occurring after acute pancreatitis as opposed 
to those associated with chronic disease. With a high
incidence of alcohol induced pancreatitis, even those 
patients who had a specific event of pain and
h y p e r a m y 1 aseamia prior to pseudocyst development may have 
had chronic changes within the pancreas (Sarner et al 
1984 ) .
Differentiating between "acute" and "chronic" 
pseudocysts is of considerable i mp ortance because the 
behaviour of cystic collections in each circumstance is 
different (Crass and Way 1981; Lasson et al 1988; Mullins 
et al 1988). The frequency of spontaneous resolution and 
complications of pseudocysts forming after an episode of 
acute pancreatitis is greater than that for collections 
forming in association with chronic pancreatitis.
AUTH O R RES O L U T I O N  (%)
Vajcner et al (1969) 21
Bradley et al (1975) 13
Cz a j a e t a l  (1975) 84
Sankaran et al (1975) 8
Go n z a l e z e t a l  (1976) 20
Bradley et al (1976) 26
Bradley et al (1978) 19
Pollack et al (1978) 30
Bradley et al (1979) 26
C r a s s e t a l  (1981) 14
Sandy et al (1981) 22
McCo nnell et al (1982) 20
Aranha et al (1983) 28
B e e b e e t a l  (1984) 18
Agha (1984) 25
O'Malley et al (1985) 16
Wade et al (1985) 12
Wa r s h aw e t a l  (1985) 14
me an 2 3
me d i a n 2 0
TABLE 3 Reports in literature (1969 - 1985)
quoting an incidence for spontaneous 
resolution of pancreatic pseudocysts.
The features of pseudocyst age and size must not be 
considered in isolation when assessing the likelihood of 
spontaneous resolution. Equally important is the clinical 
condition of the patient. If there are no signs or
symptoms of continued inflammation, pyrexia, pain,
leukocytosis, or h y p e r a m y1 a s e a m i a , then a pseudocyst is 
mo re likely to resolve than if these features are present 
(Bradley et al 1979)
Op ie's (1903) original suggestion that a pseudocyst
forms because of a communication between the pancreatic 
ductal syst em and the surface of the gland r ema ins true
and, with the advent of sophisticated interventional 
radiological techniques capable of demonstrating a fistula 
between a pseudocyst and the pancreatic duct, Op ie 1 s 
hypothesis has become accepted (Frey et al 1988). The 
presence of such a fistula is obviously important when 
considering the possibility of spontaneous resolution. If 
there is a continuous leak of pancreatic fluid into a 
cavity then resolution is less likely than if a fistula 
has sealed.
There are few studies comparing the clinical course 
of patients in w h o m  a pseudocyst resolves spontaneously 
with those ultimately requiring surgery. This prob lem is 
specifically addressed in Chapter 5.
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Surg ery  RE£££.E£l_.L£ R££ES!.££X£££
The m a j ori ty  of patients forming a pseudocyst still 
require to have them drained surgically and muc h  of the 
literature relating to pseudocysts concerns surgical
management. Le Dentu (1862) punctured and drained a 
pseudocyst via a percutaneously introduced needle. He had 
thought he was draining a liver cyst and the patient 
ultimately died. Four years later Lucke and Klebs (1867) 
drained a pseudocyst externally but again the patient
died.
The first successful surgery is attributed to Bozeman 
(1881) who removed a large pseudocyst from a 41 year old
female patient. He reported, that at laparotomy, a large 
cystic lesion was discovered arising from the tail of the 
pancreas and contained 1.5 gallons of fluid. This was 
successfully removed and the patient made  an excellent
recover y .
The following year Gussenbauer (1883) successfully 
drained a pseudocyst by a marsupia 1isation procedure. This 
remained the accepted me thod of surgical management for 
many years. Qnbredanne (1911) performed a
cystoduodenostomy using a lateral side to side anastomosis 
between a pseudocyst within the head of the pancreas and 
the duoden u m .
As a variation of this technique, t r ansduo de na1 
cystoduodenostomy was described by Kerschner (1929) and 
this approach proved more successful. In 1923 Jedlicka 
described drainage of a pseudocyst into the st oma c h . He 
excised a portion of the cyst wall and anastomosed the 
remainder to the posterior wall of the stomach.
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A  m o d i f i c a t i o n  of this was recorded by Jurasz (1931) and 
his technique is similar to that used today. Successful 
drainage into a loop of jejunum was performed by Henle and 
Hahn (1927 ) and a me thod employing a Roux en Y  technique 
was described by Koning (1946). Some surgeons still favour 
this m e th od  as the internal drainage technique of choice.
There are also reports of pseudocysts drained into 
the gallbladder (Neuffer 1932; Walzel 1926) and common 
bile duct (Carter and Slattery 1947).
In 1958 Warren et al published a review of surgical 
operations for pseudocysts. External drainage or 
ma rsupialisation we re the mo st frequent procedures (47% of 
all operations), and all methods of internal drainage 
together accounted for 4 2%. In 11% of patients the 
pseudocysts were excised. The mortality  associated with 
external drainage was 3%, and 24% of patients required 
further surgery.
Internal drainage via a cystogastrostomy carried a 
similar mortality but only 5% needed further operations. 
Other methods of internal drainage into the duodenum or a 
loop of jejun um had a high incidence (>20%) of second 
ope r a t i on s .
A decade later Becker et al (1968) published a 
similar review’ and found the proportion of patients 
undergoing each type of operation to be al mo s t the s ame a s 
that noted by Warren et al (1958) and that all methods of 
internal drainage had a low incidence of re-operation 
while this remained greater than 20% for those patients 
w h ose pseudocyst w a s drained externally.
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Over the years, the proportion of patients treated by 
internal drainage gradually increased as highlighted by 
Hastings et al (1975) who compared the relative incidences 
of each operation before and after 1962 (Table 4). In 
subsequent studies of pseudocysts (post 1976), 61% of
patients have been treated by internal drainage compared 
to 32% externally (Table 5). Internal drainage methods are 
associated with a lower morta li ty and morbidity than 
external drainage but there are times when the former may 
be inappropriate .
A  critical factor in determining the choice of 
operation and outcome has been the timing of surgery in 
relation to the development of the pseudocyst. Cerilli and 
Faris (1967) demonstrated a significant difference in 
morta lit y between those treated within 6 weeks of 
pseudocyst form ation(mor ta1ity 60%), compared to those in 
w h o m  operation was deferred beyond this time (mortality 
9%). These authors related the poor outcome of early 
drainage to the presence of pancreatic i n f 1 arrma t i on and 
the lack of a suitably fibrosed pseudocyst wall.
Mo st patients undergoing external drainage are 
treated within the first 6 week period and tend to be more 
acutely ill. Shatney and Lillehei (1981) however, 
considered patients in two groups; (1) those acutely ill 
whatever the apparent age of the pseudocyst; and (2) those 
stable at the time of pseudocyst diagnosis.
EXTERNAL DRAINAGE 
CYS TOGAS TROS TOMY
P R E - 196 2 
66% 
34%
P O S T - 1962 
27% 
73%
M O R T A L I T Y  
27%
6 %
TABLE 4 External v internal surgical drainage of 
pseudocysts; distribution of operations 
pre and post 1962 (Hastings et al 1975).
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These authors (Shatney and Lilehei 1981) found that 
mortality  and morbidity became independent of the timing 
of operation. Acutely ill patients had a higher mor tali ty  
than stable patients, but the incidence of complications 
was similar whether operation was performed before or 
after six weeks from the time of pseudocyst formation.
The external and internal drainage techniques already 
me ntioned constitute the ma jority of operations for 
pseudocysts but other me thods have been described. 
Doubilet and Mulholland (1953) have advocated drainage of 
the pancreatic duct via a tr ans d u o d e n a1 sphincteroplasty, 
believing that the proximal duct obstruction would be 
relieved and the collection would drain through the 
widened orifice. This technique has not proved successful.
Percutaneous d r a i nage o_f £ancr ea t_|c
The majori ty of patients require surgical drainage of 
their pseudocysts. Internal drainage, in particular, is a 
relatively safe procedure but there is still morbidity and 
mortality associated with surgical drainage. A  method of 
drainage that avoids operation but achieves resolution 
with minimal morbidity has appeal. Percutaneous drainage 
procedures may be an answer to such a problem.
The first percutaneous aspiration of a pancreatic
pseudocyst was reported by Le Dentu (1862 ). Five years
later Lucke and Klebs (1867) recorded a similar metho d of
drainage in one patient.
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Success with percutaneous techniques depends on 
accurate localisation of the collection and lack of an 
appropriate imaging modal it y was the predominant reason 
why this type of drainage was not vigorously pursued until 
recently.
Wiechel et al (1971) described a small group of 
patients in w h o m  fluoroscopic control was used to localise 
the pseudocyst and as a me th o d  of guiding the aspiration 
needle. The collections these authors drained were 
relatively large but with the introduction of ultrasonic 
scanning not only have smaller cysts become easier to 
localise but it was soon realised that this imaging 
technique was particularly useful as a me thod of guidance 
for percutaneous needle procedures (Holm et al 1972).
Bradley (1982) in his review of pancreatic 
pseudocysts quoted 4 authors (Andersen et al (1977), 
Barkin et al (1981), Hancke and Pedersen (1976), Mac Erlean 
et al (1980)) with a c omb ined experience of percutaneous 
drainage in thirty patients. The pseudocyst refilled 
rapidly in 21 (70%) of these subjects.
Bradley (1982) concluded "it seems unlikely that this 
technique will find an important place in the treatment of 
uncomplicated patients with pancreatic pseudocysts." 
Advances in interventional radiological techniques in the 
last decade have proved this statement wrong. A review of 
the literature (Tables 6,7 & 8) reveals almost 600
patients who have undergone some form of percutaneous 
drainage of a pseudocyst.
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A U T H O R Y E A R NUMBER
ACUTE/
CHROMIC R E S O L V E D RECUR
SUCCESS
(%)
Andersen et al 1977 8 ns 1 7 12.5%
Barkin et al 1981 8 chron i c 2 6 25%
Ge rzof et al 1979 2 acute 2 - 100%
G r o n v a 11 et a 1 1982 1 acute 1 - 100%
Hancke et al 1976 9 ns 2 7 22%
McDe rmo 11 e t a 1 1981 3 chron i c 3 - 100%
Mac Erlean et a 1 1980 5 ns 4 1 80%
TOTAL PRE-1982 
ASPIRATION ONLY
36 15 21 mean 42%
TABLE 6 Reports in literature of percutaneous aspiration
only of pseudocysts prior to 1982 detailing the 
number of pseudocysts drained, the type of the 
antecedent pancreatitis and the overall success of 
the t echn i q u e .
[ N U M B E R  = n umb er of pseudocysts
A C U T E /CHRONIC = type of antecedent pancreatitis 
ns = not specified]
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Percutaneous me thods of drainage have n ow been 
refined and modi fied to include the use of drainage 
catheters placed into the pseudocyst cavity and led out 
through the abdominal wall to allow external drainage and 
also, using a combination of percutaneous and endoscopic 
manip u l a t i o n s  to insert a catheter into the pseudocyst and 
the stomach and form a catheter " cys togas t r os t o m y1 to
achieve internal drainage (Table 8). There have been an
increasing n umb er of reports recording the experience of 
percutaneous aspiration of sterile, infected, acute and 
chronic pseudocysts using ultrasound and/or CT scanning 
as guidance. Prior to 1982 aspiration only was successful 
in 42% of patients (Table 6). This has been improved to 
success in 83% of patients following the addition of
catheter drainage techniques (Table 8).
Percutaneous aspiration, even if performed 
repeatedly, has resulted in only a small increase in
successful outcome (Table 7: post 1982). Improvement in
the results has, in the main, resulted from the use of 
prolonged catheter drainage (external or internal) with 
large diameter or multiple catheters and particularly when 
the pseudocyst has been infected. Drainage over several 
weeks or even months has been shown to be important for 
pseudocysts which communicate with the pancreatic duct 
(Henriksen and Hancke 1987).
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The increasing use of percutaneous drainage
techniques has contributed significantly to a change in 
the m a n a gem en t of pseudocysts. There is growing evidence 
to suggest that sterile collections, particularly "acute 
pseudocysts 1 can be managed by percutaneous drainage with 
the prospect of over 80% success. Infected collections 
(localised pancreatic abscesses) require a mo re aggressive 
and intensive approach (Freeny et al (1988), van 
Sonnenberg et al (1989) but successful management has been 
achieved in 90% of patients with catheter drainage. 
Patients with infected collections not resolved by 
pe rcutaneous drainage have frequently shown a significant 
improvement in their general condition so that surgical 
intervention became less hazardous (van Sonnenberg (1989). 
The use of percutaneous techniques does not preclude or 
compromise any subsequent surgical procedure but it does 
have complications. In particular, infection may be 
introduced into a sterile pseudocyst.
The results of experience of percutaneous drainage of 
pseudocysts in two hospitals and the place of this 
technique in the ma nag erne nt of patients with pseudocysts 
is discussed in Chapter 6.
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Com£_l_i_ca t^J_on£ assoc j_a_t ed wi__th ^ s e u d o c p t  formation
Pseudocyst formation is an important complication of 
acute pancreatitis with an associated mortality of between 
6 and 16% (Brilhart and Priestley 1951; Grace et al 1976; 
Hastings et al 1975 ; Hi 1 1 i s 1963 ; McConnell et al 1982 ; 
Poliak et al 1978 ; Scharplatz et al 1972 ; Thomford et al 
1969) and further complications occurring in up to 30% of 
pa t i en t s .
Problems arise as a consequence of surgical treatment 
for pseudocysts but there are also complications 
associated with untreated pseudocysts and these can be 
considered under 4 headings; 1) infection; 2) obstruction; 
3) rupture; and 4) haemorrhage (Bradley 1982).
1) Infection
Pseudocysts are generally regarded as sterile 
collections (Warshaw (1982)). When a pseudocyst becomes 
infected it should be regarded as a localised abscess. 
Such secondary infection occurs in 8-10% of pseudocysts 
but a positive bacterial culture from aspirated fluid has 
been reported in as many as 53% of collections (Shatney 
and Lillehei 1979 ). Within the base of many pseudocyst 
cavities lies necrotic tissue (Figure 7) and if this 
becomes infected there is a significant prospect that 
localised infection may be converted into a pancreatic 
abscess or diffuse retroperitoneal sepsis.
F I G U R E  7 Portion of necrotic pancreatic and peri- 
pancreatic tissue r emo v e d f r om the base of 
a large pseudocyst.
Mo r b i d i t y  is higher in patients in w h o m  the
pseudocyst is infected (Warren et al 1958) and the onset 
of sepsis is often heralded by a deterioration in the 
general condition of the patient. This clearly influences 
the choice of surgery, because internal drainage is not 
always an effective method of treating infected lesions.
2) Obstruction.
Large pseudocysts have been reported causing 
ob str uction to various adjacent structures. The most 
frequent area obstructed is the duodenum but this is 
commonly relieved by drainage of the pseudocyst.
Ob struction to the st oma ch (Folk et al 1970), oesophago-
gastric junction (Imr ie 1980 ), jejunum (Grace et al 1976) 
and colon (Jordan and Howard 1966) have been documented. 
In the situation where a pseudocyst is present in the head 
of the gland the c orrmo n bile duct is vulnerable to
compression and the resultant jaundice frequently improves 
following decompression of the collection.
A  pseudocyst may not be wholly responsible for such 
obstruction (Bradley 1982) as there may also be fibrotic 
changes around the intrapancreat ic portion of the duct 
subsequent to the effects of chronic pancreatitis (Bradley 
and Salam 1978 ). Most of the patients in w h o m  this 
complication has been reported had alcohol associated 
disease.
64
The other important structure prone to obstruction is 
the portal vein (Longstreth et al 1971; McDermott I960 ). 
Grace et al (1976) have reported a fall in portal venous 
pressure following pseudocyst decompression implying a 
direct pressure effect on the vein. Decompression of the 
pseudocyst usually relieved the portal hypertension. The 
obstructing effect of a pseudocyst can necessitate urgent 
surgery to relieve the problem.
3) Rupture
One m e c h a n i s m  of pseudocyst resolution occurs when it 
ruptures into the peritoneal cavity or into a hollow
viscus. This occurs in only a small proportion of
patients (5%, Hanna 1960) but the mortality following this 
complication is high.
Becker et al (1968) found a 40% mortality amongst
such patients and quoted a figure of 50% from previous 
literature. If the pseudocyst rupture is sudden the effect 
can be devastating, with urgent surgical intervention 
being the treatment of choice (Becker et al 1968). If the 
leakage is less dr ama tic pancreatic ascites develops 
(Brad ley 1982 ).
Rupture into bowel (Bradley and Clements 1974; 
Bradley and Clements 1975; Grace et al 1976; Hanna I960), 
biliary tract (Dalton et al 1970), pleural space (Cameron 
1978 ; Sankaran et al 1975 ) and portal vein (Zeller and
Hetz 1966) have been reported. Decompression as a result 
of rupture can precipitate rapid deterioration in a 
patient but occasionally it results in resolution of the 
collection with clinical improvement and no further
4) Ha emo r r h a g e
The reported mortality  associated with haemorrhage 
from a pseudocyst ranges from 43% (Grace et al 1976 ) to 
80% (Trapnell 1971). The most frequent source of bleeding 
is from vessels (corrmonly the splenic artery) within the 
posterior wall of the pseudocyst cavity. Clinically, a 
sudden increase in the size of the lesion and 
deter ior ation in the condition of a patient is suggestive 
of such a haemorrhagic episode (Pinkham 1945).
Instances of ha emo rrhage into the pancreatic duct 
(Leger et al 1976) causing blood loss through the ampulla 
or into the liver and bile ducts resulting in ha ema t o b i1i a 
have been reported (Dalton et al 1970, Grace et al 1976). 
A  further major source of bleeding is from the edges of a 
surgically created internal drainage st o m a . Th ere has been 
considerable debate as to whether the edges should or 
should not be sutured (Folk et al 1970, Grace et al 1976, 
Hutson et al 1973, Van Heerden and ReMine 1975).
There is no doubt that irrespective of how the stoma 
is f o rme d a secondary ha emo rrhage can occur fr om the 
lining of the pseudocyst or from the anastomosis which 
inevitably requires further surgery to control bleeding. 
Ha emo rrhage has also been reported fr om the ga stro ­
intestinal mucosa overlying a pseudocyst (Bradley et al 
1979).
The four categories detailed above account for the 
ma  jority of c omplications associated with untreated 
pseudocysts but post operative c omplications foilow i n g 
drainage procedures also cause considerable mo r b i d i t y . 
Dr ainage of the fluid fr om a pseudocyst into the st oma c h
can be inadequate treatment since it may not be an
effective treatment for the necrotic and potentially
infected tissue in the base of a pseudocyst.
Some patients who form a pseudocyst following an 
episode of severe acute pancreatitis can become 
significantly catabolic with high protein losses and
m a r k e d  weight loss (up to lib per day). Such patients 
require intensive support with parenteral
hyperalimentation. They need to be assessed frequently 
and every attempt made to stabilise their me t a b o l i s m  if 
they are to recover fr om surgical intervention in addition 
to their pancreatitis. Percutaneous needle aspiration and 
catheter drainage ma y be of the greatest value in these 
pa t i en t s .
Anaj_y^£££ o_f £££udocy^£jt f_J_uj_d
Des pite extensive literature on the subject of 
pancreatic pseudocysts there is a paucity of studies 
concentrating on analysis of the fluid.
A  summary of the literature relating to analysis of 
pseudocyst fluid is shown in Table 9.
A U T H O R SUBSTANCES ANALYSED
Aranha et al (1982) 
Baker et al (1983) 
Bradley et al (1982)
Co lhoun et al (1984) 
Freeney et al (1988) 
Frey et al (1978) 
Goke et al (1989) 
Kane et al (1983) 
Karl son et al ( 1982 ) 
Kimura et al (1982)
Kj aergaar d et al (1984) 
Kul igo wska et al (1985) 
Lasson et al (1989)
M at zinger et al (1988) 
Nunez et al (1985) 
Owens et al (1977) 
Schwerk et al (1981) 
Shatney et al (1979) 
Shetty et al (1980) 
Tatsuta et al (1986)
Wa r s h a w  et al (1985)
We aver et al (1982) 
Wilson et al (1990)
Amy 1 a s e 
Amy 1 ase
Amylase, lipase, trypsin, protein,
albumin, urea, creatinine, electrolytes,
calcium, phosphate, uric acid,
cholesterol
Amy 1 a s e
Amy 1 a s e
Amy 1 a s e
P h o s p h o 1ipase a2 
Amy 1 a s e 
Amy 1 a s e
Amylase, isoamylase, alkaline 
phosphatase, protein, lactate 
dehydrogenase, carcinoembryonic antigen 
Amy 1 a s e , iso amy 1 a s e 
Amy 1 a s e
Amy lase, alpha 1 antiprotease, alpha 2 
ma croglobulin, alpha 1 protease 
inhibitor, cl inhibitor, 
antithromb in, a n tichy mo trypsin , 
complement factor c3, albumin, cathodal 
trypsin, pancreatic elastase, 
pancreatic secretory trypsin inhibitor 
Amy lase 
Amy lase 
Amy lase 
Amy lase 
Amy lase 
Amy lase
Elastase, carcinoembryonic antigen,
C A  19-9
Amy lase, iso amy lase 
Amy lase, iso amy lase
Amylase, protein, albumin, lipase, 
tryptic ami dase, alpha 1 antiprotease, 
alpha 2 macroglobulin, free proteolytic 
activity, trypsin inhibitory capacity
TABLE 9 Details of reports in literature describing 
analysis of components of pseudocyst fluid,
( 1977 - 1990 ) .
The amylase content of fluid collected, either at the 
time of surgery (Aranha et al 1982 ; Baker et al 1983 ; 
Bradley 1982; Frey et al 1978; Kane and Krejs 1983; Kimura 
1982; Kjaergaa rd et al 1984; Lasson et al 1989; Owens and 
Hamit 1977; Schwerk 1981; Shatney and Lillehei 1979; 
Shetty et al 1980; Wa rsh aw  et al 1985; Weaver et al 1982;
Wi ls on  et al 1991) or percutaneous aspiration (Colhoun et
al 1984; Freeny et al 1988; Karlson et al 1982; Kuligowska
et al 1985; Matzinger et al 1988; Nunez et al 1985) is the
most frequently recorded. The range of values is
considerable but the high amylase content confirms the
pancreatic origin of the fluid (Lasson et al 1989). There 
has been no correlation between fluid amylase levels and 
communication of the pseudocyst cavity and the ductal
system. The highest levels should occur when a fistula 
ex i s t s .
As a variation on amylase estimation, the isoamylase 
pattern in pseudocyst fluid has been studied (Kjaergaard 
et al 1984; Wa r s h a w  et al 1985; Weaver et al 1982) and has 
been correlated with the pattern within serum in the same 
p a t i e n t s .
W a r s h a w  and Rattner (1985) suggested that the
amylase iso-enz yme pattern within pseudocyst fluid can 
indicate the presence of a persistent fistula between the 
pancreatic duct and pseudocyst. This observation has not 
been repeated by other workers.
The proteolytic activity within the cyst fluid has 
been assessed by Lasson et al ( 1989 ) and Wilson et al
(1991). Both these authors also measured alpha 1 
antiprotease and alpha 2 macroglobulin and Lasson et al
(1989) concluded that pseudocyst fluid was a mixture of
plasma proteins and pancreatic juice possessing a high 
proteolytic activity. These authors demonstrated that 
there was free and bound proteolytic activity and
suggested that this could be responsible for s ome of the 
c omp lications associated with pseudocysts.
Other enzymes within the fluid, lipase and trypsin 
(Bradley 1982) and p h o s p h o 1ipase (Goke et al 1989) have 
been me asured and Bradley (1982) reported a detailed 
analysis of several parameters (Table 9) within 15 
s p e c i me ns of pseudocyst fluid and he c omp ared these with 
the values in a sample of serum withdrawn around the time 
the fluid was collected. As expected the amylase, lipase 
and trypsin values were all greater in pseudocyst fluid.
In the present attempt to differentiate between acute 
and chronic pseudocysts and to find a marker which may 
reflect the severity of the inflammatory reaction, acute 
phase reactants, alpha 1 antiprotease, alpha 2 
macroglobulin, interleukin 6, and C-reactive protein have 
been analysed in s amp les of pseudocyst fluid fr om 12 
patients. The results are discussed in Chapter 7.
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S UMMARY
The development of a pancreatic pseudocyst is a 
serious complication of acute pancreatitis. Associated 
problems are common and many patients are very ill. The 
process that allows collections to form is poorly 
understood and the natural history of this aspect of the 
disease requires further clarification. The majority of 
reports on the subject have been retrospective reviews 
conducted over several years because the occurrence of 
pseudocyst is infrequent. Based predominantly on 
prospective data this thesis sets out to examine current 
concepts regarding the management and treatment of 
pancreatic pseudocysts.
CHAPTER 2 
PATIENTS AND METHODS
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INTRODUCTION
To fulfil the objectives of this thesis, 4 related
studies have been performed involving 4 groups of
pa t i en t s : -
1. A  group of 100 patients with pseudocysts who
presented at Gl asg ow Royal Infirmary over a 
period of 23 years (1962-1984). The majority 
(87) of these patients developed their 
collection following an episode of acute 
pancreatitis (Chapter 3). The pseudocyst 
resolved spontaneously in 22 patients and the
clinical differences and final outcome in these
patients are compared in detail with those in 
w h o m  the pseudocyst was drained surgically 
(Ch a p t e r 4 ) .
2. Twenty nine patients from three cities Leeds, 
Bristol and Glasgow who developed pseudocysts as 
a result of acute pancreatitis and who were 
studied p r o s p e c t i v e1y as part of a trial of 
therapeutic peritoneal lavage used as a me t h o d 
to treat severe acute pancreatitis (Ch a p t e r 3 ) . 
A  pseudocyst resolved spontaneously in 15 of 
these patients and they are also considered in 
detail in Chapter 4.
3. A  group of 21 patients who had their pseudocyst 
drained by percutaneous needle aspiration 
or catheter drainage (Chapter 5).
4. Twelve patients from w h o m  samples of pseudocyst 
fluid have been collected and analysed for acute 
phase reactants (Chapter 6).
Details of the patients and methods relating to the 
100 patients studied in Glas gow Royal Infirmary and the 29 
from Leeds, Bristol and Gl as gow are given in the present 
chap t e r .
100 PATIENTS W I T H  PSEUDOCYSTS PRESENTING TO G L A S G O W  ROYAL 
INFIRMARY BETWEEN 1962 A N D  1984 .
There are few prospective studies of patients who 
develop pancreatic pseudocysts following acute
pancreatitis. In order to establish the natural history of 
this complication details of 100 patients with pancreatic 
pseudocysts presenting consecutively to Glas gow Royal 
Infirmary between 1962 and 1984 have been reviewed. 
Fifteen patients from the period 1962 until 1971 were 
do cum ented retrospectively. Details of episodes of acute 
pancreatitis have been documented p r o s p ec tive1y , as part 
of a continuing study of this disease and the associated 
complications, in the other 85 patients since 1971. The 
100 patients represent approxi ma tely 7% of the total 
number of patients with acute pancreatitis recorded in the 
one institution over a 14 year period (1971-1984) (Table 
10 ) .
In conjunction with Mr C  W  Imrie and Miss L Buist 
details of this 100 patients have been published 
(Imrie C  W, Buist L & Shearer M  G  1988) (Appendix 1).
Eighty seven patients developed a pseudocyst after an 
episode of acute pancreatitis and in the other 13 the 
pseudocyst was associated with chronic pancreatitis.
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Twenty eight patients were referred from other hospitals 
either for further investigations to confirm the presence 
of a pseudocyst or for surgery for a previously diagnosed 
collection. In 23 of these patients the pseudocyst 
followed acute pancreatitis and 5 had been investigated 
for symptoms of chronic pancreatitis.
Seventy of the patients were male with a median age 
of 40 years (range 19-77 years). The 30 females had a 
m e d i a n  age of 49 years (range 21-78 years) (Table 10).
M E T HODS
The hospital records for all patients were reviewed 
personally and a detailed proforma relating to the 
development of the pseudocyst completed. The official 
records for 12 patients documented retrospectively between 
1962 and 1971, or referred from another hospital, were 
untraceable. However, extracts from their notes had been 
preserved giving limited information for these 12 
pa t i en t s .
F ro m  1971, details of patients presenting with acute 
pancreatitis or associated complications have been 
recorded prospectively on separate proformat a. All the 
relevant files have been reviewed. Despite at least two 
sources of data for the ma jority of patients, s ome 
information was occasionally lacking, particularly in 
relation to timing of development and resolution of a 
pseudocys t .
A summary of the information for each patient was 
entered into a computer data file to aid analysis. A 
transcript of the file is given in Appendix 2.
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2 9 PATIENTS W I T H  PSEUDOCYSTS F R O M  GLASGOW, LEEDS A ND 
BRISTOL.
The information relating to patients discussed in 
this section was collected during participation in a 
m u l t i - c e n t r e  trial of therapeutic peritoneal lavage for 
severe acute pancreatitis. The results of the trial have 
been published (Corfield et al 1985 ; Mayer et al 1985 ) 
(Appendix 1). During this study information was recorded 
f r om 418 patients with acute pancreatitis from 24 
hospitals (Ap pendix 3). Co nsideration of the data has 
allowed, not only an appraisal of the effect of therapy on 
patients severely ill with pancreatitis, but also a 
detailed analysis of delayed complications of acute 
pane r ea t i t i s .
Twenty nine of 418 patients with acute pancreatitis 
developed a pseudocyst, an incidence of 7% for the whole 
study. There were 15 male (median age 45 years; range 21- 
77 years) and 14 females (median age 61 years; range 
30-78 years).
All hospital records and trial prof oma ta for these 29 
patients have been reviewed personally. Details were again 
entered into a computer data file and a transcript of the 
data is given in Appendix 4.
M E T H O D S :
O RGAN I S A T I O N  OF TRIAL THERAPEUTIC PERITONEAL LAVAGE IN 
PATIENTS W I T H  SEVERE ACUTE PANCREATITIS
In order to study the effect of treatment on
patients with severe acute pancreatitis a mu 1t i-centre 
trial was necessary because no single centre could
provide a sufficient number of severely ill patients
within a reasonable period.
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It was also necessary to document as many 
patients with acute pancreatitis, of all degrees of 
severity, as possible. The trial was commenced in Leeds 
and Bristol in September 1981 and Glasgow patients were 
entered from October 1982. A standard proforma was used 
(Appendix 5) and within each centre a coordinator 
collected the data. Clinicians throughout each city were 
requested to notify all patients with acute pancreatitis 
to the coordinator and, from the three centres a total of 
24 hospitals cooperated with the study (Appendix 2).
Mr A.P. Dickson acted as the first trial 
coordinator in G l a sg ow  from September 1982 until July 
19 83. The patients (51) documented during this period have 
been included with those collected personally fr om Au gust 
1983 until July 1984 (95 patients).
The criteria for diagnosing acute pancreatitis were, 
a relevant clinical history and course (acute abdominal 
symptoms: pain, tenderness, vomiting) and an elevated
serum amylase >1200 IU/1 (Phadebas technique). All 
patients included in this analysis fulfilled these 
criteria.
After referral, patients were visited as soon as 
possible by the coordinator (usually between 12 and 36 
hours after admission) and the trial proforma completed. 
The patients were visited regularly throughout their 
hospital stay and the proforma updated. The trial design 
is shown in Table 11.
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TABLE 11
DIAGNOSIS OF 
ACUTE PANCREATITIS
ASSESSMENT OF SEVERITY 
C L I N I C A L  + CRITERIA +/- DIAGNOSTIC LAVAGE
GRADED
SEVERE
N O  INTERVENTION 
A L L  PATIENTS 
R E C O R D E D  A N D  
FO L L O W E D  UP
I
ST A N D A R D  THERAPY
CONTROL LAVAGEI
STANDARD STANDARD
THERAPY THERAPY +
(TABLE 13) LAVAGE
(TABLE 14)
Protocol for trial of therapeutic lavage in severe 
acute pancreatitis showing the patient selection 
and assessment process.
CONSIDERED FOR 
INCLUSION IN TRIAL
RANDOMISED TO
The degree of severity of acute pancreatitis was 
determine d by :-
1 ) clinical assessment
2 ) m u l tiple  laboratory criteria (Osborne et al 
1981) (Table 12)
3) diagnostic peritoneal lavage (Table 13,
Figures 8 and 9 ) (McMahon et al 1980).
Clinical assessment and mul tiple criteria results 
were available for all patients studied. In Glasgow, 
m u l ti ple factor grading was the preferred method of 
assessment and diagnostic lavage was performed in only 
30% of patients compared to over 90% in both Leeds and 
Br i s to 1 .
M A N A G E M E N T
All the patients where managed in the same standard 
manner and, in addition, 7 patients randomised to receive 
active treatment were given therapeutic peritoneal lavage.
Standard t^he r_apy £eg hmen
This consisted of intravenous fluids, adequate 
analgesia and measurement of hourly urine output (Table 
14). Nas ogastric aspiration was used if vomiting was 
present and controlled oxygen therapy was administered if 
arterial partial pressure of oxygen was less than 60 rrmHg 
(8 pKa ) at any time. Central venous pressure was 
mo nitored if urine output (<3 Om 1/hour) indicated i mp ending 
renal failure thereby necessitating a mo re accurate 
assessment of fluid balance.
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F I G U R E  8 Peritoneal dialysis catheter (Trocath, 
McGraw-Hill). Three components: trocar
needle, catheter, extension tube.
2FIGURE 9
lavage fluid
3 4 5 6 7
t
free fluid
Refe re nce fluid colour chart for assessment 
of free and post lavage ascitic fluid.
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Z!l£E£R£El.:LS: EE£.i_££IL££l lavage
Seven patients initially assessed as having severe 
acute pancreatitis were considered for inclusion in the 
lavage trial. These patients were randomised to lavage or 
control groups and informed consent obtained (Table 15). 
R a ndom is ation was achieved by referral to instructions in 
randomly allocated numbered envelopes provided by an 
independent statistician.
The man agement outlined above applied to the time the 
patients were in hospital with acute pancreatitis. The 
managem en t of patients subsequent to pseudocyst formation 
is discussed later (Ch a p t e r 3) .
STATISTICAL METHODS
When indicated statistical significance was assessed 
by the Mann Whit ney test for non-paramet r i c data and the 
chi-squared test incorporating Yates' correction.
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INFORMED CONSENT
N O  CONTRAINDICATIONS (previous abdominal surgery) 
N ASO G A S T R I C  TUBE INSERTED 
U R I N A R Y  CATHETER INSERTED
PERITONEAL DIALYSIS CATHETER INSERTED U N DER LOCAL 
A N A E S T H E S I A (Table 13)
R E T U R N  FLUID ASSESSED
LAVAGE:- HOURLY CYCLES
2 LITRES OF DIALYSATE 
POTASSIUM 4rrmo 1 IN EACH LITRE
HEPARIN 250 IU IN EVERY FOURTH LITRE
D ISCO N T I N U E D  IF a) FLUID CLEAR
OR  b) AFTER 7 2 HOURS
TABLE 15 Protocol for patients randomised to receive 
therapeutic peritoneal lavage.
CHAPTER 3
RESULTS FOR 100 PATIENTS FROM 
GLASGOW ROYAL INFIRMARY
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INTRODUCTION
This chapter considers the natural history of 
patients with pancreatic pseudocysts based on the clinical 
information relating to 100 patients from Gl asgo w Royal 
Infirmary. The results for 29 patients from Leeds, Bristol 
and Gl a s g o w  have been analysed in a similar manner and are 
presented in Chapter 4.
The total of 129 patients constitutes one of the 
largest recorded studies of patients with pancreatic 
pseudocysts in the relevant wo rid literature.
100 PATIENTS FRO M  G L A S G O W  ROYAL INFIRMARY 
Di agnos i s
The diagnosis of a pseudocyst was based on a 
combination of clini_cal, * an(3 rad i o 1 og i ca 1
information. The incidence of the most important 
clinical signs and symptoms are noted in Table 16. The 
results are given as a percentage of the total results 
available for each parameter and compared with results 
f r om the literature. All the par ame ters noted below relate 
to the point when a diagnosis of pseudocyst was being 
considered and not to the onset acute pancreatitis.
Pa i_n
Re current or persistent abd om inal pain foilow i n g an 
episode of pancreatitis, was the most common symptom 
recorded in 89% of patients. It was this symptom that led 
to further investigations in the ma jority of patients. 
The pain was located predominantly in the upper abdomen 
and epigastrium.
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SY M P T O M  
Pa i n
Tendernes s 
N a u s e a /vomi ting 
Ma s s
An o r e x i a
Abdominal distension 
Pyrexia (>37.5°C) 
Jaundice
LITERATURE R E V I E W  
INCIDENCE (%)
RANGEMEDIAN
86
64
60
54
47
44
32
11
63-100
47-100
14-78
18-96
5-83
36-50
10-81
4-48
RESULTS FOR 
100 PATIENTS 
M E D I A N  (%)
89
69
39
59
35
22  
21 
12
Elevated ser um amy lase 61
(> upper limit of normal)
Leukocytosis 48
(>10x l O ^ c e11s /1)
11-100
28-90
79
42
TABLE 16 Incidence (median %) of symptoms, signs, raised serum 
amylase and leukocytosis in 100 patients with 
pseudocysts from Glasgow  Royal Infirmary compared to 
cumulative results from relevant literature.
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Tender n e £ s
Tenderness on abdominal examination was found in 69% 
of patients, all but two of w h o m  also complained of pain. 
The tenderness, as with pain, was most marked in the upper 
a b d o m e n .
Ma s s J_ ££i_ga£_t£ic fullness
The presence of a discrete mass or fullness in the 
e p i g as tr ium on abdominal examination, was documented in 
59% of patients. A  mass was palpable in only 1 patient in 
w h o m  the pseudocyst diameter (by ultrasound) was less than 
6cm. In contrast, 64% of those with a m i n i m u m  diameter of 
7cm, as demonstrated by ultrasound scanning, had a 
clinically palpable m a s s .
Correlation between the diameter of the lesion and
v o 1ume of fluid present is difficult to assess, as the
volume was only measured in 11 patients at the time of
surgery. On the available evidence, a collection 
containing approximately 1 litre had one diameter of at
least 10 c m .
Py r ex i a
A  pyrexia (>37.5°C) was noted in 21% of patients at 
the time of pseudocyst diagnosis. The pseudocysts in these 
patients all followed an episode of acute
pancreatitis and in 80% of those with a pyrexia the
diagnosis of a pseudocyst was made during the same 
a dm ission as the pancreatitis.
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Nau£ea and vomiting
Nausea and vomiting were noted in 39% of patients. 
In 3 patients this s ymp t om resulted fr om signi f icant 
duodenal obstruction which required a by-pass in the form 
of a gastroenterostomy. The symptoms of nausea and 
vomiting per se, were not specifically related to the size 
of the pseudocyst.
We j_gh t_ J_o££ J_ Anorexi_a
Weight loss was specifically documented in only 35% 
of all subjects.
Abdomi na 1 d i s tens i on
Diffuse abdominal distension caused by intestinal 
gas or intraperitone a1 fluid was noted in 22% of 
patients. It was often difficult to differentiate between 
the presence of a mass and distension resulting from 
intestinal gas. A  prolonged paralytic ileus (persisting 
for more than 5 days) was noted in two of these patients.
Laboratory £n£o£ma_t£on 
Jaundyce
Obstruction to the common bile duct and subsequent 
jaundice is a recognised c omplication of pseudocysts, 
usually associated with collections situated around the 
head of the pancreas.
The presence of jaundice (serum bilirubin
>30 u m o l /1.) at the time of diagnosis was recorded in 
12% of patients. The pseudocyst was centred around the 
head of the gland in 66% of these patients and in the body 
of the gland in the remainder.
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Jaundice was associated with gallstone induced 
pancreatitis in half these patients and with alcohol in 
the other 50%.
Se ru m amylase was measured in 8 2 and urine amylase 
in 37 patients at the time of pseudocyst diagnosis. In 
the early part of the study (1962 - 1970) serum amylase 
was recorded in Wohlgemuth units (6 patients). Although 
not directly comparable, a value of greater than 10 
units was regarded as elevated and one of more than 40
units was equated to a level of 1200 IU/1 as me asu red by
the Phadebas method (normal range 70-300 IU/1).
^XE£E£m Xi£££E£}££ U-U was found i_n 64 XZZZi.
patients consisting of 30 (36%) with a value greater than
1200 IU/1 and a further 34 (41%) with values between 300
and 1200 IU/1. The frequency of a raised amylase
associated with pseudocysts in the published literature 
varies fr om 11 to 100% (Table 16).
Twenty five of the 37 patients in w h o m  the urine 
amylase was also measured had levels greater than 
1300 IU/1 (the upper limit of the normal range for the 
Biochemistry laboratory at Glasgow Royal Infirmary) with 
17 (68%) of these being greater than 3000 IU/1. Only
three patients with an elevated urine amylase had a serum 
amylase within the normal range (70-300 IU/1).
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Leukoc^t^o£i_£
The white blood count was raised above 
9
10x10 cells/1 in 42% of patients. Twelve patients (12%)
had a level greater than 15 x 10^ cells/1 and 7 (7%),
9
greater than 20x10 cells/1. As with the amylase levels, 
the reported occurrence of a leukocytosis (40%-90%) 
associated with pseudocysts varies considerably in the 
literature (Table 16).
Ra d i o J_o g i_c a 1_ information
A  bariu m meal with lateral erect views to show 
gastric, duodenal or colonic displacement, was performed 
in 30 patients and significant gastric displacernent was 
detected in 29 subjects. In the one exception the barium 
study was misleading as it was interpreted as showing a 
gastric carcinoma with extensive submucosal involvement. 
At subsequent surgery a large pseudocyst, distorting the 
stomach was found and drained. There was no evidence of 
any intrinsic gastric lesion.
Since 1970 ultrasonic scanning has bee ome the 
diagnostic method of choice for pancreatic pseudocysts. In 
the present study, at least one ultrasonic scan was 
performed in each of 77 patients. The dimensions of the 
pseudocyst were recorded in 66 examinations (85%). In the 
other 11 patients no corrment was made with regard to the 
size (1) of the pseudocyst, or the radiologist simply 
described the pseudocyst as "small" (4) or "large" (6). 
Such descriptive terms are inadequate since, with current 
ultrasound ma chines, it requires very little effort to 
make accurate measurements of a fluid collection while a 
scan is being performed.
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In the r ema ining 2 3 patients in wh om ultrasonic
scanning was not used as the diagnostic method, no size
for the pseudocyst was recorded in 19 patients, in 3 it
was described as "small" and "large" in 1.
In addition to ultrasound, Computerised Tomographic 
scanning was employed in 7 patients in order to establish 
a diagnosis of pseudocyst.
Time _to d i_agno£i_£ o f_ £ s e u d o c p t
The med ia n time from acute pancreatitis to the 
establishment of the diagnosis of a pseudocyst was 27 
days. The range in time was considerable (4-479 days) 
(Figure 10). The time was calculated from the onset of 
acute symptoms until the time a collection was confirmed 
by radiology (barium meal, ultrasound or CT scanning) or 
operation. In patients who had a measureable fluid 
collection around the pancreas demonstrated by ultrasound 
at an early stage (within 10 days of acute pancreatitis) 
and subsequently had further confirmation of pseudocyst 
formation (repeat scanning or surgery), it was considered 
valid to regard the earlier period as the time to 
diagnosis despite the fact that a fibrous, granulating 
wall may not have formed within the earlier period. 
Patients who developed transient peripancreatic fluid 
collections following acute pancreatitis have been 
excluded from this thesis.
TIME TO
DIAGNOSIS
(days)
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* = median
FIGURE 10 Graph illustrating the distribution of the 
time from acute pancreatitis until 
diagnosis of a pseudocyst.
Glasgow Royal Infirmary patients.
Complete information to allow an accurate assessment 
of a definitive formation time was only available in 67 
patients. The majority of pseudocysts were diagnosed 
within four weeks. The considerable variation in the time 
to development of a pseudocyst is a corrmon finding in 
other studies of patients with pseudocysts. The majority 
of reports indicate that when there is a high proportion 
of patients with alcohol induced disease the time from a 
preceding episode of acute pancreatitis until confirmation 
of a pseudocyst is often difficult to determine.
S i te o£ Pseudocyst
The site of origin of a pseudocyst in relation to the 
pancreas as determined by ultrasound scanning or at 
laparotomy was from the body of the gland in 42% of 
patients, around the head in 25%, at the neck in 22% and 
in the tail in 11%.
AE T I OLOGY
The principal aetiological factors responsible for 
the preceding acute pancreatitis are shown in Table 17. 
Alcohol was the cause in 59 patients; gallstones in 27; 
trauma in 4 ; operation in 1; and in only 9 did the cause 
remain undetermined.
Four patients had both gallstones and alcohol as 
potential causes of their acute pancreatitis. In two of 
these patients gallstones have been regarded as the 
predominant factor and conversely alcohol in the others.
A E T IOLOGY NUMBER OF  PATIENTS
MALE FEMALE TOT
A1coho 1 49 10 59
G a 11s tones 13 14 27
Unknown 6 3 9
Trauma 2 2 4
Post operation - 1 1
TOTAL 70 30 100
TABLE 17 Aetiology of antecedent acute
pancreatitis in 100 patients 
from Glasgow Royal Infirmary 
who developed pseudocysts.
4 patients had both
gallstones and alcohol as 
aetiological factors.
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AJ_coho j_
In common with previous studies, alcohol was
the predominant aetiological factor 59 (%) and this group
comprised ma inl y young men (49) (median age 37 years: 
range 21-62 years). The 10 females had a median age of 
49 years (range 21-58 years). All these patients 
admitted to drinking significant quantities of alcohol on 
a regular basis (estimated m i n i m u m  of 80g alcohol per
day). Eleven (19%) had recurrent episodes of severe 
abdominal pain and were regarded as having chronic
pancreati t i s .
Ga 1 lstones
Twenty seven patients (27%) had gallstone induced 
pancreat i t i s . Th e me dian age of the 13 ma les (55 years, 
range 36-77 years) was greater than that of the 14 
females (48 years, range 30-74 years). The presence of 
gallstones was confirmed at the time of pseudocyst
drainage in 26 (96%) patients although only 7 had
concomitant biliary tract surgery (cholecystectomy in 5 
and cholecystostomy in 2) .
The remaining patient had gallstones identified by 
oral cholecystography during follow up.
Nineteen of the 27 patients with gallstones 
ultimately had biliary tract surgery. No record of such 
surgery was found in the other 8 subjects.
On e patient later developed chronic pancreatitis 
because of recurrent bile duct stones which developed 
after a cholecystect omy .
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Tr auma t^ i_c
The pseudocysts were post traumatic in origin, 
in 4 patients. All 4 suffered blunt abdominal injuries 
associated with road traffic accidents.
Post o^erat W e
On e patient developed a pseudocyst as a result of 
pancreatitis foilowing an elective cholecystectomy at 
which a p e r -operative cho langi ogram was performed and the 
common bile duct was deemed to be free of stones.
Id i o p a th i c
The aetiology was regarded as being of an idiopathic 
nature in 9 (%) patients. All of these patients had
biliary tract investigations, ser um c a 1c i um
estimations and the majority (6) had negative viral 
serology and blood lipid estimations. Repeat 
investigations were performed in 5 patients during a 
follow up period but there was no uniformity to these 
investigations because the patients were under the care 
different consultants.
One male patient suffered repeated episodes of 
pancreatitis and developed chronic pancreatic pain. An 
ERCP demons trated duct changes consistent with a diagnosis 
of chronic pancreatitis. He denied any alcohol intake and 
no other specific cause was found despite repeated 
investigations.
OUTCOME
The pseudocyst resolved spontaneously in 22 patients 
(22%). In a further 6 patients there was evidence of 
resolution of a pseudocyst at a ti me prior to the event 
noted for this analysis. All six required surgical 
drainage of the second or recurrent pseudocyst. These 28
patients are discussed further in Chapter 5.
Surgical drainage was performed in the other 78 
patients (78%).
Twelve patients died (mortality 12%), all of w h o m  
developed their pseudocysts following an episode of acute 
paner ea t i t i s .
PATIENTS UNDERGOING DRAINAGE OF A  PSEUDOCYST
Drainage procedures were performed in 78 patients 
(Table 18).
The most corrmon procedure was a posterior 
cystogastrost omy , p e r f o rme d in 47 patients. In every 
patient the st oma 1 edges of the st oma c h we re sutured to
the fibrous wall of the pseudocyst.
An accurate me a s u r erne nt of the interval fr om the 
episode of acute pancreatitis until surgical intervention 
was available in 34 of these patients (68%). The median 
time to surgery was 86 days (range 15-482 days) (Figure
11). The range for the time to surgery is considerable, 
but no patient had a further documented episode of 
pancreatitis in the interim period.
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FIGURE 11 Graph illustrating the distribution of the 
time from acute pancreatitis until surgical 
drainage of a pseudocyst. Points grouped 
according to the type of operation 
performed.
Glasgow Royal Infirmary patients.
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The patient in w h o m  the time to surgery was 
estimated to be 482 days had alcohol as the aetiology of 
his pancreatitis and may well have experienced further
minor episodes of acute pancreatic inflamma tion without 
attending hospital or his general practitioner.
Eight patients had a cystogastrost omy p e r f o rme d
within 6 weeks from a diagnosis of pancreatitis. In all 
eight, at the time of operation, the pseudocyst wall was 
regarded as adequately thick ("mature") to allow a 
cys togas t ros tomy to be performed safely . Two of these 
eight patients (25%) died however, both as a result of 
secondary haemorrhage.
Three (7%), of the other 42 patients undergoing
cystogastrost omy six we eks after their acute pancreatitis, 
died (Table 19). All three (patients CM, JW, W C  in Table 
20) had been re-admitted electively for surgical drainage 
of their pseudocyst. The cause of death in each is noted 
i n Tab 1e 2 0.
Exte_rnaJ_ drainage
Eleven patients had the pseudocyst dealt with by
laparotomy and external drainage with tube drains. The 
median time to operation in the 10 patients for w h o m  
accurate data was available was 34 days (range 9-248 
days) (Figure 11). The four patients treated surgically 
after 47 days had been discharged following the acute 
episode of pancreatitis and rea dm itted with recurrent 
symptoms. The pseudocyst was then diagnosed and treated. 
Two of the five patients whose pseudocyst was drained 
after six weeks died compared to 3 of the five drained 
within six weeks (Table 19).
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O P E R A T I O N
Cys togas t ros tomy 
External drainage
TIME TO SURGERY F R O M  ONSET 
OF ACUTE PANCREATITIS
< 6 WEEKS 
2/8 
3/5
> 6 WEEKS 
3/42 
2/5
TABLE 19 Number of patients who died related to the
time from acute pancreatitis to surgery 
(before or after 6 weeks) and to the type 
of surgery performed.
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In all of these patients the surgeon considered 
external drainage to be the appropriate procedure because 
of the clinical condition of the patient . All were 
extremely ill at the time of surgery, and three of the 
five who had their operation within six weeks of onset of 
their pancreatitis had developed multiple organ failure 
prior to surgery (Table 20). The poor outcome was more a 
reflection of early disease severity and was not
necessarily related to the type of operation performed.
DistaJ_ £ancreat_j_£ £e^ectj_on
A  distal pancreatic resection was performed in 
eight patients. In each of the subjects the cavity was in 
the tail of the pancreas and the pseudocysts were small 
(<6cm m a x i m u m  diameter). There were no serious post 
operative problems in these patients. This type of surgery 
has a limited place in the management of pseudocysts but 
can be curative in selected patients.
Four of these pseudocysts in the tail of the pancreas 
occurred in patients with chronic pancreatitis, an 
important factor in determining the outcome.
Cys t o^e j^unos t omy |Roux en Y)_
Drainage into a Roux loop of jejunum was 
performed in 7 patients. In one, the procedure was 
c omb ined with a cystogastrost omy because a bilocular 
pseudocyst extended across the head and body of the gland.
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One patient from this group died (mortality 14%) as 
a result of sepsis (Table 20). In the other 6 there was
no evidence that the loop had beeome detached from the
pancreas as has been previously reported (Trapnell 1971, 
W a r s h a w  and Rattner 1985). Two of these patients had 
associated chronic pancreatitis and one subsequently c ame 
to a total pancreatect omy because of continued chronic
pain.
Cy stoduodenost omy
The pseudocyst was drained into the duodenum in 
three patients. This method of drainage was chosen 
because the collection, in the head of the gland, was in 
close proximity to the duodenum and a direct route of 
drainage was favoured.
In one patient, cystoduodenostomy was combined with 
a cystogastrost omy because of the bilocular nature of the 
cyst in the head and body of the gland. There were no
major complications associated with cystoduodenostomy.
a t^ 2.££££Ojt omy_
Four patients were treated by simple aspiration of a 
pseudocyst in the head of the gland at the time of 
laparotomy. In one, the pseudocyst had encroached upon the 
duodenum to such an extent that a gastroenterostomy was 
performed. This pseudocyst had been diagnosed by 
ultrasound and was 8cm in diameter. At the time of the 
laparotomy it had reduced considerably, and only a small 
quantity of fluid was aspirated.
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In a further patient in this group, the drainage 
procedure was combined with a transduodenal 
sphincteroplasty in an attempt to improve the drainage of 
the pancreatic duct. A  third patient developed a second, 
larger pseudocyst 7 months after aspiration of the 
original one. This second lesion was successfully drained 
by a c y s t o g a s t r o s t o m y . In the final patient in this group, 
aspiration alone proved successful in dealing with the 
p r o b 1 em without further intervention being necessary. All 
four patients had alcohol associated pancreatitis.
In patients with small localised pseudocysts simple 
aspiration at laparot omy has been surpassed by 
percutaneous ultrasound guided aspiration which avoids the 
necessity of a formal operation.
Percutaneous a£Ei_EE.jLL£!l
N o n -o p e r a t i v e , percutaneous needle aspiration under 
ultrasound guidance was used to drain the pseudocyst in 5 
patients. Prolonged catheter drainage was attempted in 
one of these patients. In three subjects the collection 
refilled within 4 weeks (range 10-28 days) and surgery was 
required. External drainage was used in one patient and a 
cystogastrostomy in the other two. Therefore, percutaneous 
drainage alone was successful in only 2 patients. Neither 
had any subsequent evidence of refilling of a pseudocyst.
This method of drainage is discussed in more detail 
i n Ch a p t e r 6 .
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MORTALITY AND MORBIDITY
Twelve patients died because of their pancreatic 
pseudocyst. Details of these patients are given in Table 
20. One patient died prior to elective drainage of a 
recurrent pseudocyst. He had experienced a second severe 
episode of pancreatitis culminating in the appearance of 
his second pseudocyst two years after the original lesion. 
He was admitted for elective drainage and became pyrexial, 
jaundiced and developed a leukocytosis. On the evening 
prior to operation he suffered a circulatory collapse and 
resuscitation was unsuccessful. Acute pancreatitis and a 
pseudocyst were confirmed on post m o r t e m  examination. 
There was no evidence that the pseudocyst had ruptured and 
it is possible that the cause of his deterioration was 
related to a septicaemic event in association with the 
paner ea t i t i s .
The other 11 patients who died all had surgical 
drainage of their pseudocysts. Five patients were treated 
by cystogastrostomy (mortality 10%), five underwent 
external drainage (mortality 45%) and one a 
cystojejunostomy (mortality 14%) (Table 20). There were no 
significant differences in the mean times from operation 
to death for each operation.
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Cau£e of death: Sepsis
The major factor contributing to death was sepsis
which occurred in 8 of the 12 patients who died. It was 
noted in three patients in association with haemorrhage 
and was present in a further 5. In four of these patients 
septicaemia was manifest following a drainage operation. 
Three had undergone external drainage of sterile 
pseudocysts but culture of fluid fr om the drains 
subsequently grew pathologically significant bacteria in 
all three. A  fourth patient underwent a cystojejunostomy 
but his condition deteriorated because of continued 
intraperitoneal sepsis and pneumonia. The median time from 
operation to death in patients with sepsis was 26.5 days 
(Table 20) and these patients remained seriously ill
throughout their post operative period. Four of these
patients had gallstones as the aetiology of their acute 
pancreatitis (Table 20) but none had bj_j_j_a£y tract surgery 
concomitant with d £a j_n a ge . It is now considered
that the failure to eradicate stones for the biliary tree 
is a serious threat to local and generalised sepsis in 
such patients ( Imr ie et al 1988 ).
The remaining patient in w h o m  sepsis possibly 
contributed to death was the one described previously who 
died prior to drainage of a recurrent pseudocyst. With the 
exception of this last patient, all with septic 
complications received antibiotic therapy at some time 
during their illness.
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Ga strointestinal ha emo rrhage occurred in 5 patients 
and was a major factor contributing to death in each. In 3 
of these patients the bleeding followed surgical drainage 
of a pseudocyst and originated fr om either the 
cystogastrostomy stoma or from within the pseudocyst 
cavity. This occurred despite the use of haemostatic 
s t oma 1 sutures at the initial operation. All three had 
further surgery and secondary suturing of the stoma. One 
of these three patients died 11 days after the second 
operation as a result of a further haemorrhage. A  second 
patient developed multiple retroperitoneal abscesses and 
required six further operations to drain pockets of pus. 
He wa s treated in an intensive care unit for mo s t of his 
illness and eventually his abdominal wound was left open 
and packed but he succumbed from multi-organ failure and 
sepsis 47 days after the onset of his acute pancreatitis. 
The third patient of this group also developed septicaemia 
following a second operation to re-explore the pseudocyst 
c a v i t y . He had been referred fr om another hospital for 
treatment of established renal failure which developed 
after the onset acute pancreatitis.
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In one of the 2 r ema ining patients ha emo rrhage 
occurred as a spontaneous event associated with an 
untreated pseudocyst. This patient produced a massive
h a ema t erne sis 4 days after his pseudocyst had been
diagnosed. Upper gastrointestinal endoscopy revealed a 
large amount of clot within the stomach and a tense 
swelling distorting the antrum and duodenum. An urgent 
laparotomy was performed and a ruptured artery was found 
stretched across the internal di ame ter of the pseudocyst. 
The haemorrhage was controlled but over the subsequent 
week the condition of the patient progressively
deteriorated. He developed deep venous thromboses in both 
legs, renal failure and septicaemia, factors which
eventually caused his death.
The remaining patient in w h o m  haemorrhage contributed 
to death had severe acute pancreatitis of unknown 
aetiology. He made initial progress following the acute 
episode but developed persistent vomiting as a result of a 
large bilocular pseudocyst obstructing the duodenum. At 
operation this obstruction was relieved by draining the 
pseudocyst but within a week of surgery he developed 
haematemesis and melaena. Repeated blood transfusion was 
required to ma intain his ha emo globin at a satisfactory 
level. He was regarded as unfit for further surgery and 
he died 20 days after his operation. No post m o r t e m  
examination was performed.
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Ot^her causes of death
Three other patients died. One following a cardiac 
arrest precipitated by a my ocardial infarction on his 
first post-operative day. Coronary artery disease was 
confirmed at post m o rtem examination. The pseudocyst in 
this patient was filled with thick green fluid which was 
sterile on culture. A second patient died 4 days after 
surgery as a result of acute renal and respiratory 
failure. Post m o r t e m  examination revealed a residual 
pseudocyst, bronchopneumonia and pyelonephritis.
The third patient died because of persistent
pancreatic i n f 1 arrma t i on and a duodenal fistula following 
external drainage of a small collection in the head of the 
pancreas. It is possible that infection also contributed 
to this d e a t h .
Ot h e r com£j_J_ca^t J_on£
Ten other patients who underwent cystogastrostomy 
experienced a variety of c omplications (Table 21). 
Similarly, 3 of those whose pseudocyst was drained
externally experienced significant problems. One of the 
seven patients who had a Roux en Y cy s t oga s t ros tomy 
drainage died but there were no major complications in the 
other 6. Although the numbers are small, this type of 
drainage procedure can produce satisfactory results and is 
favoured by some surgeons. Those who had a 
cystoduodenostomy or a distal resection were without
significant problems in the post operative period. The 
complications occurring in the group of 22 patients in 
whom the pseudocyst resolved spontaneously are also
detailed in Table 21. All were relatively minor.
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M O R T A L I T Y  RELATED TO AETIOLOGY
When considered in relation to the aetiology of the
preceding pancreatitis the mo rtality figures ass ume 
considerable importance (Table 22). (Imr ie et al 1988 ). In
six (50%) of the 12 patients who died, a pseudocyst
developed following an episode of gallstone induced acute 
pancreatitis. The morta t_y^ £ej_a t_e d po phpp £.£pPRp°gX. was 
t h e r e f o r e , 2 2^ % p 6 o_f 2J_ £ £p p e£ p sP compaped po only 5% (3
d eaphpP Ppom phe 5_9^ papyenpp wyph apcohop pnduced acute 
pane r ea t i t i s . This difference was significant (p <0.05 Chi 
squared test) and may, in part, be attributed to a
difference in age of the patients with gallstone 
pancreatitis (median age of those dying 57 years, range 
52-66 years) when compared to those with alcohol
associated disease (median age of those dying 35 years, 
range 29-40 years). Two of the three deaths related to 
alcohol were caused by sepsis and/or haemorrhage. The 
third patient died of respiratory and renal failure. Of 
the 6 gallstone related fatalities, 5 were caused by 
sepsis and/or haemorrhage. The remaining patient died as a 
result of a my ocardial infarction. None o£ phe p a t i e n ts 
with gappspones had deppnpppve bpppayy pyacp pup ge_r y ap 
the time of s u r gpcap dpapnape o£ phepp £££Pp2.c y p p . It is 
possible that persistent infection within the biliary tree 
contributed to the sepsis in these patients.
A E T I O L O G Y
NUMBER OF 
PATIENTS DEATHS OO
Ga 1lstones 
A1 coho 1 
Unknown 
Tr auma
Post operation 
TOTAL
TABLE 2 2
27 6 (5M: IF) 22*
5 9 3 (3M) 5*
9 2 (2M) 2 2
4 1 (IF) 25
1
100 12
Number and percentage of patients 
with a pseudocyst who died related to 
the aetiology of acute pancreatitis.
(* significant difference between the 
mortality amongst those with an 
alcohol aetiology compared to those 
with gallstones as the cause. Chi 
squared test, p=<0.05)
(M  = ma 1 e : F = f ema 1 e )
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RE C URRENT PSEUDOCYSTS
After surgical drainage or spontaneous resolution of 
the pseudocyst, a second collection developed in 12 
patients (12%). In this group of patients the preceding 
acute pancreatitis was caused by alcohol in 7, gallstones 
in 3 , t r a uma in 1 and the aetiological factor r ema i n e d 
unknown in the remaining patient. Six of these occurred 
within four weeks of drainage of the original collection. 
The initial drainage procedure had been by percutaneous 
aspiration in 3 of these patients and cystogastrostomy in 
the other three. Four of these six patients were treated 
successfully by a cystogastrostomy on a second occasion 
and one required external drainage. The remaining patient 
required external surgical drainage 18 days after 
percutaneous aspiration. He developed major complications 
(sepsis and haemorrhage) and ultimately died.
In the six remaining patients, the second collection 
developed between 7 months and 3 years after the initial 
lesion. The first pseudocyst had been drained surgically 
in five of these patients and it had resolved 
spontaneously in the other patient. It is difficult to 
determine whether these second collections were 
recurrences of the original or new pseudocysts at a 
different site.
The second collection was treated successfully by 
cystogastrostomy in three patients, spontaneous resolution 
occurred in a further two patients and the final patient 
died on the day prior to surgery.
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SUMMARY
1. This review is an analysis of data on 100
consecutive patients with pancreatic
pseudocysts. They were unselected and form the 
major part of the experience encountered in one 
institution over a period of 23 years. A
pseudocyst formed following acute pancreatitis 
in 87 patients.
2. Seventy eight pseudocysts required drainage and
22 resolved spontaneously. The overall mortality 
was 12% and in 11 of these 12 patients surgery
was undertaken as part of their management. The 
mortality amongst patients undergoing external 
drainage (45%) wa s greater than that amo ngst 
those drained by other procedures (10%), and the 
mortality amongst patients in w h o m  surgery was 
performed within six weeks of pseudocyst 
development was greater than that of those in 
w h o m  drainage was performed following this 
peri o d .
3. Various complications occurred in a further 13
patients (13%), and a second pseudocyst 
developed in a further 12 (12%) at various
t ime s .
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4 . Only four patients suffered c omp lications caused 
by the presence of a pseudocyst (3 duodenal 
obstruction requiring gastroenterost omy : 1
g a s t r o - intestina1 haemorrhage). Delayed surgery, 
beyond 6 weeks was, therefore, found to be an 
adequate method of pseudocyst management in this 
study.
5. The complications of delayed rupture, and 
fistula formation did not occur; haemorrhage 
occurred in only one patient. This is in 
contrast to the findings of Bradley et al (1976) 
who reported that the incidence of complications 
directly related to a pseudocyst increased after 
6 weeks from the time of diagnosis and these 
authors advocated surgical drainage around this 
t ime .
6. With few delayed complications occurring beyond 
6 weeks and the median time to surgery (for 
internal drainage procedures) being greater than 
12 weeks from the time of pseudocyst diagnosis 
it is r ecorrmended that _t h £e_rj_od i_s_ a more 
appropriate waiting time before con£j_de£j_ng s ome 
form of intervention.
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7. Alcohol was the predominant aetiological factor 
(59%) initiating the acute pancreatitis which 
preceded pseudocyst formation. Gallstones were 
responsible in 27%. However, the m o r tality 
a££oci_a_ted wj_^ t h ga^^s^one induced £s eudocy_s t s
£A.£EAX.L£E!1JlJ-X. g£ea t^ e r_ than that in 
£a_tj_en_t£ wj_ t_h £seudoc^s t s f £££}££!^ after alcohol 
i_nd u ced acute REE££_£a t 2. X 5%).
8. Irrespective of the aetiology, sepsis and 
haemorrhage were the most important factors 
contributing to death in at least 8 patients. 
Sepsis associated with cholelithiasis and a 
partially obstructed biliary system are also 
important factors and on the basis of these 
results Imr i e et al ( 1988 ) have advised that 
patients forming pseudocysts as a result of 
gallstone induced pancreatitis should have 
biliary tract pathology dealt with at the time 
of pseudocyst drainage.
9. The clinical sign of a palpable abdominal mass 
correlated with the presence of a pseudocyst of 
at least 6cm diameter. Seventy four percent of 
the patients with a palpable mass had a 
pseudocyst of this size and all these underwent 
surgical drainage.
CHAPTER 4
RESULTS FOR 29 PATIENTS FRCM 
LEEDS, BRISTOL AND GLASGOW
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INTRODUCTION
The details for the group of 29 patients from Leeds, 
Bristol and Glasgow who developed pseudocysts after acute 
pancreatitis are presented in the same format as in the 
preceding chapter and the same definitions of the clinical 
features are used. This study represents one of the 
largest prospective series of patients forming a
pseudocyst after an episode of acute pancreatitis. The 
information collected in the 3 cities (Chapter 2) provided 
an unique opportunity to analyse the c omplications 
associated with acute pancreatitis.
CLINICAL FEATURES
The clinical signs and symptoms of patients at the 
time of diagnosis of the pseudocyst are summarised in 
Table 23.
ASSESSMENT OF SEVERITY OF ACUTE PANCREATITIS
In this group of 29 patients Glasgow multiple 
prognostic factors (Table 12) predicted only 10 (34%) as
being "severe" within 48 hours of admission. Diagnostic 
lavage, (Table 13. McMahon et al 1980 ) performed in 24 
patients was a better predictive procedure, but still only 
identified 13 (54%) as severe (Chapter 2). No study to
date has found a consistent indicator to predict the 
patients suffering acute pancreatitis who are likely to 
form a pseudocyst.
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NUMBER OF GRI
S Y MPTOM / SIGN PATIENTS % STUDY (%)
Pa i n 29 100 89
Tendernes s 27 93 69
Pyrexia (> 37.5°C) 18 62 21
Mas s 15 50 59
N a u s e a /vomi ting 8 28 39
Di s tens i on 9 30 22
Jaund i ce 5 17 12
Para lytic ileus 2 7 2
An orexi a 1 3 35
Hyperamy 1aseami a 
(>300IU/1 Phabedas)
22 76 77
Leukocy tos i s 23 79 42
(>10x 10 c e l l s /1)
TABLE 2 3 Incidence of symptoms, signs, raised serum amylase
and leukocytosis in 29 patients with pseudocysts 
from Leeds, Bristol and Glasgow compared to the 
result for patients from Glasgow Royal Infirmary.
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The intention of initial severity assessment, 
however, is to identify at an early stage of illness, 
those patients who are likely to become severely unwell 
and require intensive management. The formation of a 
pseudocyst is a serious buT dejjryed complication of acute 
pancreatitis and as such early assessment can not 
necessarily be expected to predict it. Estimation of 
acute phase reactants (e.g. C-reactive protein) may be 
more valuable in assessing delayed complications.
LABORATORY INFORMATION
Jaund i ce
The serum bilirubin was elevated (> 3 0 |imo 1 / 1 ) i n
on 1 y five patients (17%), three of w h o m had g a 11s tones as
the underlying cause of their acute pancr ea t i t i s . No
spec ific aetiological factor was found in the other two
( i d i opa th i c ).
Hy£er a m y 1a s e a m i a
At the time of pseudocyst diagnosis the serum amylase 
was greater than 300 IU/1 in 22 patients (76%) and greater 
than 1200 IU/1 in 11 (38%).
Leukocy tos i s
The white blood cell count was greater than
10x10^ cells/1 in 23 ( 79%) of the 29 patients with the
9
level being greater than 15x10 cells/1 in 10 (34%).
RADIOLOGICAL INFORMATION
The pseudocysts were detected by ultrasonography in 
26 patients (90%) and by CT scanning in the other three. 
This latter form of imaging was also used in three other 
patients to confirm ultrasound findings.
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Dimensions of the pseudocyst were recorded in 19 
(65%) of the 29 patients, the largest di ame ter being taken 
as the most significant. In an additional 5 (19%)
patients, the lesion was simply described as "large" which 
has been regarded as i mp lying a di ame ter of at least 5 c m . 
The remaining 5 patients did not have the dimensions of 
the pseudocyst recorded. Three of the pseudocysts in these 
5 patients were of sufficient size and clinical 
importance to warrant surgical drainage. Repeated 
ultrasonic scans showed resolution in the other two.
Following admission with acute pancreatitis, the 
median time to clear identification of a collection by 
ultrasound or CT scanning was 19 days (range 2-49 days) 
(Figure 12). Six (21%) patients had been discharged after 
the acute episode of pancreatitis without a pseudocyst 
being diagnosed despite ultrasound scanning in 4. All six 
patients developed further abdominal pain and five were 
r e a dm i 11 e d as erne rgencies at a me d i a n t i me of 14 days 
(range 3 - 2 3  days) following original discharge form 
hospital. A pseudocyst was diagnosed during the second 
admission. The remaining patient had the diagnosis made by 
a CT scan performed as an out patient.
50
40 -
30 -
20 -
10 -
CAT scanultrasound
* = median
FIGURE 12 Graph illustrating the distribution of the 
time from acute pancreatitis until 
detection of a pseudocyst by ultrasound 
or CT scanning.
Leeds, Bristol & Glasgow patients.
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A E T I O L O G Y
Fourteen (48%) of the episodes of acute 
pancreatitis were caused by gallstones, 7 (24%) by
alcohol, 1 (3%) by a proven ampullary carcinoma, and in
the remaining 7 (23%), no specific cause was found (Table
24) despite repeated investigations. The predominance of 
gallstones as the most corrmon aetiology was unexpected 
wh e n c omp ared to the results fr om the earlier Glasg ow 
Royal Infirmary study in which alcohol was, by far, the 
mo s t c onmo n causal factor.
The distribution of aetiological factors noted above 
was similar to that of all 418 patients with acute 
pancreatitis (54% gallstones: 20% alcohol: 27% idiopathic) 
(Corfield et al 1985) studied in Leeds, Bristol and 
G 1asgow.
Eleven patients (78%) with gallstones had biliary 
calculi confirmed at the time of cholecystectomy or post 
mortem. Of the other 3 (20%), two had the stones confirmed
by ERCP and the other by ultrasound scan alone.
Seven patients had alcohol induced pancreatitis. On e 
ma le patient developed acute pancreatitis foilow i n g a 
solitary bout of excess consumption of alcohol. The other 
six drank a min imum of 5 pints of beer per day (90-120g 
alcohol) on most days of the week. One patient from this 
group developed chronic pancreatitis following his 
original pancreatic pseudocyst. He ultimately required a 
distal pancreatectomy to remove a small chronic cyst from 
the tail of the gland, four years after his initial acute 
pancrea t i t i s .
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One other patient had small pseudocysts (<3.5cms) 
detected by ultrasound scan on mo re than one occasion over 
a period of three years. None of the patients with alcohol 
as the underlying cause for their pancreatitis had
evidence of gallstones.
Six of the seven patients in w h o m  the aetiology 
remained unknown had repeated imaging of the biliary tract 
without gallstones being detected, but none underwent 
E R C P . Ideally all these patients should have had this 
investigation performed.
TREATMENT
The initial, standard management for all patients
has been described earlier (Table 13). In addition, 14
patients (48%) had a period of parenteral or enteral
hyperalimentation. The duration of feeding ranged from 3 
to 44 days with a median of 8 days. Antibiotics were
administered to 23 patients (77%) at some time during
thei r ill n e s s .
The other specific treatment used was therapeutic
peritoneal lavage. This was performed as an initial
therapy in 6 patients. None of these six patients died 
compared to 2 of the 23 patients who did not receive 
lavage (Table 25). The mortality results were not 
significantly different but these two groups of patients 
were not strictly comparable. All patients treated with 
lavage were graded as having severe disease at the time of 
admission, whereas, only 7 of the other 23 were similarly 
graded. The acute pancreatitis in other 16 patients was 
categorised as mild.
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N U MBER DEATHS %
LAVAGE 6 0 0
(A11 severe )
N O  LAVAGE 2 3 2 9
N O  LAVAGE 7 1 14
(severe )
(Difference in mortality not significant, Chi-squared test)
TABLE 2 5 Number of patients and mortality in those treated 
with 48 hours of peritoneal lavage compared to the 
patients in w h o m  this treatment was not employed.
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With such small numbers it would be inappropriate to 
make firm conclusions regarding the effect of peritoneal 
lavage therapy upon the development of a pseudocyst.
OUTCOME
Eleven (38%) of the 29 patients required surgical 
drainage of the pseudocyst and there was one death 
(mortality of 9%) (Table 26).
The pseudocyst resolved spontaneously in 15 (52% of
all the patients)(discussed in Chapter 5) of the other 18 
patients, in a further 2, the collection was still present 
at the time of the last documented follow up but in both 
these patients no further admissions to hospital were 
noted over a 4 year period.
The remaining patient died without surgery, giving a 
m ortality of 5% for those without drainage.
SURGERY
Surgical drainage of the pseudocyst wa s p e r f o rme d in 
11 patients. In six, a jd o £ t^ e £ i_o r_ c y s togas t ros tomy wa s 
p e r f o rme d in a standard fashion with a st oma size of at 
least 4cm and the stomal edges oversewn. No patients died 
in this group and there were few complications.
Roux en Y  was performed in 3
patients, all of w h o m  were from Bristol. Two were treated 
in the same surgical unit reflecting a preference for this 
type of drainage. The third patient was referred to a 
surgical unit in London. She had a bilocular pseudocyst 
extending across the body and head of the pancreas. The 
Roux en Y technique was chosen to achieve adequate 
drainage of both collections.
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C Y S T O
GAST R O S T O M Y
6
TABLE 2 6
PATIENTS 
29
SURGERY
11
R OU X 
EN  Y  
3
EXTERNAL
D R AIN
2
N O  SURGERY 
18
RESOLVE
15
STILL
PRESENT
2
DIED
DEATH
1
Clinical outcome and surgical operations in 29 
patients with pseudocysts from Leeds, Bristol and 
G1asgow.
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Ex_ter_nal_ dr^a^nage of a pseudocyst was employed in two 
patients. In trape ritonea1 rupture of the pseudocyst had 
occurred in both. One of these, a 56 year old man, had 
been discharged following his acute pancreatitis but was 
r e a dm  itted 17 days later with s ymp t oms of increasing 
abdominal pain and was found to have a pseudocyst. His 
symptoms did not settle and at laparotomy (33 days after 
the onset of acute pancreatitis) the pseudocyst was found 
to have ruptured. There was a large amount of
serosanguinous fluid, with a high amylase concentration, 
within the peritoneal cavity. This was drained via large 
diameter plastic drains but abdominal packing was 
necessary to control haemorrhage encountered during the 
surgery. On remova 1 of these packs a pancreatic fistula 
became established but, over a period of 6 months, this 
gradually resolved without surgical intervention.
The second patient requiring external drainage 
initially appeared to be recovering from his pancreatitis, 
but, 21 days after the onset of acute pancreatitis, he 
developed an epigastric mass which suddenly decreased in 
size in association with severe abdominal pain, tenderness 
and hypotension. Laparotomy, at this time, revealed a 
ruptured pseudocyst with pockets of fluid in the right 
upper quadrant and right paracolic gutter. The peritoneal 
cavity was drained but p o s t - o per at ive1y the patient 
developed cardiac failure, pneumonia and suffered a 
gastro-intestinal haemorrhage, which proved fatal, 2 weeks 
after his operation. A post m o r t e m  examination was not 
performed and no source of the bleeding was identified.
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The aetiology of his acute pancreatitis also remained 
u n k n o w n . This patient was the only one who died after
surgical drainage of a pseudocyst giving a mo rtality of
9% (1 of 11 patients) for all those undergoing surgery.
However, mortal it y associated with rupture of a pseudocyst 
and external drainage was 50% (1 of 2 patients).
The m e di an time to surgery for all 11 patients was 49 
days (range 21-266 days) (Figure 13) from the time of
acute pancreatitis. Only three operations (27%) were
performed within six weeks of the detection of the 
pseudocyst and of these 2 were external drainage. The 
other early operation was a cystogastrostomy performed
without complication at 28 days.
PATIENTS W H O  D I D  NOT U N DERGO SURGERY
Eighteen patients did not have their pseudocysts 
drained. In 15 (i.e. 52% of the 29 patients with a
pseudocyst from, Leeds, Bristol and Glasgow) the 
pseudocyst resolved spontaneously. In two patients a
collection was still present and asymptomatic at the time 
when last seen at follow up. The £ema j_n j_n£ £a t^en t^ d^ed 
without undergoing surgery. This patient who died was an 
elderly lady whose initial peri-pancreatic fluid 
collection (? pseudocyst) was delineated by ultrasound six 
days after being admitted to hospital with acute 
pancreatitis. She developed several c omp lications vizi 
bilateral pleural effusions, h y p e r g1ycaemi a , renal failure 
and was regarded as unfit for surgery. Other methods of 
drainage such as percutaneous aspiration were not 
emp 1o y e d .
280 
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(days)
240 - 
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gastrostomy
cysto-
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external
drainage
FIGURE 13 Graph illustrating the distribution of the 
time from acute pancreatitis until surgical 
drainage of a pseudocyst. Points 
grouped according to the type of 
operation performed.
Leeds, Bristol & Glasgow patients.
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Her respiratory condition deteriorated and she had a 
fatal cardiac arrest on the 25th day of her illness. Post 
m o r t e m  examination confirmed acute pancreatitis with 
pseudocyst formation, and coronary artery disease.
In two patients, the pseudocyst was still present at 
the last documented follow up. In one of whom, the 
continued presence of a pseudocyst was identified by 
ultrasonic examination over a period of six months but
this patient refused to undergo surgery. He was discharged 
and no further episodes of pancreatitis were recorded 
during a follow up time of 4 years.
The second patient had a 5x7.5cm pseudocyst 
identified, by ultrasound scan, 1 mon th after her episode 
of acute pancreatitis. She failed to attend for follow 
up but no further admissions were traced over a period of 
f ou r years.
FOLLOW UP
Three of the 27 patients available for follow up
died. Two succumbed from causes unrelated to acute 
pancreatitis or pseudocyst formation and the third as a 
result of widespread me tastases fr om a n amp u 11 a r y
carcinoma which had initially caused acute pancreatitis.
Four of the remaining 24 patients experienced
recurrent abdominal symptoms. Two^ _^n whom _the £fi.^ I£floc^ s^ t 
had initial 1 £ r e£oJ_ved spontaneous developed f.ur.^h er_
cystic lesions. In one of these a second large pseudocyst 
formed in the body of the pancreas 3 years after the
first.
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This patient had gallstone induced acute pancreatitis 
and a renal adenocarcinoma was coincidentally discovered 
by ultrasound scan during his initial admission. 
Treatment of this latter condition was given priority and 
a nephre ctomy was performed. His gallbladder was not 
removed at this time. At the last noted follow up, the 
recurrent pseudocyst had refilled following percutaneous 
aspiration and surgical drainage was being considered.
The second patient with a further cystic lesion had 
alcohol induced chronic pancreatitis. He had recurrent 
chronic pain and a small cyst formed in the tail of the 
pancreas 3 years after the first episode. A  distal 
pancreatectomy was successfully performed resulting in an 
improvement of his symptoms.
Recurrent abdominal pain developed in two further 
patients both of w h o m  had a cystojejunostomy as the method 
of drainage of their pseudocysts. Both required 
readmission to hospital on at least one occasion but there 
was no evidence of a recurrent pseudocyst and neither had 
elevated ser um amy lase levels.
COMPLICATIONS
The importance of the aetiology causing acute 
pancreatitis complicated by a pseudocyst was noted earlier 
in this chapter. Amongst the present group of 29 patients 
there were no deaths in those with alcohol induced disease 
but one (7%) of the gallstone induced group died.
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Complications directly related to the pseudocyst 
itself were not common in this series but two did rupture 
spontaneously with an associated mor tality of 50%.
A  period of six weeks has been suggested as the 
op t i m u m  time to delay prior to surgery to allow the lining 
of the pseudocyst to mature  (Chapter 1). One
cystogastrostomy was performed 28 days after detection of 
the pseudocyst without difficulty and with adequate tissue 
fibrosis to effect a satisfactory drainage stoma. There 
were no technical problems with the delayed drainage
procedures .
SUMMARY
1. All 29 patients detailed in this section
developed a pseudocyst following acute
pancreatitis. They were recorded during a study 
involving 418 patients with acute pancreatitis. 
The distribution of aetiological factors amongst 
the patients with pseudocysts was very similar 
to that in all 418 patients studied. Th i s 
implies that no a e t^ i_o l^ ogy_ _i_s more 1 i k e 1 y
to result in £££HS!.££X£J: £o£ma_t j_o n . This is
contrary to the results in the world literature 
and this is the first study to show such a 
relationship. All previous studies, including 
the 100 patients from Glasgow Royal Infirmary 
noted earlier, have shown a striking 
preponderance of alcohol induced pancreatitis 
leading to pseudocyst formation.
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The higher risk of death associated with
gallstone acute pancreatitis complicated by 
pseudocyst formation (7%) compared to alcohol 
induced disease (mortality nil) was noted again 
but the numbers of patients are sma 11.
The medi an time to surgery (internal drainage) 
was 60 days (Figure 6 ). This again confirms that 
a "waiting" period of 6 weeks is inappropriately 
brief when considering the ideal time for 
i nte rven t i o n .
CHAPTER 5
SPONTANEOUS RESOLUTION OF 
PANCREATIC PSEUDOCYSTS
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INTRODUCTION
Having considered the natural history of the 
development and outcome of pseudocysts following 
pancreatitis in a total of 129 patients the present 
chapter focuses on spontaneous resolution of pseudocysts. 
The background information on this aspect of pseudocysts 
was presented in Chapter 1.
PATIENTS F R O M  G L A S G O W  ROYAL INFIRMARY STUDY
As noted in Chapter 3 spontaneous resolution of a 
pseudocyst occurred in 22 patients and in addition, in a 
further 6 a pseudocyst had resolved prior to the reference 
event recorded in the study, giving a total of 28 
patients. Details for three of the patients presenting 
between 1962 and 1971 were very limited and their official 
hospital records are now untraceable. These patients have 
been excluded from further analysis.
Sixteen of the 25 patients with sufficient 
information for analysis were male (median age 43 years, 
range 20-84 years). The median age of the 9 females was 44 
years (range 30-73 years).
D i a g n o s is
In addition to clinical and biochemical information, 
the diagnosis of a pseudocyst was confirmed by ultrasound 
scanning in 24 of the 25 patients and by CT scanning in 
the other. CT scanning was used in 3 other patients, ERCP 
in 2 and a barium meal in 6 to confirm the findings of 
ultrasonic scanning.
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Ae t_i_o l_ Acute and Chronic Pancreatitis.
Alcohol was the cause of the pancreat itis in 14 (56%) 
(12 male, 2 female) of the 25 patients : gallstones in 7
(28%) (2 ma  1 e , 5 f ema le) and in the r ema ining 4 (16%) (2
male, 2 female) no specific cause was found. The 
distribution of aetiological factors within this group of 
25 patients with resolving pseudocysts was similar to that 
in the 100 patients as a whole (chapter 3).
A  pseudocyst developed after an episode of acute 
pancreatitis in 23 of the 25 patients (92%). The other two 
were known to have proven chronic pancreatitis at the time 
their collection formed. A  further 3 patients ultimately 
developed chronic pancreatitis despite the fact that their 
pseudocysts formed as a result of their first episode of 
acute pancreatitis. Three of these 5 patients with 
pseudocysts associated with chronic pancreatitis developed 
second collections and all 5 had alcohol induced disease.
Time to Dj_agno£j_£ of_ a P£££doc^s£
The period from acute pancreatitis to the 
confirmation of a pseudocyst by ultrasound, CT scanning or 
b a r i um studies, together with appropriate clinical and 
laboratory findings has been regarded as "the time to 
d i agnos is".
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The me di an  time to diagnosis of 21 patients was 18 
days (range 4-74 days) (Figure 14). Three of the remaining 
four patients formed their pseudocysts associated with 
chronic pancreatitis. An accurate time to diagnosis was 
impossible to calculate in one subject and in the other 
two the period between a proven episode of acute 
pancreatitis and pseudocyst formation was 13 and 14 months 
respect i v e 1y .
The fourth patient in this group in which there was 
no precise time to diagnosis experienced 5 episodes of 
acute pancreatitis over a period of 9 months. The first 
episode was alcohol induced but the others were not 
related to this aetiological factor. A  pseudocyst, 5cm in 
diameter, formed in the tail of the pancreas 3 months 
after the second episode of acute pancreatitis. This 
collection resolved over a period of 2 mo n t h s . A 
pseudocyst later recurred in the tail of the pancreas and 
was removed by distal pancreatic resection (Figure 15). 
Histological examination confirmed the specimen to be a 
pseudocyst (Figure 16).
M a x imum Si_ze o_f P£££d££X£l.
The m a x i m u m  sizes of the pseudocysts in 19 patients, 
as measured by ultrasound or CT scanning are displayed in 
Figure 10. No measurements were made on the scans of the 
other 6 patients and the collections were merely reported 
as "small" (4) or "large" (2). Such poor scan reporting is 
unsatisfactory. The ma x i m u m  diameter in twelve (48%) 
pseudocysts was 6cm or greater. The median size was 7cm.
TIME TO
DIAGNOSIS
(days)
70 -
65 -
60 -
55 -
50 -
45 -
40 -
35 -
30 -
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 * 22
20 -
 *18  *18
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resolving 
pseudocysts 
(1)
patients
requiring
surgery
(2)
* = median
patients with 
resolving 
pseudocysts 
from Glasgow 
Royal Infirmary 
(3)
FIGURE 14 Graph of time from acute pancreatitis until 
diagnosis of the pseudocyst in :
1) patients from Leeds, Bristol and Glasgow in 
whom a pseudocyst resolved spontaneously
2) patients from Leeds, Bristol and Glasgow 
who underwent surgical drainage
3) those from Glasgow Royal Infirmary in 
Whom a pseudocyst resolved spontaneously
PANCREAS
WALL
FIGURE 15 Gross operative specimen of
pancreatic resection showing a 
pancreas and a pseudocyst with 
fibrosis.
PC = pseudocyst 
W A L L  = thick fibrous wall of pseudocyst
a distal 
por t i on of 
surrounding
Me asure in centi me t r e s .
FIGURE 16 Distal pancreatic resection:
Histology of the resected specimen showing 
dense fibrous tissue surrounding the 
pseudocyst cavity and no true epithelial 
1 i n i n g .
L = Lumen of pseudocyst.
Haemotoxylin and eosin xlOO.
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The sizes of pseudocysts requiring surgery are also 
displayed in Figure 17. The median diameter for these 
collections was 10cm (range 4-20cm ) but the difference
between these and the size of the pseudocysts which 
resolved was not significant (Mann Whitney test) although 
there was a trend for the larger pseudocysts to be more 
likely to require surgery.
i_n i_c a 1^ and La bo£a tory_ Info rma t i o n
Table 27 summarises the important clinical signs and 
symptoms in patients in w h o m  a pseudocyst resolved 
spontaneously and those who required surgery for their 
pseudocyst. The most striking difference was the £resence 
of a mass. Only 16% of the pseudocysts which resolved 
spontaneously were recorded as being clinically palpable, 
despite the fact that 48% of th em we re at least 6 cm i n 
diameter. In contrast 68% of those pseudocysts which 
required surgical intervention were palpable. Vomiting and 
anorexia we r e mo re c orrmo n in this latter group but 
otherwise, the clinical and laboratory findings were 
s imi 1 a r .
HyjDeramy;l aseami a ^>^()£ L^ was more frequent in
patients who required surgery but a leukocytosis was 
present in almost the same proportion (Table 27). The 
presence or absence of these features in a patient with a 
pseudocyst was not helpful in determining which 
collections would resolve.
20-, • •••
18-
16-
14-
MAXIMUM
DIAMETER
(cm)
1 2 -
1 0 -
*  10
8-
6 -
4-
2 -
*7
pseudocysts
requiring
drainage
pseudocysts
resolving
spontaneously
* = median
FIGURE 17 Graph illustrating the distribution of 
the maximum diameter (cm) of a 
pseudocyst as recorded by ultrasound. 
Points grouped into the pseudocysts 
which underwent surgical drainage and 
those which resolved spontaneously.
139
O P E R A T E D RESOLVED
n umb e r % n umb e r %
Pa i n 57 93 24 96
Tende r ne s s 43 69 19 72
Pyrexia (>37.5°C) 12 20 5 20
MASS 41 67 4 16
Vomi ting 26 43 7 28
Anorexi a 26 43 5 16
Di s tens i on 11 18 6 24
Ileus 2 3 3 12
Jaundice 8 13 3 12
S e r um amy lase
>300 IU/1 50 81 17 68
>1200 IU/1 25 40 8 32
Leukocytos i s 
> 10x 109c e 11s / 1 26 46 9 36
>15xl0^cells/1 9 16 5 20
TABLE 2 7 Incidence of symptoms, signs, increased serum
amy lase and leukocytosis in patients fr om G 1 a s g ow
Royal Infirmary whose pseudocyst required surgery 
compared to those in w h o m  a pseudocyst resolved 
spontaneous 1y .
There was a significant difference in the results 
(%) for the presence of a palpable abdomi n a 1 ma s s 
in the patients whose pseudocyst resolved
spontaneously compared to those which required
operation (p=<0.05 Chi squared test).
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T j_me to Re£oj_u t i on
The time to c omjD J_e ^ e resolution for all 2 5
pseudocysts is shown in Figure 18. Clinically, all
patients were improved at the time of resolution. 
Ultr asoun d scanning confirmed resolution in 19 patients 
but in the other 6 clinical findings alone were accepted
as evidence of resolution. All 6 patients were reviewed as 
outpatients for between 3 and 43 months (median 12 months) 
before being discharged.
Three of these 6 pseudocysts resolved within a 
period 6 weeks from the time of diagnosis of a pseudocyst 
and three after this time. Therefore, if the data for
these patients were to be disregarded, the median time to 
resolution would remain unaltered.
The median time t_o compj_e^te ££££l_u£i_on was 3_ m o n t hs 
(range 14 day_s to 2b_ mon t h wj_t h on 9^
(36%) resolving wi thj_n o£ a_round 6^ weeks J^4 t^ o £4 dayjO 
from the time of d j_agno£j_£ of a R£££^ o cy_£ t_. A  typical 
example of spontaneous resolution is shown in figures 19 
and 20. The ultrasonic scans demonstrated a fluid
collection (7.5 x 4c m ) cephalad to the pancreas developing 
within 7 days after acute, alcohol induced pancreatitis 
(Figure 19). The patient with this pseudocyst had 
persistent abdominal pain, which prolonged his hospital 
stay to 17 days at the time of his original emergency 
admission with pancreatitis. His clinical condition 
gradual ly improved and after 5 weeks a repeat scan (Figure 
20) demonstrated reduction in the collection to 2.8 x 
2 . 5 c m .
TIME (months) 
TO
RESOLUTION
26
••
6 weeks
Glasgow Royal Infirmary Leeds, Bristol & Glasgow
* = median
FIGURE 18 Graph illustrating the distribution of
times from acute pancreatitis to complete 
resolution of a pseudocyst. Results plotted 
in two groups, Glasgow Royal Infirmary 
patients and those from Leeds, Bristol and 
Glasgow.
15044 
02/03/84 
REC *
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R EXP SCTR 
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DST.::07,5Cn
FIGURE 19 Ultrasound scans of a pseudocyst with
dimensions 7.5 x 4 cm prior to spontaneous 
resolution. (dimensions measured between 
crosses ) .
PC = pseu do cys t
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URINE
FIGURE 20 Ultrasound scans of same pseudocyst as
Figure 19 but after a period of 5 weeks. 
The collection has now decreased in size to 
2.8 x 2.5cm. (dimensions measured between 
crosses ) .
P C  = pse ud o cy s t
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The greatest time of 26 months to complete resolution 
was in a patient who, after her gallstone induced 
pancreatitis, attended as an out patient for over 2 years 
during which time repeated ultrasound scanning showed a 
persistent 5 cm pseudocyst. This eventually disappeared 
and she underwent cholecystectomy. There was no evidence 
of a collection at the time of surgery.
The m a x i m u m  pseudocyst size is plotted against the 
time to resolution in Figure 21. The graph illustrates 
that there is no direct correlation between the two 
parameters and smaj^ do not necessar i_J_y
r e £o 1_v e r a p i d ly .
F o 11ow U£
The media n period of outpatient follow up was 19 
mo nths (2 to 136 mo nths). Six patients (24%) developed a 
second pseudocyst, five within six months of the original 
collection. In one patient the second collection resolved 
spontaneously but the others required surgical drainage. 
Three of the five patients with chronic pancreatitis 
produced a second pseudocyst and had continuing clinical 
problems but all the other patients were well, without 
further pancreatic disease, at the time of last follow up.
TIME TO
RESOLUTION
(months)
26 1 
24 -
22 -
20 -
18 -
16 -
14 -
12 -
10 -
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6
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0 “ l
10
SIZE (cm)
FIGURE 21 Graph of maximum pseudocyst size (by 
ultrasound) against time to complete 
resolution for 19 pseudocysts showing that 
large collections do not necessarily take 
the greatest time to resolve.
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PATIENTS F R O M  LEEDS, BRISTOL A N D  GLASGOW.
A  pseudocyst resolved spontaneously in 15 (52%) of
the 29 patients in this study. The diagnosis of a
pseudocyst was confirmed by ultrasound in 13 patients and 
C T  scanning in two.
A e t i o 1 ogy J_ Acut_e and Ch_roni_c Pancreatitis
In contrast to the previous group of patients f r om 
G l a s g o w  Royal Infirmary, biliary disease was the most 
frequent cause of acute pancreatitis c omplicated by a 
pseudocyst (8 patients, 53%. 4 male and 4 female): alcohol
was the aetiology in 5 (33%) (all male) and a specific
cause remained undetermined in the other 2 patients (13%).
All the pseudocysts formed as a result of an 
episode of acute pancreatitis. On ly one patient had 
previous episodes of pancreatitis caused by alcohol and in 
this subject a small pseudocyst had been noted previously.
TLne t^ o Dj_agno£j_£ o£ a Pseudocy s t
The times to diagnosis of a pseudocyst are shown in
Figure 14 and these values from the patients in Leeds, 
Bristol and Glasgow are compared with those from the 
Gl as go w Royal Infirmary study. The median time was 22.5 
days (range 3 - 4 9  days). Collections diagnosed early 
(within 10 days) could not, at that stage, have been 
considered true pseudocysts but c omp arison of the ti me t o 
diagnosis with the time to resolution (Figure 22) 
illustrates that 3 of the 4 "pseudocysts" diagnosed by 
ultrasound scanning within this period persisted for 
longer than 6 weeks and only one apparently resolved in 21 
days .
TIME (days) 
TO
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FIGURE 22
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Graph of time from acute pancreatitis to 
diagnosis of a pseudocyst against time to 
complete resolution for 12 pseudocysts.
Of the 4 pseudocysts diagnosed within 10 
days of acute pancreatitis only one 
resolved within 21 days and could therefore 
have been a transient effusion.
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One patient with chronic pancreatitis had a small 
(3.5cm) pseudocyst present at the time of acute 
pancreatitis and a time to diagnosis was not estimated. 
There was no significant difference (Mann Whitney test) in 
the times to diagnosis between pseudocysts which resolved 
spontaneously (median time 22 days; range 3-49 days) and 
those that ultimately required drainage (median 18 days; 
range 12-23 days).
M a x i m u m  Size o_f ?££ndocy^£t_
The m a x i m u m  size of 10 of the pseudocysts is shown in 
Figure 23. Three of the other 5 were described as "large" 
and there was no size recorded on the ultrasound scans of 
the other 2 patients. On ly 3 (30%) were 6 cm or greater
and the med ian size was 5cm. This was 3cm smaller than the 
me dian size of those treated surgically a difference 
which was not statistically significant (Mann Whitney 
test).
Clinical and Labo r_a£or^ ormat i_on
The data for the clinical signs, symptoms and 
laboratory information are given in Table 28 and compared 
with the results in the patients whose pseudocysts were 
drained surgically.
MAXIMUM
MEASURED
DIMENSION
(cms)
10
8.5
7 -
---*5
pseudocysts pseudocysts
requiring
drainage
NO SIZE : 
"LARGE"
resolving
spontaneously
2
3
= median
FIGURE 23 Graph illustrating the distribution of the
maximum diameter (cm) of a pseudocyst as 
recorded by ultrasound. Points grouped into 
the pseudocysts which underwent surgical 
drainage and those which resolved 
spontaneously.
Patients from Leeds, Bristol and Glasgow. 
Note that no size was given for 5 of the 
collections and in 3 others the pseudocyst 
was described as "large”.
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OPERATED RESOLVED
n umb e r % n umb e r %
Pa i n 11 100 15 100
Tendernes s 10 91 14 93
Pyrexia (>37.5°C) 6 55 10 67
M A S S 9 82 4 27
Vomi t i ng 4 36 3 20
Anorexi a 1 9 - -
D I S T E N S I O N 8 73 1 7
Ileus 2 18 - -
Jaund i ce 1 9 2 13
S e r um amy lase
>300 IU/1 10 91 10 67
>1200 IU/1 7 64 4 27
Leukocy tos i s 
> 1 0 x 1 09c e 11s /1 10 91 8 53
>15xl09cells/l 5 45 4 27
TABLE 2 8 Incidence of symptoms, signs, increased serum
amylase and leukocytosis in patients from Leeds, 
Bristol and Glasgow whose pseudocyst required 
surgery compared to those in whom a pseudocyst 
resolved spontaneously.
The results (%) for the presence of a palpable 
a b d om i n a 1 ma s s , b d om inal distension and
leukocytosis >10x10 cells/1 were significantly 
different (all p=<0.05 Chi squared test) in the 
patients wh ose pseudocyst resolved c omp a r e d to 
those in whom operation was necessary.
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As in the group of 25 patients from Glasgow Royal
Infirmary, t_he presence of_ a m a ss on c^j_nj_ca 1 examination
was significantly more common in the patients requiring
surgery and in the present group there were also
significant differences in incidence of abdominal
dt_e^ns^J_on and the number with a £f greater
9
than c e Hjs/_ 1 (Table 28). These two latter
differences were more pronounced than in the larger group 
of G l a s g o w  patients.
A s s e s sment
By multiple factor assessment at the time of 
admission with acute pancreatitis, 11 of the patients 
(73%) in w h o m  a pseudocyst resolved spontaneously were 
deemed to have mild and 4 severe acute pancreatitis. 
Amongst the patients requiring surgery 6 (54%) were
considered as having mild and 5 severe acute pancreatitis.
Diagnostic peritoneal lavage was performed in 24 of 
the 29 patients with a pseudocyst but again only 13 (54%)
of episodes of acute pancreatitis were graded as severe. 
Early assessment of severity of acute pancreatitis was not 
a useful indicator of those likely to develop pseudocysts. 
To date there is no specific marker that allows prediction 
of possible pseudocyst formation early during an episode 
of acute pancreatitis (Chapter 4).
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Tj_me to Res^o j_u t i on
The median time to c om£j_e t^ e resolution was 4 5 
days range (15-132 days) in 13 patients (Figure 18).
Resolution was confirmed by repeated ultrasound 
scans in 7 patients, by CT scanning in 3 and in a further 
three patients, the reduction in size was confirmed at 
the time of subsequent cholecystectomy.
Of the 2 patients with no accurate time of resolution 
recorded one was found, incidentally, to have a renal 
adenocarcinoma (see above). When he had recovered from his 
pancreatitis he was transferred to the care of a urologist 
and the precise time to resolution of his pseudocyst was 
not documented. This patient subsequently developed a 
second pseudocyst 2 years later. This collection was 
initially drained by percutaneous aspiration but 
ultimately required surgery. The remaining patient had 
resolution of his pseudocyst confirmed solely by clinical 
examination without further ultrasonic or CT scans being 
performed. He was followed up for 19 months without 
further symptoms.
FoJ_J_ow U jd
The median period of follow up of all 15 patients was 
5.5 months (range 2-54 months). Two patients developed 
further pseudocysts. One, the patient with a renal tumour, 
is reported above. The second patient had a 4cm pseudocyst 
revealed by CT scanning within one mo nth of proven 
resolution of a similar sized collection. The second 
pseudocyst eventually resolved spontaneously after a 
period 14 months.
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SUMMARY
There were some differences in this group of 15 
patients when compared to the 25 from Glasgow Royal 
Infirmary in w h o m  a pseudocyst resolved (Table 29) but
there were important similarities summarised below:-
1. The median times to resolution were 45 and 90 
days confirming that the majority of pseudocysts 
resolved after a period of 6 weeks. The 
background to this particular time is discussed 
i n Ch apter 1. Fr om the present data it is 
recommended that "waiting period" before 
considering intervention should be 12 weeks w ^ h  
the proviso that the c 1 i n i ca 1 condj_^tj_on of_ t^ he 
patient i_£ not d e _ t •
2. Both studies produced a 3 cm difference in the 
median ma x i m u m  pseudocyst diameter between the 
collections which resolved spontaneously and 
those which underwent surgery. Despite the 
fact that these differences did not achieve 
statistical significance there was a trend for 
pseudocysts greater than 6 cm in d i ame ter to be 
mo re likely to require s ome f o rm of surgical 
dra i n a g e .
Median time to 
resolution (days)
Median m a x i m u m
size (c m ) on ultrasound
% resolving > 6 weeks 
% size > or = 6cm
G1 asgow 
Roya 1 
In f i rma r y 
Re suits
Leeds 
Br i s to 1 
G1asgow 
Re suits
90 45
64%
48%
52
30:
TABLE 29 Comparison of the time to complete resolution of
a pseudocyst, the m a x imum diameter by ultrasound 
scan, the percentage of collections resolving 
after six weeks and the percentage of resolving 
pseudocysts greater than 6 cm between the
patients from Glasgow Royal Infirmary and those 
from Leeds, Bristol and Glasgow.
149
3. In the study of patients from Leeds, Bristol and 
G l a sgow sgontaneous £_£££j_£t ion occurred in the 
ma j o r i t y 032J>2* This is an important finding and 
should strengthen the arg ume nt for delay in 
intervention and careful and repeated monitoring 
of patients forming a pseudocyst after acute 
pancreat i t i s .
4. The c 1i n i c a 1 ££.££££££ o£ a palp able abdominal
mass in a patient with a pseudocyst indicates 
that the collection is at least 6cm in diameter 
and is more likely to require drainage than 
resolve spontaneously.
5. The othe£ s i gn i f i cant £li£i_££i_ d i_f_£e£ence£
9
(abdominal di stens 1 eukocy tos i s >_1 C x^.1 0
cells/1) between patients with resolving 
pseudocysts and those requiring surgery noted in 
the study from Leeds, Bristol and Glasgow were 
more pronounced than in the 100 patients from 
Glasgow Royal Infirmary alone. These features 
have been included in a new assessment system 
for the prediction of outcome in patients who 
develop a pseudocyst after acute pancreatitis 
(Chap t e r 8).
6. Late recurrence of a pseudocyst following
spontaneous resolution occurred in a total of 7 
patients and surgical drainage was necessary for 
the second collection in 5 (71%) of these.
7. No patient from either group experienced 
significant delayed complications associated 
with the pseudocyst.
CHAPTER 6
PERCUTANEOUS ASPIRATION OF 
PANCREATIC PSEUDOCYSTS
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INTRODUCTION
Despite the fact that a majority (52%) of pseudocysts 
in patients from the Leeds, Bristol Glasgow study resolved 
spontaneously when all the 129 patients are considered 
together the majority (89, 61%) required some form of
surgical drainage. Although internal surgical drainage 
procedures are relatively safe there is still a morbidity 
and m o  rtality associated with surgical intervention. A  
me thod of drainage that avoids operation but achieves 
resolution with minimal morbidity has appeal. Percutaneous 
drainage procedures have been considered as a solution to 
this problem (Chapter 1).
The present chapter considers the experience of 
percutaneous needle aspiration of pancreatic pseudocysts 
in two G l a sgow hospitals (The Royal Infirmary and Stobhill 
Ge n e r a 1 Ho s p i t a 1 ) .
PATIENTS
Between 1981 and 1988, 21 patients with pancreatic
pseudocysts from Glasgow Royal Infirmary and Stobhill 
General Hospital, Glasgow have undergone percutaneous 
drainage procedures. There were 14 males (median age 37 
years; range 23-77 years) and 7 female patients (median 
age 47 years; range 30-78 years). A total of 26 
aspirations were performed. In sixteen patients a 
pseudocyst was drained once. The remaining five patients 
had two aspirations. In two instances aspiration was 
repeated within 7 days and in a further two patients a 
second separate collection was identified and aspirated at 
6 months and 2 years respectively after the original 
pseudocys t .
The remaining patient had a collection aspirated followed 
by an attempt at catheter drainage after 4 weeks (Table 
30 ) .
The diagnosis of a pseudocyst was confirmed by 
ultrasonic scanning in all patients. The collection 
developed following acute pancreatitis in 13 patients and 
was associated with chronic pancreatitis in 8. The 
aetiologies of the preceding pancreatitis are shown in 
Table 30.
Three of the patients did not present to hospi ta 1 as
a n erne r g e n c y but were referred to a surgical clinic for
i nves t i gat i on of abdominal pain. The presence of a
pseudocyst was subsequently detected by u 1 t rasound
scann i n g .
METHODS
All percutaneous aspirations were performed with 
ultrasound guidance and the procedure undertaken using 
local anaesthesia. A  preliminary ultrasound scan was 
performed (Figure 24) to assess the size of the pseudocyst 
and to determine the most direct route to the collection 
avoiding the colon, liver and spleen. A fine gauge needle 
(19-22 gauge) was then introduced into the cavity and the 
position confirmed. Fluid was aspirated (Figure 25) and 
s p e c i me ns sent for bioch em ical and bacteriological 
examination. As much fluid as possible was then withdrawn 
and the needle removed. Scanning was repeated to assess 
the completeness of aspiration and the size of the empty 
cavity. Another scan was performed after 5-7 days (Figure 
26) to assess whether the pseudocyst had refilled or not.
N U M B E R  OF PSEUDOCYSTS 
21
A S P I R A T I O N
T H E RAPY
SUCCESSFUL
A S P I R A T I O N
THERAPY
FA I L E D
15
M e dian time 
f r om  pancreatitis 
to aspirati on 
(range days)
18 days 
(14-21)
29 days 
(11-120)
Median m a x i m u m  
pseudocys t 
d i ame ter 
(range c m )
11 cm 
(8-11.5)
1 0 cm 
(6-22 )
Aetiology of pancreatitis
Alcohol 3
Ga 11 stone 2
Post operation 1 
Ca rein oma
10
4
Bacteriology of fluid
Sterile 5
Infect ed 1
13
2
Surgical drainage following unsuccessful aspiration
Cy stogastrost omy 
External drainage 
Distal pancreatectomy
Re fill no surgery
10
2
1
TABLE 3 0 Details of time to aspiration, m a x i m u m  pseudocyst 
size, aetiology of pancreatitis and bacteriology of 
fluid in pseudocysts in which aspiration was 
succesful and those in which it failed.
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FIGURE 24 Ultrasound scans of a pseudocyst
(11.5 x 7.5 c m ) prior to percutaneous 
aspiration. (dimensions measured between 
crosses ) .
PC = ps e u d o c y s t
FIGURE 25 Photograph of patient undergoing
percutaneous drainage of a pseudocyst by 
c a t h e t e r .
Procedure has been performed using local 
anaes the tic.
Note the colour of the aspirated fluid.
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FIGURE 2 6 Ultrasound scan of a pseudocyst (s ame
patient as Figure 24) following
percutaneous aspiration. (di me nsions not
ma rked but echolucent area is obviously 
smaller than in figure 24).)
PC site of aspirated fluid
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A  drainage catheter were used in only three patients. 
In two patients the catheter was allowed to drain from 
the pseudocyst cavity and out through the anterior
abdominal wall. Unfortunately these catheters both fell 
out after 2 and 4 days respectively. In the third patient 
an a 11 emp t wa s ma de to establish a catheter
cystogastrostomy (Hancke and Henriksen 1985). This
involved passing a fine bore hollow needle through both 
wa11s of the stomach and into the pseudocyst. A  guide wire 
was then inserted down the needle and a double pigtail 
catheter slid over the wire until one of the curled ends 
lay within the pseudocyst cavity. A  gastroscopy was then 
performed and the catheter was grasped and the other end 
placed in the 1ume n of the st oma ch thereby creating a 
communication between the pseudocyst and the stomach via 
the catheter. This catheter unfortunately, migrated into 
the pseudocyst cavity after 2 days and the patient
developed signs and symptoms of infection. At this time
surgery was performed in order to remove the catheter and 
drain the pseudocyst. With the exception of this last
patient, there were no immediate complications of the 
p r o c e d u r e s .
RESULTS
The median time from the onset of an episode of acute 
pancreatitis to aspiration of a pseudocyst was 21 days
(range 11-120 days) in 13 patients. It was not possible to 
calculate this period accurately in the other 8 patients.
Six of these suffered chronic pancreatitis and had no 
clear precipitating event of acute pancreatitis, a further 
patient was referred to a surgical out patient clinic and 
had no acute symptoms and the sixth patient developed a 
sma 11 pseudocyst in the tail of her pancreas associated 
with m e t a s t a t i c  carcinoid tumour elsewhere in the gland. 
Details of the results are summarised in Table 30.
Percutaneous aspiration was successful in reducing 
and eventually contributing to the resolution of a 
pseudocyst in 6 (29%) patients. There was no evidence of
recurrence within a m i n i m u m  follow up period of 10 months 
in 4 of these patients. Of the other two, one failed to 
attend and the other patient died within 5 weeks of 
aspiration as a result of her m e t a static colonic 
carcinoma. There was no evidence that her pseudocyst had 
refilled within that period.
The aspiration failed to resolve the pseudocyst in 
the other 15 patients (71%). Thirteen of these patients 
underwent surgical drainage; 10 c y s t o g a s t r o s t o m y , 2
external drainage and one distal pancreatect omy at a 
m edi a n  time of 21 days (range 2-330 days) from the time of 
aspiration. In the other two patients repeated ultrasound 
scanning showed the continued presence of a pseudocyst of 
similar size to the original collection.
The £££udocy_£t_ £e£j_J_j_ed within 1^0^ day^s^ j_n 1_0_ ^6^7%)of 
these 1_5_ and by_ 21 d ay_s in another 2. In two
further patients with alcohol induced chronic pancreatitis 
percutaneous aspiration could be regarded as being 
partially successful in that their pseudocysts did not 
refill within a period of 6 mo n t h s f r om  the procedure. 
Aspiration of the second collection in one of these 
patients proved inadequate and he then underwent a 
c y s t o g a s t r o s t o m y . The other required a distal 
pancreatect omy for a recurrent pseudocyst in the tail of 
the pancreas. The one remaining patient who was treated 
with surgery had a sma 11 (5 c m ) cystic lesion in the tail
of her pancreas which probably developed as a result of 
met a s t a t i c  carcinoid tumour within the pancreas. The exact 
time that this refilled was not clear but it caused her no 
symptoms over a follow up period greater than 2 years. It 
was interesting to note that the amylase level in the 
fluid of this cyst was only 143 IU/1, compared to levels
ranging fr om 8600 IU/1 to 460400 IU/1 in the s amp 1e s f r om 
the other pseudocysts.
The median m a x i m u m  pseudocyst diameter in this group 
of patients as measured by ultrasound was 11cm (range 8-
11.5cm) for those which resolved after aspiration compared 
to a me dian of 10 cm (range 6-22 c m ) for those wh i c h 
required to be drained by operation or in which the 
pseudocyst refilled. There was no significant difference 
in these di ame t e r s (Ma n n Wh itney test).
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The volume of fluid aspirated varied from 5 0ml to 
1400ml (median 350ml) and did not correlate directly with 
the m a x i m u m  measured diameter. During all procedures the 
immediate post aspiration scan showed satisfactory 
evacuation of the cavity which would suggest that the 
early recurrence of fluid was genuine refilling rather 
than m i s s e d  fluid at the time of aspiration.
Specimens from the pseudocysts were sterile in 18 
patients but contained bacteria in 3. On e s amp 1 e g r e w  a 
Streptococcus species, one Staphylococcus aureus and 
another grew both a Proteus species and Escherichia coli. 
This last collection resolved following aspiration and 
systemic antibiotics without the patient experiencing any 
major complications.
After surgical drainage only one patient (8%) 
experienced complications. He underwent external drainage 
of his pseudocyst 18 days after aspiration but became 
septicaemic, despite the collection being sterile on 
aspiration, and eventually died of respiratory failure. 
Although not proven in this patient, it is possible that 
the percutaneous intervention resulted in infection being 
introduced into this pseudocyst.
The results presented show rather a low success 
rate of 29% for percutaneous aspiration of a 
pancreatic pseudocyst. This figure is similar to 
that recorded in the world literature which 
considers aspiration alone as a m e t h o d  of 
treatment for pancreatic pseudocyst (Table 6).
Three patients in w h o m  the collection responded 
to this form of treatment (50% of the successes) 
presented to the hospital without significant 
acute symptoms. All three had alcohol associated 
pancreatitis and one had chronic symptoms.
One infected collection was successfully treated 
by aspiration and systemic antibiotic therapy 
but, in contrast, infection was probably 
introduced into one pseudocyst ultimately 
leading to retroperitoneal sepsis and death of 
the patient. The technique is not without risks.
CHAPTER 7
ANALYSIS OF ACUTE PHASE REACTANTS 
IN PSEUDOCYST FLUID
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INTRODUCTION
Despite extensive literature on the subject of 
pancreatic pseudocysts there is a paucity of studies 
concerning analysis of pseudocyst fluid. This chapter 
describes analysis of acute phase reactants Interleukin 6, 
alpha 1 antiprotease, alpha 2 macrog l o b u l i n  and C  reactive 
protein in pseudocyst fluid from 12 patients.
The present study was undertaken in the light of 
the clinical information obtained in the other parts of 
this thesis and in an attempt to find a marker which might 
reflect the severity of the inflanmatory reaction within a 
pseudocyst and differentiate between acute and chronic 
pseudocys t s .
A  sunmary of the literature relating to analysis of 
pseudocyst fluid is given in Chapter 1.
PAT I ENTS
S amp les of pseudocyst fluid we re collected fr om  12 
patients at the time of surgical drainage (9) or 
percutaneous needle aspiration (3). All patients 
eventually underwent surgery. Details of the patients are 
given in Table 31. Fluid was collected from 9 male 
(median age 46 years; range 37 - 66 years) and 3 female
patients (median age 41 years; range 26 - 72 year).
Eight of the pseudocysts were regarded as 1 acute". 
Six of these collections irrmediately followed an episode 
of acute pancreatitis. The aetiological factor of the 
pancreatitis was alcohol in 2 of these 6 patients,
gallstones in 1 and the aetiology was undetermined
(idiopathic) in the other 3 patients.
go
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The fluid samples were obtained by percutaneous 
needle aspiration in two of these six patients at 7 and 21 
days after the collection had first been identified by 
ultrasound scan. The other four samples were collected 
during surgical drainage at a m e dian time of 60 days 
(range 50 - 120 days) after pseudocyst formation. The
remaining two of the 8 patients with "acute" pseudocysts 
presented with symptoms of abdominal pain and 
hyper amy 1 aseami a associated with the presence of a large, 
established pseudocyst. Both patients regularly drank 
large quantities of alcohol but neither had previous 
evidence of pancreatic disease and the precise time of 
development of the pseudocyst could not be determined. The 
fluid s amp 1e wa s obtained by needle aspiration after 3 
days in one of these patients and at the time of surgery 
in the other.
The pseudocysts in the remaining four patients were 
regarded as chronic (Table 31). All four had experienced 
previous episodes of pancreatitis induced by alcohol in 3 
and following abdominal trauma in the other. In two of 
these patients the age of the pseudocyst could not be 
determined accurately. The other two collections had been 
present for 12 and 24 months prior to drainage and sample 
col lection.
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METHODS OF SAMPLE ANALYSIS
All the fluid samples were collected in sterile 
containers and were stored at -20°C for variable periods 
(Table 32). All assays were performed in the Pathological 
Biochemistry Department of G l a s g o w  Royal Infirmary. The 
amylase was measured on a separate sample at the time of 
col lection.
Inter 1eukin 6
This was assayed using a sensitive c o 1ourimetric cell 
culture assay using Interleukin 6 dependent mo use
hybridoma cells (7TDI cells). The amount of cell growth 
and replication is proportional to the level of
Interleukin 6 present within a sample or standard
solution. Cell growth following a set period of incubation 
was estimated using a fluorescent cell probe (MTT = 3-
[4, 5 -d ime thyk th i a z o l-2-yl]-2,5,diphenyltetrazoli um bromi de 
thiazolyl blue).
All serum samples were heat treated (56°C for 3 0 
minutes) and diluted to provide a final sample volume of
3
50|ix 1 . Each sample and standard was added to 50ul (2x10 ) 
7TDI cells giving a total volume of 100^1 in each well of 
a tissue culture plate. The plates were then incubated 
for 4 days at 37°C with an atmosphere of 8% carbon 
dioxide. After this the fluorescent probe (MTT) was added 
to each well and allowed to equilibrate for 4 hours. The 
cells were then disrupted using 50ul of Triton X. The 
resultant released fluorescence was measured the following 
day by determining the absorbance at 540nm. The
Interleukin 6 levels for the test samples were derived by 
reference to a standard curve.
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These were measu r e d  on an Encore Centrifugal 
Analyser using a turbimetric immunoassay with appropriate 
anti-sera (Atlantic Antibodies). Diluted serum samples and 
specific antisera to the test protein are pipetted 
separately onto a transfer disc. The disc is then placed
into the centrifugal analyser where the sample and
antisera are mixed and the resulting turbidity, which is 
proportional to the amo unt of specific protein present, 
i s me a s u r e d .
9  P r o te i n
This was analysed on the Abbot TDX fluo rime ter using 
a fluorescent polarisation immunoassay employing a 
commercial reagent pack. The pack contains an antibody to
C-reactive protein (CRP), a fluorescing labelled CRP and a
pretreater .
The principle of the test is based on the fact that
the Abbot TDX fluorimeter produces a plane, polarised 
light which excites the labelled CRP (the fluorophore) and 
raises it to a higher state. After excitation the
fluorophore returns to a steady state and a light of a 
different energy level and wavelength is emitted.
The sample, antibody and labelled CRP are mixed 
together and the labelled CRP competes with the CRP in the 
sample for binding sites on the antibody. The unbound
labelled CRP is free to rotate and, within the analyser, 
it depolarises the exciting light and polarisation is 
decreased. This change is inversely proportional to the
level of CRP within the samp 1e .
This was measured using the Phadebas test (Pharmacia 
Diagnostics, Sweden). The technique is based on the 
ability of amylase to split a starch polymer. A  water 
insoluble cross-linked starch molecule carrying a blue dye 
is provided in tablet form in the test kit. The starch is 
hydrolysed by amy lase resulting in wa ter soluble blue 
fragments. The absorbance of the blue solution is m e a s u r e d  
in a phot ome ter and is proportional to the amy lase 
activity.
RESULTS
The results for each patient are shown in Table 32. 
In samples from six patients a^1_ results were at the lower 
limit of sensitivity of a ll the assays. The implications 
of this finding will be discussed subsequently.
Interleukin 6^
In all 12 s amp les the values of this par ame ter we r e 
less than the lower limit of the assay indicating 
Interleukin 6 could not be detected within these specimens 
of pseudocyst fluid.
Alpha 1^ Ant i protease (normal serum values 1.3 - 2.1 g/1)
In 6 samples the values were <0.2g /1 (lower limit of 
test) implying that there was no alpha 1 antiprotease 
present within the fluid. Four of the results were within 
the normal serum range (3 acute pseudocysts and 1 
chronic). The other 2 results were lower than normal (both 
chronic pseudocysts).
AJ_pha 2_ MaC£op|^obuJ_j_n (normal serum range 1.1 - 3 . 9g / 1 )
Alpha 2 macroglobulin was detectable in samples from 
only 3 of the 12 patients. Interestingly all three also 
had alpha 1 antiprotease in the specimen (Table 32). All 
three patients had alcohol associated disease and 2 had 
chronic pancreatitis.
C  Reactive P_r O £e£n (normal serum value < 20 mg / 1 )
On ly 4 fluid s amp les contained detectable levels of C  
reactive protein. Three of these were elevated and
associated with acute pseudocysts. All three patients with 
these elevated levels had large areas of pancreatic 
necrosis and two subsequently had prolonged infection. The 
fourth result was within the normal serum range and was 
f r om  a c h r o n i c p s e u d o c y s t .
D I S C USSION
The results obtained in this study reveal that
levels of the analytes above the lower sensitivity of the 
assays occurred in 6 of the 12 patients.
At the time of the Interleukin 6 analysis it was 
observed that almost all test cells became non-viable.
With high levels of proteases within the pseudocyst fluid 
it is likely that a cell culture assay is inappropriate 
for analysis of this type of specimen. The continuing 
enzymic action may also have been responsible for the 
other low results. The fluid samples were stored at -20°C 
within 1 hour of collection but even at this t emp e r a t u r e
protease activity continues.
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One possible solution to this problem would be to 
inhibit protease activity rapidly at the time of sample 
collection by adding inhibitors such as aprotinin to the 
fluid.
Another possible explanation for the apparent lack of 
Interleukin 6 is that it was truly absent from pseudocyst 
fluid. This substance is produced by various lymphoid and 
non-lymphoid cells, T cells, B cells, monocytes and 
fibroblasts and has a multitude of functions. One of which 
is its action as an intermediary substance in the acute 
phase response (Kishimoto 1989). Interleukin 6 stimulates 
the biosynthesis of acute phase proteins and induces the 
production of C  reactive protein and alpha 1 antiprotease 
in h uma n hepatocytes (Ca stell et al 1988). Ser um levels 
correlate well with those of C-reactive protein in 
patients with severe burns (Nijstein et al 1987) strongly 
suggesting a contributory role in the acute phase 
r e s p o n s e .
Patients developing pseudocysts, especially following 
acute pancreatitis, exhibit elevated serum levels of C- 
reactive protein (Mayer et al 1984). The local 
i n f 1auma tory response within a pseudocyst is likely to 
produce Interleukin 6 and, prior to the present analysis 
it was reasoned that the levels of this reactant would be 
elevated within cyst fluid particularly that obtained from 
acute pseudocysts. The results do not fit this hypothesis. 
Further analysis with simultaneous fluid and serum 
sampling is necessary.
Data from two studies (Lasson et al 1989, W i l s o n  et 
al 1991) reporting levels of alpha 1 antiprotease and 
alpha 2 m a croglobulin estimated by both immunological and 
functional assays has shown that levels of alpha 1 
antiprotease in pseudocyst fluid are c orrmo nly within the 
normal serum range but that alpha 2 macro g l o b u l i n  levels 
tend to be low. This finding is similar to the serum 
response of this substance in acute pancreatitis (Lasson 
and Ohlsson 1984; McMahon et al 1984). The current results 
recorded for alpha 1 antiprotease and alpha 2 
ma croglobulin are consistent with these other studies. It 
was, however, observed that more than half the results 
for alpha 2 macroglobulin were at the limit of assay 
sens i t i v i t y .
In the case of alpha 2 macroglobulin the low levels 
are probably a true reflection of events within 
pseudocyst. In view of the rarity of analysis of this 
substance in pseudocyst fluid further observations are 
neces sa r y .
The C-reactive protein results were elevated (>20 
mg / l) in 3 of the four s amp les with values greater than 
the lower limit of the assay. The four pseudocysts from 
which these samples were taken developed as a result of 
alcohol induced pancreatitis. The 3 patients whose 
specimens recorded raised levels of C-reactive protein all 
had large pseudocysts with considerable amounts of tissue 
necrosis. Two of these patients went on to develop 
a b s c e s s e s .
In common with analysis of serum C-reactive protein 
in patients with acute pancreatitis, the elevated values 
of C-reactive protein within pseudocyst fluid were 
associated with severe acute pancreatitis. Clearly, the 
numbers in this study are very small but further studies 
are me r i t e d  to confirm this positive finding.
SUMV1ARY
1. Ov erall, this analysis of acute phase proteins 
within pseudocyst fluid has been, to s ome 
extent, disappointing but it represents a
preliminary study which has attempted to
quantify the differences between acute and 
chronic pseudocysts in terms of a marker of 
severity of the infl arrma tory response.
2. The results for C-reactive protein within the 
fluid were the most positive feature in three 
of the acute pseudocysts but if these are 
paralleled by the serum response of this 
reactant then analysis of the fluid may be 
superfluous.
CHAPTER 8 
CONCLUSIONS AND DISCUSSION
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INTRODUCTION
In this concluding chapter the important findings of 
this thesis are discussed and a new approach to the 
assessment and management of patients who form pancreatic 
pseudocysts is presented.
THE N A T U R A L  H I S T O R Y  OF PANCREATIC PSEUDOCYSTS 
Whi_ch £at_i_ent^s ame J_ikely_ to form a £seudocyst ?
Because the majority of studies of patients with
pseudocysts have c ome f r om me dical centres wh ere alcohol 
was, by far, the most common aetiological factor causing 
acute pancreatitis there has been a tendency to regard 
patients with this cause as being more likely to develop a 
pseudocyst (Anderson 1972; Aranha et al 1983; Becker et al 
1968; Bradley et al 1976; Caravati et al 1966; Crass and 
Way 1981; Erb and Grimes I960 ; Folk and Freeark 1970 ; 
Frey 1978; Gonzalez et al 1976; Grace and Jordan 1976;
Hastings et al 1975; Judd et al 1931; Kaiser et al 1964; 
McConnell et al 1982; Sankaran and Walt 1975; Scharplatz 
and White 1972; Thomford and Jesseph 1969; Tucker and
We bster 1972).
Pseudocysts forming with a background of chronic
pancreatitis are almost all alcohol associated, primarily 
because alcohol is the major cause of this type of 
pancreatitis. When considering pseudocysts which develop 
as a result of acute pancreatitis, the results fr om the 
study of 29 patients from Leeds, Bristol and Glasgow 
(Chapter 4 ) , clearly demonstrated that no single aetiology 
was predominant. The distribution of causal factors in the 
patients who formed a pseudocyst was almost identical to 
that of the 418 patients with acute pancreatitis.
This finding is not unexpected if the pathogenic 
factors for pseudocyst formation (Figure 1) are regarded 
as c orrmo n to all types of infl arrma tory pancreatitis, no 
matter the cause. There are no differences in the 
histological appearances of acute infl arrma tory
pancreatitis whether caused by the two common aetiologies, 
gallstones or alcohol. Periductal necrosis is the common 
histological feature of the pancreatitis induced by either 
of these aetiologies (Foulis 1980). There are some 
differences in the distribution of pancreatic d ama g e in 
ischaemic pancreatitis when compared to other causes but 
the net effect however, is still areas of necrosis that 
can potentially produce leakage of fluid from the ductal 
system into the surrounding tissues and cause pseudocyst 
f o rma t i o n .
The formation of a pseudocyst is not confined 
to patients of one sex or age group. Seventy of the 100 
patients from the Glasgow Royal Infirmary study were male, 
49 (70%) of w h o m  had alcohol associated disease. The
median age of these 70 males was 40 years (range 19-77 
years) and that of the 30 females was 49 years (range 21- 
78 years). In the Leeds, Bristol and Glasgow study of 29 
patients, the sex distribution was almost equal with 15 
males (median age 45 years: range 21-77 years) and 14
females (median age 61 years: range 30-78 years).
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There has been considerable research into assessment 
and grading of disease severity in patients with acute 
pancreatitis (Williamson 1984) but the information
provided in this thesis indicates that initial assessment 
either by multiple factor grading (Table 12) or diagnostic 
peritoneal lavage (Table 13) at the onset of acute 
pancreatitis gives no indication as to the eventual 
development of a pseudocyst (Chapter 4). There were
similar proportions of patients who formed a pseudocyst 
whose acute pancreatitis was graded as mild or severe. The 
information from the 418 patients with acute pancreatitis 
from Leeds, Bristol and G l a sgow revealed that of the 113 
whose pancreatitis was graded as severe by prognostic 
criteria 10 (9%) developed a pseudocyst wh ereas of those
305 patients with "mild" pancreatitis 19 (6%) formed a
pseudocys t .
There are no specific features which allow early 
prediction of this c omp lication in patients with acute 
pancreatitis. Even the repeated measurement of acute phase 
reactants, C-Reactive protein in particular, whilst 
reflecting continued infl arrma tory reaction, is a n o n ­
specific indicator of impending complications (Buchler et 
a 1 198 6 ; Mayer et al 1985)
When do deveJ_op _?
The advent of ultrasonic scanning has greatly 
enhanced understanding about the natural history of the 
development and course of pancreatic pseudocysts (Bradley 
1982 ) .
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Ultrasound can easily identify fluid around the 
pancreas following acute pancreatitis and whilst such a 
collection may progress to become a true pseudocyst with 
the development of a fibrous, granulation wall, it could 
potentially resolve and therefore be regarded as a 
transient pancreatic effusion (Bradley et al 1976, Bradley 
1982). To prove that a collection is a "true" pseudocyst 
it would be necessary to confirm the pancreatic origin by 
fluid analysis, nature of the surrounding wall by biopsy 
and a conmunicat ion between the collection and the 
pancreatic duct by ERCP in all patients. These procedures 
might be inappropriate and be an unnecessary intervention 
in patients whose pseudocysts resolve spontaneously. There 
is, as yet, no study which utilises such thorough 
confirmation. In recent years improvements in the 
resolution of CT scanners have resulted in enhanced tissue 
definition to an extent where the m o r p hology of a 
pseudocyst and the thickness of the wall can be assessed 
without recourse to biopsy.
One important factor in differentiating between an 
effusion and a true pseudocyst is the time a collection 
has persisted. The majority of effusions will resolve 
quickly, within 3-4 weeks of formation but true
pseudocysts persist for longer (Bradley et al 1976). 
Experimental evidence suggests that it takes 4 to 6 weeks 
for a fibrous, granulating wall to form (Warren et al 
1957 ) .
The validity of this evidence in relation to 
pseudocyst formation in man has been discussed in Chapter 
1. The experience in the present work indicates that, on 
occasion, a definitive fibrous wall may be formed within 2 
to 3 weeks. Throughout this study considerable care has 
been taken to avoid including patients with transient 
effusions in the analysis of results.
The median time from an episode of acute pancreatitis 
to confirmation of a pseudocyst by imaging or surgery was 
19 days (range 3-49 days) for the patients from Leeds, 
Bristol and Glasgow and 27 days (range 4-479 days) for 
those from Glasgow Royal Infirmary. A  pseudocyst was 
therefore, most frequently diagnosed between the second 
and fourth weeks following an episode of acute 
pancreatitis. At this time a collection was more likely to 
be a pseudocyst than a transient effusion.
The diagnosis of a pseudocyst was based, not only on 
imaging evidence, but also on clinical and laboratory 
information. The majority of patients studied had symptoms 
and signs such as abd om inal pain, a palpable ma s s or 
distension and a raised serum amylase or leukocytosis at 
the time of pseudocyst diagnosis. Such a combination of 
factors is less frequently found when a simple transient 
effusion is present.
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Wh en clinical, laboratory and i ma ging criteria are 
all positive, diagnosing a pseudocyst is not difficult.
Occasionally, however, a pseudocyst forms insidiously
without major systemic upset. Indeed, of 29 patients in
the Leeds, Bristol and Glasgow study, 6 (20%) had been
discharged from hospital, apparently recovered from their 
acute pancreatitis only to be readmitted, within 2-3 weeks 
with a well developed pseudocyst.
The presence of a communication between the 
pancreatic ductal syst em and the surface of the gland is 
an important feature in the pathogenesis of a pseudocyst 
(Chapter 1). The progression of events: acute
pancreatitis - areas of necrosis - duct c orrmu nication 
fluid release - sequestration, is critical to pseudocyst 
formation. The fact that the majority of pseudocysts do 
not seem to form until the second to fourth weeks after
acute inflammation suggests that a communication m ay not 
always form immediately but rather it takes some time for 
an area of necrosis to break down completely and allow 
fistula formation. It had been hoped that analysis of 
acute phase reactants within pseudocyst fluid ma  y have 
provided information about the presence of a fistula but 
the results were not helpful (Chapter 7).
A  potential method of interrupting the progression of 
this sequence of events is to remove the accumulated fluid 
using percutaneous needle aspiration of the pseudocyst. 
Experience shows that, to be effective, catheter drainage 
has to be employed or the aspiration repeated on several 
occasions (Chapter 6) and these techniques are not without 
comp lications.
178
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It would be of considerable value to be able to 
select patients in w h o m  it could be confidently predicted 
that their pseudocyst would resolve spontaneously and 
without complication. The differences in clinical and 
laboratory results between patients with resolving 
pseudocysts and those in w h o m  surgical drainage was 
performed have been stressed in Chapter 5.
The clinical features of abdominal distension, a 
palpable ma ss, a raised ser um amylase and leukocytosis 
occurred in a greater proportion of those undergoing 
surgery and in addition, more of the pseudocysts which 
were drained surgically were greater than 6cm in diameter 
on ultrasound scan.
It has been suggested that if a c omb ination of large 
diameter, raised serum amylase and elevated white blood 
cell count was present then spontaneous resolution was
unlikely to occur (Bradley 1982). The data in this thesis 
has been further examined taking into consideration five 
important features of pseudocyst formation viz. a diameter
of 6 cm; a serum amylase of 450 IU/1; a leukocytosis of
9
12x10 cells/1; a palpable abdominal mass; abdominal 
distension (Table 33) in an attempt to create an
assessment system for predicting spontaneous resolution. 
The features listed in Table 33 have been derived from the 
results in this thesis and were based on information
available at the time of pseudocyst diagnosis. The 
pseudocyst diameter, as determined by ultrasound scanning, 
is the central feature of this assessment system.
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The results for this system as applied to the 100 
patients from Glasgow Royal Infirmary and the 29 from 
Leeds, Bristol and G l asgow are detailed in Table 34.
The sensitivity and specificity of the system with 
respect to predicting spontaneous resolution if less than
3 criteria were positive, were greater in the Leeds, 
Bristol and Glasgow patients when compared to those from 
G l a s g o w  Royal Infirmary. Confirmation of the value and 
potential use of this system will only come when it is 
applied p r o s p e c t i v e 1y to patients who form pseudocysts.
An other important feature in relation to spontaneous 
resolution of a pseudocyst is the time for which a
collection has been present. The relevance of a period of
six weeks has been discussed in Chapter 1. The m e d i a n 
times to complete resolution were 45 and 90 days 
respectively for the Leeds, Bristol and G l a s g o w  and 
G l a s g o w  Royal Infirmary studies. These results suggest,
that in the ma j^O££ t^y_ o_f pa^t ^ e n t_£, a pseudocyst ma y  be 
safely observed for at least 12 weeks whilst waiting for 
spontaneous resolution to occur and before s ome f o rm o f 
surgical drainage becomes mandatory. During this waiting 
period it is essential that the pseudocyst is repeatedly 
assessed by ultrasonic or CT scanning. A progressive 
increase in size of a collection or any deterioration in 
the clinical condition of a patient may hasten surgical 
intervent ion.
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100 PATIENTS F R O M  
G L A S G O W  ROYAL INFIRMARY
P OSITIVE C R I T E R I A  <3 3 or more
R E S O L V I N G
PSEUDOCYSTS 11 7
DR A I N E D
PSEUDOCYSTS 2 0 3 7
SENSITIVITY 61%
SPECIFICITY 65%
2 9 PATIENTS F R O M  
LEEDS BR I S T O L  G L A S G O W
<3 3 o r m o  r e
12 3
1 11
80%
92%
TABLE 3 4 Results of assessment system applied to data from 100 
patients from Glasgow Royal Infirmary and 29 from Leeds, 
Bristol and Glasgow.
C a n £om£j_j_ca t_j_on£ o£ ££eudocy_sts be £r e d j_c t^ ed and avoided?
Pseudocyst fo rma tion is a serious c omplication of 
pancreatitis be it acute or chronic. The m o r t a l i t y  of 10% 
recorded in both groups of patients studied for this 
thesis is consistent with that recorded in the established 
literature which shows a range of mortality of 6-16% 
(Brilhar t and Pr iestley 1951; Grace and Jordan 1976; 
Hastings et al 1975; Hillis 1963; McConnell et al 1982;
Pollack et al 1978; Scharplatz et al 1972; Thomford and
Jesseph 1969). The major i t y  of deaths in the patients 
studied in this thesis resulted from at least one of the 
important complications viz. haemorrhage, sepsis, rupture, 
or obstruction all of which were stressed by Bradley 
(1982 ) .
Measurement of acute phase reactants, C-React ive 
protein in particular (Buchler et al 1986; Mayer et al
1985), and the use of contrast enhanced, dynamic CT
scann i ng (Cl av ien e t al 1988; Jeffrey et a 1 198 2 ;
Ki v i saa r i e t a 1 1 982 ; Lawson 19 83; Mainwaring et al 1989;
S i e g 1 ema n e t a 1 1980 ; van Sonnenberg et al 1985; Wh i t e e t
al 1986) are two i mp ortant techniques of disease
asses smen t that have been used with increasing f r equency
in the last few years in patients suffering acute 
pancreatitis. Both modalities give an indication of 
disease severity and CT scanning can reveal the m o r p h o 1ogy 
of a pseudocyst and the retroperitoneal area around the 
pancreas. The information available from this type of 
imaging has become an important adjunct in the management 
of patients with severe acute pancreatitis.
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Contrast enhanced dynamic CT scanning was performed 
in only 10 of the 129 patients considered in this thesis. 
With such a limited experience of this technique no 
corrment can be made on its value in the management of 
these patients but this technique becoming a valuable 
asses sme nt tool in the ma nag erne nt of patients with severe, 
complicated acute pancreatitis .
There are no reports of successful prophylactic 
measures designed to prevent the major complications 
caused by pancreatic pseudocysts. Theoretically, early 
percutaneous pseudocyst drainage could potentially protect 
against spontaneous rupture and obstruction by removing 
the fluid. Decompression of a large pseudocyst could also 
decrease the likelihood of ha emo rrhage fr om within the 
cav i t y .
The reported incidence of complications occurring in 
untreated pseudocysts varies between 18 and 42% (Becker 
and Pratt 1968 ; Gi 1 lman et al 1974 ; Thomford and Jesseph 
1969; Sankaran and Walt 1975). Bradley et al (1979) 
reported that an increasing proportion of patients 
developed complications when a pseudocyst had been present 
for more than 6 weeks. These authors used this data to 
support a policy of surgical intervention around this 
t ime .
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The m a j ority of their patients suffered alcohol 
induced pancreatitis and although their results have been 
quoted by others to support similar management (Beebe et 
al 19 84; Wade 1985), there is little additional evidence 
for the concept that the longer the delay to definitive 
treatment, the more likely complications will occur (Agha 
1984; Andersson et al 1989; Aranha et al 1983; Beebe et al 
1984; Lasson et al 1988; O'Malley et al 1985; Wade 1985). 
Indeed, the data in this thesis does not support the 
findings of Bradley et al (1979) which demonstrated an 
increasing proportion of patients suffering c o m p 1 icat ions 
the longer a pseudocyst r ema ined untreated.
Although c omp lications can occur in any patient with 
a pseudocyst the results in Ch apters 3 and 4 have 
highlighted the importance of the aetiology of the
antecedent acute pancreatitis. The mortality in the
Gl a s g o w  Royal Infirmary study was significantly greater 
in patients with gallstone induced acute pancreatitis (22% 
mortality) when compared to those with alcohol (5%
mortality) as the causal factor. Consideration must be 
given to concomitant biliary tract surgery at the time of 
pseudocyst drainage and prophylactic antibiotic therapy to 
reduce the incidence of septic complications (Imrie et al 
1988 ) .
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M A N A G E M E N T  OF  PATIENTS W H O  DEVELOP A  PSEUDOCYST
The m anagement of patients forming a pseudocyst has, 
in the main, been a policy of "wait and see" and, if
necessary intervene. This thesis has focussed on patients 
in w h o m  such a policy has been adopted. There is some
hope, however, that, in future, a change in mana g e m e n t  m ay 
decrease patient mo rtality and mo r b i d i t y .
What should be regarded as a basic plan of man a g e m e n t  
for patients with pseudocysts is outlined in Table 35. 
This scheme is based on conservative mana g e m e n t  of 
patients with a pseudocyst using repeated ultrasound or CT 
scanning and clinical assessment over a period of 4 to 6 
weeks then deciding the need and timing of intervention 
aimed at draining the collection. Complications are dealt 
with as they arise.
Emp loying an asses sme n t s y s t em as described in this
chapter would be of value if it could reliably predict
patients in w h o m  a pseudocyst was eventually going to 
resolve spontaneously without c omp lication or the need for 
any form of intervention. In addition, for those patients 
in w h o m  early estimation of outcome predicts that they 
will ultimately not resolve spontaneously, there is a 
place for an improvement in management involving planned 
intervention with the aim of reducing mortality and 
morbidity and decreasing the number of patients ultimately 
being subjected to formal operation. As suggested earlier 
such intervention could be achieved by percutaneous 
drainage and a proposed scheme of management incorporating 
early assessment and outcome prediction combined with 
percutaneous Hra i nanp 1 ^  t’-.k.I-'*.
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A  plan of this nature relies, to a considerable 
extent, on close cooperation between enthusiastic 
clinicians and radiologists to provide a complete 
investigative and therapeutic service at all times.
Percutaneous aspiration and drainage may not obviate 
the need for surgery in all patients and the technique is 
not without risk, but there is evidence to suggest that 
dec omp ression of a fluid collection leads to clinical 
improvement which allows time to plan elective drainage 
with the patient in a more favourable condition (Freeny et 
al 1988, van Sonnenberg et al 1989).
In future, the success of m o  re aggressive ma nag eme n t 
of patients with pseudocysts will depend on refinement of 
methods of assessment and interventional techniques.
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Importance of Cause in the Outcome of 
Pancreatic Pseudocysts
Clement W. Imrie, f r c s , Laura J. Buisl, f r c s , Michael G. Shearer, f r c s , G l a s g o w ,  S c o t l a n d
Among 100 consecutive patients with pancreatic 
pseudocysts, a biliar)’ cause for the preceding acute 
pancreatitis was found in 2 7 , for a mortality rate of 
2 2  percent. Patients with alcohol abuse as the cause 
had a more favorable prognosis, with a 5 percent 
mortality rate among 59  patients (p < 0 .0 5 , chi- 
square test). Despite an age difference between the 
two groups, we consider that this feature of patients 
with pancreatic pseudocyst warrants attention and 
we make recommendations herein with respect to 
therapy. Pseudocysls developed in 86  patients con­
sequent to an episode of acute pancreatitis, and all 
12 deaths (1 4  percent) were in this group. None of 
the remaining 14 patients whose pseudocysts were a 
feature of chronic pancreatitis died. Of the 81 pa­
tients in whom amylase levels were measured, 76  
percent had an increased level.
A lthough pancreatic pseudocyst is a well-documented and interesting complication of pancreatitis, the lit­erature on the subject is beset by two major problems. 
The first is that differentiation between pseudocysts asso­
ciated with chronic pancreatitis and those consequent to 
an attack of acute pancreatitis is infrequently stressed [7- 
5]. One study particularly emphasized the higher mortal­
ity rate associated with acute pancreatitis compared with 
the chronic condition [<5]. The second problem is that the 
cause of the pancreatitis in relation to the disease’s out­
come has not been studied previously. This may partly be 
because gallstones were considered a causal factor in only 
a small proportion of the total number of patients in the 
majority of studies, with 17 to 25 percent being the high­
est figures encountered [7-3,5,7,8]. The major purpose of 
the present study is to focus on the various outcomes in 
patients with pancreatic pseudocysts associated with al­
cohol abuse, gallstones, and trauma, using data derived 
predominantly from prospective studies of patients with 
acute pancreatitis seen from 1971 to 1984 in the Glasgow 
Royal Infirmary. In addition, more light is shed on the 
incidence of hyperamylasemia among these patients. We 
also discuss the lower mortality rate when pseudocysts 
were an incidental finding in patients with chronic pan-
From the Division of Surgery, Royal Infirmary, Glasgow, Scotland.
Requests for reprints should be addressed to Clement W. Imrie, 
FRCS, Department of Surgery, Wards 34-36, Glasgow^ Royal Infirma­
ry, Glasgow G4 OSF, Scotland.
creatitis compared with pseudocysts found as a conse­
quence of acute pancreatitis.
PATIENTS AND METHODS
Eighty-five patients (85 percent) were documented as 
having pancreatic pseudocysts during prospective studies 
commencing in January 1971, and 15 cases were docu­
mented in a mainly retrospective study between 1962 and 
1970 [9]. Pseudocysts developed in 86 patients (86 per­
cent) after emergency hospital admission for an episode 
of acute pancreatitis. Only 14 pseudocysts were detected 
in patients with chronic pancreatitis. They were docu­
mented during elective admission for pseudocyst treat­
ment. Symptoms of chronic pancreatitis subsequently de­
veloped during the follow-up period in two other patients.
Of the patients studied, 62 of the 86 with pseudocysts 
consequent to acute pancreatitis derived from our own 
hospital catchment area, in which 879 patients with acute 
pancreatitis were admitted during the same time period. 
The incidence of pseudocysts as a complication of acute 
pancreatitis was therefore 7 percent overall, being more 
common in those with an alcohol-related cause (11.5 
percent) than in those with gallstones (4 percent). The 14 
patients with chronic pancreatitis and pseudocysts repre­
sented only 7 percent of those screened at the hospital 
over this period.
The management of patients with acute pancreatitis 
at our hospital is initially conservative in patients with 
gallstones and in those with alcohol abuse as the causes 
[70,77]. Only those with trauma as the cause undergo 
immediate laparotomy. A minority of gallstone patients 
in this period were operated on early in the course of the 
disease, but the hospital policy from 1978 onward ihas 
favored definitive biliary surgery during the same admis­
sion. This has been detailed in previous publications 
[72,75], including the earlier policy of delayed interven­
tion in patients with gallstones, those patients being usu­
ally readmitted for elective or semielective surgery [14].
The diagnosis of pancreatic pseudocyst was only ac­
cepted if there was a combination of clinical findings 
together with positive biochemical data, imaging data, or 
both. The most frequent and significant clinical signs 
were pain, abdominal distention and epigastric fullness, 
vomiting, anorexia, and weight loss. Other symptoms of 
obstructive jaundice and gastrointestinal hemorrhage oc­
curred infrequently. A secondary or persistent increase in 
the serum amylase level, urinary amylase level, or both 
was the most frequent biochemical abnormality. In the 
early years of the study, a barium meal study with lateral 
erect views was the most common imaging technique, but 
with the introduction of ultrasonography, the latter be­
came the method of choice. The value of ultrasonography 
in this situation has been frequently stressed, not only for 
its facility in detecting pseudocysts, but for monitoring
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TABLE I
Causes of Pseudocysts
Cause Total Men W omen
Alcohol abuse 59 49 10
G allstones 27 13 14
Unknown 9 6 3
Trauma 4 2 2
Postop 1 1
Total 100 70 30
their progression or regression [15-17]. In a few in­
stances, computerized tomographic scanning was' also 
used to provide supplementary information, but this was 
not a routine procedure.
In most patients (78 percent), the pseudocyst was 
confirmed at operation or at the time of drainage by other 
methods. In others, it was monitored by ultrasonographic 
scans or barium meal study. In 97 percent of patients, the 
pseudocyst had a minimum diameter of 5 cm, the excep­
tions being three patients with smaller cysts occurring in 
the head of the pancreas.
The Student’s t test and the chi-square test were the 
statistical methods used.
RESULTS
There were 70 male and 30 female patients, the men 
having a mean age of 43.7 years and the women, 47.7 
years. Forty-nine of the 59 patients (83 percent) in whom 
alcohol abuse was considered the primary cause of pan­
creatitis were men, whereas just under 50 percent of the 
27 with gallstone-associated disease were men (Table I). 
Those considered to have alcohol abuse as the cause all 
drank in excess of 80 g of alcohol per day, and had done so 
for many years. In many, heavier bouts of drinking imme­
diately preceded the episode of acute pancreatitis.
Blunt abdominal trauma was considered to be the 
cause of pancreatitis in four patients. The pseudocyst 
developed in one patient after an episode of postcholecys­
tectomy pancreatitis. The remaining nine patients had no 
clear cause identified. A history of moderate alcohol in­
take was obtained in two of the patients with a gallstone 
cause and in three of the patients in the trauma group. 
Four of the 59 patients who had alcohol abuse as the 
primary cause had another factor identified as well. Two 
were subsequently found to have stones in the gallbladder 
only, whereas one had positive viral titers for Coxsackie B 
infection. In addition, an annular pancreas was identified 
at a later date in another patient.
In 81 patients (81 percent), the serum amylase level 
was estimated at the time of diagnosis (Phabedas meth­
od, normal range 150 to 300 IU/liter). In 37 patients, 
amylase levels were also measured in the urine (upper 
limit of normal, 1,300 IU/liter). In 27 patients (33 per­
cent), the serum amylase level exceeded 1,200 IU/liter, 
and in an additional 35 (43 percent), it was in the range of 
300 to 1,200 IU/liter. The urine amylase level was above 
3,000 IU/liter in 17 (46 percent) of the 37 patients in 
whom it was measured. When all those with a serum 
amylase level in the equivocal range (300 to 1,200 IU/
TABLE II
Operations, Deaths, and Causes of 
Pancreatic Pseudocyst
Operation Total GS Other D eaths
Cystogastrostom y 50* 27
External drainage 11 5
Roux-Y loop drainage 71 4
Distal resection 8 6
Cystoduodenostomy 3* 3
Aspiration at laparotomy 4* 4
* Three patients required a second  cystogastrostom y.
' One patient had a  Roux-Y loop plus cystogastrostom y. 
f One patient required a cystoduodenostom y and cystogastrostom y.
* One patient had aspiration followed by cystogastrostom y.
AA =  alcohol abuse; GS =  gallstones.
liter) were included, an abnormally increased amylase 
level was present in 62 of the 81 patients (76 percent).
Spontaneous regression occurred in 22 of the 100 
pseudocysts (22 percent), usually within 6 weeks of diag­
nosis. The median size of these resolving pseudocysts was 
8 cm (range 3 to 10 cm).
Seventy-six patients underwent a total of 80 opera­
tions (Table II). Cystogastrostomy was the most frequent 
operation and was performed in 50 patients, 3 of whom 
required a second operation because the pseudocyst re­
curred. In each of these patients, an additional cystogas­
trostomy was carried out with success. One patient treat­
ed by initial aspiration of small pseudocysts in the head of 
the pancreas at the time of laparotomy required a second 
operation for a subsequent larger pseudocyst several 
months later, and a cystogastrostomy was then per­
formed. In three more patients with multiple small pseu­
docysts in the head of the gland, simple aspiration at 
laparotomy proved to be an adequate procedure. Two 
patients had a combination of procedures to drain bilocu- 
lar pseudocysts in the body and head of the pancreas. One 
had a cystogastrostomy and a cystoduodenostomy, and 
the other had a cystogastrostomy and Roux-Y loop drain­
age of the lesion in the pancreatic head.
Six patients died after cystogastrostomy for a 12 per­
cent mortality rate. The highest mortality rate associated 
with surgery occurred in those treated with external 
drainage (45 percent) (Table II). This operation was 
performed when the pseudocyst wall was immature, usu­
ally relatively early after the first clinical suspicion of the 
diagnosis. Sepsis was not present at the time of operation.
Death occurred in 12 of the 100 patients, all of whom 
underwent operation. Those in whom gallstones were 
considered the primary cause had a mortality rate of 22.2 
percent, which was four times greater than that in pa­
tients with pseudocysts associated with alcoholJtbuse (p 
<0.05, chi-square test) (Table IIIj.
Overall, 50 percent of the patients who died from 
pancreatitis had a gallstone cause. An outline of the ma­
jor complicating factors, together with age, cause, and 
operative procedurein the 12 patients who died, is provid­
ed in Table IV. The three youngest patients (all less than 
40 years of age) had alcohol abuse as the cause, whereas 
the age range for biliary disease was 52 to 70 years (mean
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TABLE III
Causes of Death
Cause Total Deaths %
Gallstones 27 6 22
Alcohol 59 3 5
Unknown e 2 22
Trauma 4 1 25
P ostop t
age 59 years). The major cause of death was sepsis (seven 
patients), with severe hemorrhage occurring in three. 
Two of the remaining patients also had this complication. 
The other deaths were associated with a recurrence of 
pancreatitis in one patient, cardiorespiratory failure in 
another patient, and total pancreatic necrosis compound­
ed by a possible myocardial infarction in the final patient 
(Table IV).
Percutaneous aspiration of the pseudocyst was the 
primary procedure in six patients, but in four of these 
patients the pseudocyst recurred and surgery was neces­
sary. Therefore, this procedure alone was only successful 
in two cases.
One of these six patients died, and he was the oldest 
patient in the group who died. He had long-standing 
cardiorespiratory disease and, although the initial at­
tempts at aspiration were successful, reaccumulation of 
fluid occurred so rapidly that surgery was deemed neces­
sary. At operation, a large piece of peripancreatic slough 
weighing 160 g was removed from the depths of the 
pseudocyst. This patient also had significant abnormali­
ties in the results of liver function tests, suggesting that 
gallstones may have been responsible for the pancreatitis. 
However, family permission for a postmortem examina­
tion was refused.
None of the 14 patients with pseudocysts associated 
with chronic pancreatitis died. Therefore, the mortality 
rate in patients who had pseudocysts complicating an 
attack of acute pancreatitis was 14 percent, and the mor­
tality rate was 0 in the smaller group of 14 patients w'ith 
pseudocysts complicating chronic pancreatitis.
COM M E N T S
Problems arise as to what constitutes a pancreatic 
pseudocyst. For this reason, the definition we used is 
described in detail in the “Patients and Methods" section. 
As noted in our introduction, few previous reports have 
made reference to the proportion of patients in whom the 
pseudocyst is a consequence of a documented attack of 
acute pancreatitis, as opposed to those in whom such 
complications develop in association with chronic pancre­
atitis. In the present study, it is clear that the former 
group constituted the majority of our patients. This group 
had a significantly higher mortality and morbidity rate 
than the group associated with chronic pancreatitis.
This is an important point, and in future studies of the 
subject, there should be a clear differentiation between 
these two groups of patients based on their clinical pre­
sentation. Most studies emanating from North America 
have a preponderance of pseudocysts resulting from alco-
TABLE IV
Deaths Associated with Pancreatic Pseudocysts
Ape (yr)
& Sex Cause O peration C ause  of D eath
48. F Trauma ED Septic  shock
86, M Gallstone ED S eptic  shock, renal failure
53, F Gallsione ED Duodenal fistula, recu rren t AP
57, M Gallstone CG hem orrhage. AF
39, M Alcohol ED R espiratory failure
52, M Gallstone Roux-Y Sepsis
29. M Alcohol CG S epsis
57, M Gallstone CG Ml
70. M Gallstone CG S epsis , hem orrhage
35, M Alcohol CG S epsis , hem orrhage
71, M Unknown* ED S ep sis , hem orrhage
60. M Unknown CG H em orrhage
* Patient had abnorm al results on liver function te s ts  suggesting
gallstones, but cause ot d isea se  w as regarded  a s  unknown.
AF =  atrial fibrillation; AP =  acu te  pancreatitis; CG =  cy sto g astro s­
tomy; ED =  external drainage; Ml =  myocardial infarction.
hol-associated chronic pancreatitis [1,4-7], which biases 
both treatment and outcome, as has been suggested previ­
ously [4]. Our results emphasize the importance of the 
cause of pancreatitis in determining outcome in patients 
with pancreatic pseudocysts, specifically the mortality 
rate for those with a gallstone cause that was four times 
greater than that in patients with alcohol abuse as the 
cause. Although the age difference between the patients 
with the two major causes was significant (alcohol group, 
mean age 39 years and gallstone group, mean age 53 
years, p <0.05 by Student’s t test), other factors must be 
taken into account.
The cause of death in seven patients was overwhelm­
ing postoperative sepsis, and this was complicated by 
gastrointestinal hemorrhage in three. Two additional pa­
tients had hemorrhage as the primary cause of death. In 
both patients, it occurred several weeks after the initial 
cystogastrostomy.
Sepsis w'as present in both of the young patients who 
died w'ith alcohol-associated pseudocysts, whereas four of 
the six patients with unequivocal evidence of gallstones 
had septicemia. The disturbing prevalence of death in the 
gallstone group and the high incidence of sepsis underline 
the necessity for close clinical supervision. It seems wise, 
therefore, that patients with a biliary cause of pancreati­
tis be cared for more diligently.
In view of the major risk of sepsis and hemorrhage 
complicating pseudocyst drainage, it is sensible to remove 
all gallstones at the same operation in order to minimize 
the risk of cholangitis and possible septicemia in the post­
operative period. This will lengthen the time of the pri­
mary operation for drainage of the pancreatic pseudocyst 
but may be an important step tow-ards reducing the mor­
tality and morbidity rates of this condition. We also rec­
ommend administratioh of appropriate prophylactic anti­
biotics in the form of an aminoglycoside, a modern 
cephalosporin, or a modified penicillin.
Hemorrhage' during and after pseudocyst drainage 
can be an awesome surgical problem [18,19). Incorpora­
tion of the splenic artery and vein into the posterior wall
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of the pseudocyst is the most common source of bleeding, 
and preoperative angiography can be helpful to forewarn 
of this problem. At operation, needle aspiration of the 
pseudocyst to determine the nature of the fluid content 
was of value before definitive drainage. Of the five pa­
tients who died with associated hemorrhage, four bled 
heavily from the pseudocyst at the time of surgery. In one, 
bleeding derived from an artery stretched across the in­
ternal diameter of the pseudocyst to the point of rupture. 
In the remaining patients, bleeding was from the wall of 
the pseudocyst and proved difficult to control.
Arterial embolization might have been utilized in 
these patients by means of angiographic techniques, but 
in most, this preoperative procedure was not performed. 
A patient in whom a stretched artery within the pseudo­
cyst ruptured did survive only to die many days later from 
sepsis. The hazards of both sepsis and hemorrhage in 
patients with pancreatic pseudocysts has been highlight­
ed by others [4,7,18,19], To our knowledge, this is the 
first study that brings into focus the increased risk of 
sepsis and hemorrhage in patients with a pseudocyst after 
gallstone-induced pancreatitis.
The need for an accurate clinical definition of a pseu­
docyst becomes important when assessing the patients in 
whom the lesion resolves spontaneously. During the pro­
spective phase of our study, regression of pseudocysts was 
monitored with ultrasonographic scanning in the major­
ity of patients. This was usually associated with both 
clinical improvement and a return of the blood and urine 
amylase levels to within normal limits. Our experience 
concurs with that of Bradley et al [7] and Bradley and 
Clements [17] who reported that spontaneous regression 
6 vyeeks after diagnosis is relatively uncommon.
Although many medical textbooks mention the possi­
bility of hyperamylasemia in a patient with a pseudocyst, 
the frequency with which this is recorded varies consider­
ably (11 to 100 percent) [2,20], Seventy-six percent of 
patients in our study who had amylase monitoring dem­
onstrated an increase in either the blood or urine amylase 
iovel. It is recognized that if recurrent pain develops in a 
patient with an increased serum amylase level, an in­
creased urinary amylase level, or both (perhaps associ­
ated with epigastric fullness and an abdominal mass) 
after an attack of acute pancreatitis, then there is a high 
probability that a pseudocyst is present. Further investi­
gations should then be performed and, if necessary, re­
peated to confirm or refute this diagnosis.
Finally, six patients underwent percutaneous aspira­
tion of a pseudocyst as the first method of treatment. 
Surgical drainage became necessary in four of them. Our 
more recent experience with this technique has produced 
similar results, and we have not found the success rates 
quoted by other investigators in small studies [21,22], We 
have only infrequently used repeated aspirations or
prolonged catheter drainage for fear of introducing infec­
tion.
This predominantly prospective study allowed more 
careful assessment of the role of cause in the outcome of 
pancreatic pseudocyst than had previously been achieved. 
It also enabled further data on the frequency of amylase 
elevation in blood and urine to be recorded for such pa­
tients, adding useful information to the characterization 
of this complication after an episode of acute pancreatitis.
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CONTROLLED CLINICAL TRIAL OF PERITONEAL LAVAGE FOR T H E  T R EA TM EN T OF
SEVERE ACUTE PANCREATITIS
A. D a v id  M a y e r , F.R.C.S, M ic h a e l  J. M c M a h o n , Ph.D., C h .M . ,  F.R.C.S., A n d r e w  P. C o r f i e l d , F.R.C.S., 
M a r t i n  J. C o o p e r , M.S., F.R.C.S., R o b in  C.N. W i l l ia m s o n , M .D., M .C h i r ., F.R.C.S.,
A l a n  P. D ic k s o n , F.R.C.S., M ic h a e l  G. S h e a r e r , F.R.C.S., a n d  C l e m e n t  W. I m r ie , F.R.C.S.
A b stract W e perform ed a multicenter, random ized, co n ­
trolled clinical trial of therapeutic peritoneal lavage  (2 liters 
per hour for three days) in 91 patients with se v e r e  acute  
pancreatitis. P atients w ere entered into the study if se v e re  
pancreatitis w a s indicated by multiple laboratory criteria or 
diagnostic peritoneal lav a g e . All patients received  full su p ­
portive treatm ent. The m edian time betw een the o n se t of 
sym ptom s and random ization w a s 38 hours. Forty-six pa­
tients v/ere a ss ig n ed  to the control group and 4 5  to the 
lavage group. There w ere 13 deaths (28 per cent) and 16
DESPITE improvements in intensive medical care, the mortality rate for patients with early signs of 
acute pancreatitis remains as high as 40 to 60 per 
cent.1'4 Experimental studies have suggested that bio­
logically active compounds accumulate in peritoneal 
fluid and are responsible for the shock-like systemic 
illness that is characteristic of the acute phase of severe 
pancreatitis.5'8 If this hypothesis is correct, it is rea­
sonable to attempt to modify the natural history of the 
disease by removing the ascitic fluid by means of peri­
toneal lavage.
Since Wall9 and Gjessing10 independently de­
scribed clinical improvement in a few patients with
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patients with major com plications (35  per cen t) in the c o n ­
trol group, a s  com pared  with 12 d e a th s  (27 per cent) and  
17 patients with major com plications (38 per cent) in the  
lavage group. L avage did not ap p ear  to m odify the length  
of survival, the in c id en ce  of pan creatic  co llection s (p se u ­
d ocysts or a b s c e s s e s ) ,  or the p lasm a a m y la se  co n cen tra ­
tion. C onsidering the statistical pow er of the d esign , w e  
conclude that the outcom e of se v e re  pancreatitis w a s not 
greatly, if at all, influenced by the regim en of peritoneal la­
vage  used  in this study. (N Engl J Med 1985; 312:399-404 .)
acute pancreatitis in whom lavage had been used, 
there have been several enthusiastic anecdotal reports 
on lavage therapy,11'16 but only two randomized con­
trolled trials have been described. Stone and Fabian17 
reported a significant reduction in mortality in pa­
tients with alcohol-related pancreautis, but the results 
are difficult to interpret because many patients were 
removed from the control group after 24 hours. An inter­
im report on a Swedish study18 included too few pa­
tients for a conclusive result to be expected but showed 
no evidence of a trend in favor of lavage therapy.
The majority of patients with acute pancreatitis 
have a benign, self-limiting disease for which a treat­
ment as invasive as peritoneal lavage is both unneces­
sary and potentially harmful.3 Furthermore, in a 
therapeutic trial the efTect of such treatment on the 
more severely ill patients becomes obscured if large 
numbers of patients with mild attacks are included. It 
is only the recent emergence o f  reliable prognostic cri- 
teria1,3,19 that has made a trial o f  therapeutic lavage 
feasible. Even if the only patients considered arc those 
with severe attacks, the number of patients required to
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achieve a result within a realistic period precludes a 
single-center study.
In order to evaluate the clinical application of thera­
peutic peritoneal lavage, we have carried out a multi­
center, prospective, randomized, controlled clinical 
trial in 91 patients with objective evidence of severe 
acute pancreatitis.
M e t h o d s
B etw een Septem ber 1981 and February 1984, 413 patients with 
428 attacks o f  acute pancreatitis were referred by clinicians in 24 
hospitals to a coordinator at one o f  three centers. All patients were 
exam ined by the coordinator as soon as possible after referral and 
were considered suitable for inclusion in the study if  the following  
criteria were met: the diagnosis o f acute pancreatitis had been estab­
lished on the basis o f  consistent clinical findings and a plasm a am ­
ylase level above 1200 IU  per liter, or at diagnostic laparotom y (in 
three patients only); severe pancreatitis was predicted either by the 
findings o f  d iagnostic peritoneal lavage19 or by m ultiple laboratory 
criteria20 w ith in 48 hours o f adm ission to the hospital (Table 1); 
there w ere no m edical contraindications to either o f the treatment 
iCgimens stipulated by the protocol (e.g ., m ultiple laparotom y  
scars); and inform ed consent had been obtained from the patient or 
relatives and from the attending clinician.
Patients w ho satisfied these criteria were random ly assigned by 
sealed envelope to receive either standard conservative treatment 
(control group) or the sam e standard treatm ent plus therapeutic 
peritoneal lavage (lavage group). T he study was approved by the 
ethics com m ittees o f  the participating hospitals.
Standard Conservative Treatment
T his treatm ent was continued for at least three days. A nasogas­
tric tube w as inserted into the stom ach and aspirated hourly. Intra­
venous crystalloid solutions were given according to clinical re­
quirem ents and were supplem ented by plasm a in order to m aintain  
a positive central venous pressure. O xygen therapy, based on arteri­
al blood gas analysis, was adm inistered by face mask if arterial 
oxygen tension (P O 2) was less than 9 kPa; assisted ventilation was 
instituted  i f  oxygen therapy was unsuccessful in m aintaining the 
P O ?. A ntib iotics were prescribed only if there was clinical evidence 
o f  concurrent infection.
Peritoneal Lavage
Lavage was carried out with a standard peritoneal dialysis can­
nula (T rocath, M cG aw  Laboratories, G lendale, Calif.). T he sam e 
cannula was used for both diagnostic and therapeutic peritoneal 
lavage. W ith use o f  an aseptic technique and local anesthesia with  
lidocaine (2 per cent) and epinephrine (1:200,000), the cannula was 
introduced into the pelvis through a 5-m m  m idline subum bilical 
incision. After, aspiration o f any free ascitic fluid, diagnostic lavage  
. was performed with 1 liter o f isotonic sa lin e .19 T herapeutic lavage 
was instituted with hourly 2-liter cycles o f  a warmed, balanced, 
isotonic peritoneal dialysis solution (Dialafiex 61, Boots Ltd., N ot­
tingham , U .K .) to w hich 4 mm ol o f  potassium  chloride and 250 IU  
o f sodium  heparin per liter had been added. T he hourly volum e  
infused was reduced to 1 liter in two patients with respiratory diffi­
culties. Sam ples from the lavage effluent were obtained initially and 
then every 12 hours and were sent for bacteriologic exam ination. 
Lavage was continued for 72 hours or for longer if the lavage return 
fluid rem ained dark-colored (two patients only). Therapy was close­
ly supervised by the coordinator in order to ensure uniformity o f 
m anagem ent, and clinical progress was monitored throughout the 
hospital adm ission. All patients who survived were followed in the 
outpatient departm ent for at least six weeks.
Com plications w ere classified as fatal, major, or minor. Pancreat­
ic necrosis, pancreatic or peripancreatic fluid collections, intraab­
dom inal abscess, septicem ia, cholangitis, renal failure, gastrointesti­
nal hem orrhage, venous throm boem bolism , diabetes requiring  
insulin therapy, and pulm onary com plications associated with hy­
poxem ia (P O j above 8 kPa) or with abnormal radiologic signs were
Fcb- I*, 1985
Table 1. Prognostic System s Used to Select Patients for Inclusi 
in the Trial. n
1. Multiple laboratory criteria
Severe pancreatitis w a s  predicted if three or m o r e  of the following 
criteria w e r e  m e t  during the first 4 8  hours of admission:
1. B l o o d  white-cell count > 1 5 0 0 x i 0 9 per liter
2. P l a s m a  glucose >  10 m m o l  per liter a n d  n o  previous history of 
diabetes
3. P l a s m a  urea > 1 6  m m o l  per liter an d  not falling for six hours
4. P l a s m a  lactate de h y d r o g e n a s e  > 6 0 0  I U  per liter
5. P l a s m a  aspartate aminotransferase > 2 0 0  I U  per liter
6. P l a s m a  uncorrected c a lcium < 2 . 0  m m o l  per liter
7. P l a s m a  a l b u m i n  < 3 2  g  per liter
8. Arterial blood P 0 2 < 8 . 0  k P a
II. Diagnostic peritoneal lavage
Severe pancreatitis w a s  predicted if o n e  or m o r e  o f  the following 
criteria w e r e  met:
1. M o r e  than 2 0  m l  of ascitic fluid
2. Dark-colored ascitic fluid*
3. Peritoneal lavage fluid darker than a pale straw color.*
*A standard color chart was used to  assess fluid co lo r.19
defined as m ajor com plications. B acteriologic evidence o f  a respira­
tory tract infection w ithout hypoxem ia and w ithout abnorm al ra­
d iologic signs, bacteriuria w ithout system ic signs o f  sepsis, and a 
transient psychosis associated w ith alcohol w ithdraw al were all de­
fined as minor com plications.
Because there is no generally  accepted defin ition that distin­
guishes a pancreatic abscess from an infected pancreatic pseudo­
cyst,21 the term “pancreatic collection” was used to describe a col­
lection o f  fluid w ith in the pancreas or peripancreatic tissues (i.e., 
either a pscudocyst or an abscess). A pancreatic collection was de­
scribed as infected if  bacteria were cultured from sam ples o f fluid 
w ithin it.
Statistical Analysis
D uring the design o f  the study, analysis o f  the perform ance o f the 
prognostic system s suggested that about 70 per cent o f  the patients 
w ho were random ly assigned to the control group w ould have a fatal 
or major com plication .19-20 C onsideration o f  the T ype I and Type II 
errors22 indicated that it w ould be reasonable to analyze the results 
after 40 patients w ith severe pancreatitis had been entered into each 
group. This w ould give a pow er o f  90 per cent for detecting a 50 per 
cent reduction in m ortality and major m orbidity in the lavage group 
at a two-tailed significance level o f  P < 0 .0 5 . As a result o f this 
analysis, the trial was concluded after 11 additional patients who 
had already entered the study had com pleted the protocol.
T he two-tailed norm al approxim ation o f  W ilcoxon’s two-sample 
rank-sum test (z), corrected for continuity, and the chi-square test, 
incorporating Y ates’ correction for continuity, were used to test for 
statistical significance.
R e s u l t s
Inclusions, Exclusions, and Withdrawals
Of the 428 attacks of acute pancreatitis in patients 
referred for assessment, 118 were predicted to be se­
vere by the prognostic criteria. The mortality and 
morbidity rates associated with these 118 attacks were 
26.3 per cent and 34.7 per cent, respectively (31 
deaths, 24 nonfatal pancreatic collections, and 17 oth­
er major complications), as compared with a 2.9 per 
cent mortality rate and a 10.0 per cent morbidity rate 
associated with the 310 attacks that were predicted to 
be mild (9 deaths, 12 nonfatal pancreatic collections, 
and 19 other major complications).
Data on 25 of the attacks that were predicted to 
be severe were excluded from t h e  analysis b e c a u s e
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(1) prediction of severe pancreatitis by multiple labo­
ratory criteria was delayed for more than 48 hours 
after admission (19 attacks with 1 death and 6 major 
complications); (2) abdominal scars precluded lav­
age (5 attacks with 1 death and 1 major complication); 
or (3) peritoneal dialysis was required in order to 
treat acute renal failure (1 attack with 1 death). In 
addition, two patients who were initially thought to 
have severe pancreatitis on the basis of laboratory 
criteria were withdrawn from the study because the 
clinical diagnosis was found to be erroneous. One 
had a thoracoabdominal aortic aneurysm with bilat­
eral renal infarction; the other, who had infected, 
bile-stained peritoneal fluid, had a perforated gall­
bladder. Both patients died within 24 hours of admis­
sion, and neither had evidence of acute pancreatitis 
at autopsy. Diagnostic peritoneal lavage revealed an 
erroneous clinical diagnosis in three other patients 
who had been referred to the study: two had perfora­
tions of the biliary tract, and one had a perforated 
duodenal ulcer.
Comparability of Groups (Table 2)
Forty-five patients assigned to the lavage group and 
46 assigned to the control group were retained in the 
trial. There was a preponderance of men in the lav­
age group and of women in the con­
trol group (chi-square = 4.20,
P<0.05), but the two groups were 
well matched for age, etiologic fac­
tors, and clinical and biochemical 
indexes of severity. There was no 
significant difference in the dura­
tion of sym ptom s (z =
P =  0.53) or in the delay from the 
diagnosis of pancreatitis to ran­
domization (z =  0.916, P = 0.36).
Mortality and Morbidity (Table 3)
There were 12 deaths and 17 pa­
tients with major complications in 
the lavage group (27 per cent mor­
tality and 38 per cent morbidity) 
and 13 deaths and 16 patients with 
major complications in the control 
group (28 per cent mortality and 35 
per cent morbidity). If the true dif­
ference in mortality and major mor­
bidity was 50 per cent, the prob­
ability that this result was due to a 
Type II error (at a two-tailed sig­
nificance level o fP <0.05) is 0.11.
The median age of the patients 
who died was 70 years; only one 
was under 50. Five of these patients 
had gallstones and three had alco­
holism. The cause of death remains 
obscure in 17 patients, although au­
topsies were not performed in 6. Six 
patients in the lavage group and
eight in the control group died within one week 
of admission from multiorgan failure associated with 
fulminant pancreatitis, but the timing of death in 
the two groups was not sign ificantly  different 
(z =  1.109, P =  0.267). Nine of the 14 early deaths 
were attributed to pulmonary complications. In addi­
tion, one patient in each treatment group died from 
acute renal failure, and one patient in the lavage group 
and two in the control group died from cardiovascular 
failure.
The fatal and major complications are listed in 
Table 3. The proportion of patients with a compli­
cation, the incidence of individual complications, and 
the time spent in the hospital were similar in the two 
groups. Thirty patients who survived the first week of 
the illness acquired a pancreatic collection, which 
was recognized at a median time of 21 days after ad­
mission (range, 4 to 42). Eight of the 14 collections 
in the lavage group (57 per cent) were infected, as 
compared with 6 of the 16 in the control group (37 
per cent). This difference was not significant (chi- 
square =  0.50).
The mean plasma amylase concentrations during 
the first five days after admission in the two groups of 
patients are shown in Figure 1. Amylase levels did not 
appear to be influenced by peritoneal lavage.
Table 2. Comparison o f  Clin ical,  Biochemical, and Etiologic Factors in Patients Who 
Were Included in the Trial.’*
Lavage Group 
(N =  45)
C ontrol G roup 
(N =  46)
M e a n  a ge ± S . D . 5 7  ± 1 9 59c; 18
S e x  (M/ F ) 29/16 18/28
Previous pancreatitis 4 3
Ischemic heart disease 3 8
Prov e d  gallstones 16 16
Alcohol abuse 13 11
H o u r s  f r o m  onset of s y m p t o m s 2 6  (8-108) 2 8  (4-96)
to admission —  m e d i a n  (range)
H o u r s  f r o m  admission to ran­ 12 (1-48) 5 (0-48)
domization —  m e d i a n  (range)
C o m a t o s e  o n  admission 4 4
Systolic blood pressure < 1 0 0  m m  H g 4 3
A b d o m i n a l  rigidity 3 9 3 9
P O ; < 8  IcPa 21 15
White-cell count < 1 5 0 0 x 1 0 * 2 8 2 7
Glucose > 1 0  m m o l  per liter 18 19
U r e a  > 1 5  m m o l  per liter 6 6
Multiple criteria score
< 3 21 19
3 -4 18 2 0
> 4 6 7
Predicted "severe" b y  diagnostic 37 31/34 t
peritoneal lavage
Predicted "severe" b y  both 
prognostic systems
16 12/34 t
‘ Figures are num bers o f patients except w here otherw ise indicated
*Ortly 34 of the 46 patients in the control group underwent diagnostic pentoneal lavage.
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Com plications of Lavage
None of the deaths in the lavage group was attribut­
ed to peritoneal lavage. However, respiratory difficul­
ties may have been caused by the therapy in two 
patients, and severe lower abdominal and scrotal 
swelling occurred in another, presumably because of 
leakage of fluid into the abdominal wall. One other 
patient, who had symptoms of alcohol withdrawal, 
refused further lavage after four cycles. In addition, 
the lavage cannula was inadvertently introduced into 
the urinary bladder in one patient. It was repositioned 
into the peritoneal cavity without untoward sequelae.
The patients in the lavage group lost a median of 
44 g of protein per day into the lavage effluent (range, 
23 to 160 g per day) and were given significantly more 
intravenous plasma over the initial three days (medi­
an, 2900 ml; range, 0 to 13.800) than were the patients 
in the control group (median, 400 ml; range 0 to 8100) 
(PC0.01).
With the exception of the patient with a perforated 
gallbladder (who was withdrawn from the study), 
none of the study patients had bacteria detected on 
microscopy of the initial sample of free peritoneal fluid 
or of subsequent samples of lavage return fluid. In four 
patients (one in the lavage group and three in the 
control group) a scanty growth of coliform bacteria 
was obtained after culture of the free peritoneal fluid. 
Two of these four patients (both in the control group) 
died —  one from fulminant pancreatitis with early 
abscess formation, the other as a result of an infected 
pancreatic collection; in a third patient (in the lavage 
group) a sterile pancreatic collection developed. Or­
ganisms were also cultured from the therapeutic 
lavage effluent in four patients; one died from pulmo­
nary complications and another had a sterile pancre­
atic collection, but none of them had intraperitoneal 
septic complications.
D i s c u s s i o n
This study evaluated peritoneal lavage therapy in a 
selected group of patients with objective signs of severe 
pancreatitis. The prognostic systems proved reliable 
for the identification of severe disease: the overall mor­
tality rate for the 91 patients studied was 27.5 per cent, 
which contrasts with a 2.9 per cent mortality rate for 
the patients with 310 attacks that were assessed as 
mild by the prognostic criteria.
Therapeutic lavage did not appear to influence ei­
ther mortality or morbidity. This finding contrasts 
with the results of the controlled trial carried out by 
Stone and Fabian,17 as well as with favorable reports 
on lavage in experimental pancreatitis.23'26 The delay 
between the onset of pancreatitis and the beginning of 
lavage therapy may account for the discrepancy be­
tween experimental results and the results of this clini­
cal trial. The median time between the onset of symp­
toms and randomization was 38 hours (range, 4 to 
132). Even if therapy had been started as soon as the 
diagnosis of acute pancreatitis was made, without
Table 3. Fatal and Major Complications in the 91 Patients with 
Acute Pancreatitis Who Were Included in the Trial.
C o m p l ic a t io n L a v a g e  G r o u p  
(N -  45)
C o n t r o l  G r o u p  
(N -  46)
no. o f  complications
Fatal
F u l m inant pancreatitis 6 8
Infected pancreatic collection 3 5
Chest infection 2 0
Renal failure 1 0
M a j o r *
Pancreatic collection (infected) 11 ( 5 ) 11 ( 1 )
Chest infection 12 9
Diabetes 2 2
R en a l  failure 2 2
S epticemiai 3 0
Gastrointestinal h e m o r r h a g e 1 1
P u l m o n a r y  e m b o l i s m 1 0
*Therc were 12 deaths and 32 m ajor com plications in 17 patients in the lavage group and 13 
deaths and 25 m ajor com plications in 16 patients in  the control group.
tD efined as a positive blood culture together with leukocytosis (> 1 5 0 0 x  106 per liter) and 
pyrexia (tem perature > 38°C ).
awaiting evaluation for prognostic criteria, only a mi­
nority of patients would have started treatment within 
24 hours of the onset of symptoms.
Ranson and Spencer27 observed that peritoneal la­
vage appeared to prevent early mortality in patients 
who met the criteria for severe pancreatitis during the 
first 48 hours after admission. However, they recorded 
a high incidence of late septic complications in pa­
tients given lavage therapy, and there was no overall 
improvement in survival in these patients, as com­
pared with historical controls. We were unable to con­
firm a reduction in early mortality in our lavage 
group. Indeed, two of the five early deaths occurred 
within 24 hours of admission, before the results of the 
multiple laboratory studies used to establish prognos­
tic criteria were available.
Ideally, patients entered into the control group 
should have received no peritoneal intervention. How­
ever, because the efficacy of therapeutic peritoneal 
lavage may depend on the speed with which it can be 
instituted23 and because of delay in obtaining results 
from the laboratory-based system, diagnostic lavage 
was used to obtain an early prognosis in 34 of the 
patients in the control group (9 of whom died). It is 
possible that diagnostic lavage with a single liter of 
isotonic saline had a therapeutic effect. An additional 
advantage of diagnostic lavage was its ability to detect 
an erroneous clinical diagnosis of acute pancreatitis.
In this-study, antibiotics were prescribed only to 
treat infective complications of acute pancreatitis. 
There is no evidence that antibiotics influence the out­
come of an attack of pancreatitis,28'30 although pub­
lished trials have included too few patients to disprove 
their efficacy.31 There is a potential risk of contamina­
tion of the peritoneal cavity during therapeutic lavage, 
and peritoneal irrigation with saline may im'pair the 
function of peritoneal macrophages.32 However, bac­
terial contamination of the lavage fluid occurred in 
only four patients and was not associated with in­
traabdominal septic complications. Furthermore, the
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Figure 1. Plasma Amylase Concentrations during the First Five 
Days after Admission in 45 Patients in the Lavage Group (Broken 
Line) and 46 Patients in the Control Group (Solid Line).
The initial values in both groups were obtained before randomiza­
tion. Data points represent mean values; error bars indicate the 
S.E.M. There were no significant differences in amylase concen­
trations in the two groups at any time.
incidence of intraabdominal abscess in the lavage 
group (eight abscesses, three fatal) was similar to that 
in the control group (seven abscesses, five fatal).
The reasons for using peritoneal lavage therapy in 
acute pancreatitis are that the peritoneal cavity forms 
an important reservoir of pancreatic enzymes and 
their digestion products, and that lavage in the early 
phase of the disease precludes the systemic absorption 
of potentially toxic compounds.7 Our study does not 
necessarily contradict this reasoning: the delay in de­
livering treatment may have crucially undermined the 
effectiveness of the therapy. However, emphasis on the 
importance of the transperitoneal route for the absorp­
tion of pancreatic enzymes and their digestion prod­
ucts into the plasma may be misplaced. A recent study 
Has suggested that the principal route of transfer of 
enzymes from the pancreas to the plasma in severe 
pancreatitis is via lymphatics and veins that drain the 
gland.33 The observation that therapeutic lavage did
not reduce plasma amylase levels is consistent with 
this theory. Severe pancreatitis is usually associated 
with local tissue necrosis and hematoma formation. 
The action of pancreatic enzymes on this avascular 
retroperitoneal tissue may generate toxic digestion 
products,34 which could be absorbed directly into re­
troperitoneal lymphatics.
The results of this study suggest that a three-day 
regimen of therapeutic lavage with a conventional 
peritoneal dialysis solution does not influence the out­
come of an attack of severe acute pancreatitis. Prompt 
recognition of the severe attack and immediate initi­
ation of therapy must be considered priorities for fu­
ture studies.
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S u m m a r y  T h e  p ro g n o stic  value o f  th ree pred ictive 
ind ices w as com p ared  in 436 attacks o f  acute 
p ancreatitis  in 418 p a tien ts . T h e  ou tcom e o f  an attack  was 
g raded  as u n co m p lica ted  (324), com plica ted  (70), or fatal (41 )■
1 attack  was ex c lu d ed  because o f  p u n c tu re  o fth e  caecum . T h e  
overall m o rta lity  rate  w as 9 -4 % . C lin ical assessm ent on 
adm ission  iden tified  on ly  34%  o f  p atien ts whose attack  was 
severe (ie, com p lica ted  o r fatal). M u ltip le  laboratory  criteria 
<».'d p eritoneal lavage w ere  m ore sensitive (61%  and 53%, 
respectively) w hile  re ta in in g  d iagnostic  accuracy (79%  and 
74% ). A n e rro n e o u s d iagnosis o f  pancreatitis  was corrected  
by the fin d in g s on  lavage in 5 p a tien ts. T h e  m ajor advantage 
o f  peritoneal lavage over m u ltip le  laborato ry  criteria  was the 
sh o rte r delay  betw een  adm ission  to the study  and 
d e te rm in a tio n  o f  severity  (m edian  4 v  24 h), bu t visceral 
p u n c tu re  d u rin g  in se rtio n  o f  the cannula occurred  in 2 o f  253 
p atien ts (0 -8 % ). W h en  used  together, the th ree  indices 
correctly  p red ic ted  82%  o f th e  attacks w ith  a severe outcom e 
and id en tified  all p a tien ts  d estined  to die w ith in  10 days o f 
adm ission .
Introduction
T h e  incidence o f  acu te  pancreatitis  is increasing .' Serious 
com plications su p e rv en e  in 2 0 -3 0 %  o f  cases, w ith a fatal 
outcom e in 8 - 2 0 % .1-5 E arly  d ifferen tia tion  o f patien ts w ith 
m ild and severe disease is im p o rtan t if  p rom pt intensive
m anagem en t is to b en efit th o se  w ith  severe disease. T h is  
d iffe ren tia tio n  sh o u ld  be as specific  as possib le, since  the 
m o n ito rin g  a n d . trea tm en t o f  severe p an c rea titis  are  bo th  
costly  and  invasive.
W hen p a tien ts  are  ad m itted  to  h o sp ita l w ith  acute  
p ancreatitis , experienced  c lin ic ians can  iden tify  on ly  ab o u t a 
th ird  o f  those in w hom  se rious co m p lica tio n s w ill d evelop .6 
N o  single  b iochem ical test is co m p le te ly  accurate . A m ong 
b lood tests, ra ised  fib rin o g en 7 and  m e th aem alb u m in 8-10 and 
low calcium  levels4,11 have b een  su g g ested  as d e te rm in an ts  o f  
severity , b u t  they  are  in sensitive . B esides in d ica tin g  one 
p articu la r co m plica tion  o f  the  disease, a rte ria l hypoxaem ia 
m ay also co rre la te  w ith  a poor overall p ro g n o sis .4’12 T h e  
p red ictive roles o f  e n d o to x aem ia ,13 changes in co m plem en t 
p ro te in s ,14 and  early  co m p u ted  to m o g ra p h y  scan s15 req u ire  
fu rth e r  evaluation . C u rre n tly , the  m ost usefu l gu ides to 
p rognosis derive from  m u ltip le  lab o ra to ry  c r ite r ia 16,17 and 
analysis o f th e  flu id  ob ta in ed  by p erito n ea l lavage.4,18,19
T h e  m u ltip le  labo ra to ry  crite ria  in tro d u c ed  by R anson  et 
al20 and m od ified  by Im rie  et a l3,17 are n ow  generally  accepted 
as p rov id ing  the best assessm en t o f  severity  in acute 
p ancreatitis . T h e y  are based  on th e  fea tu res o f  shock  (fluid 
loss, falling haem otocrit, se ru m  a lb u m in , acidosis) and 
w idespread tissue in ju ry  (hypocalcaem ia, ra ised  liver 
enzym es, u raem ia , hypoxia, hyperg lycaem ia). T h e  draw back 
o f  this type o f  assessm ent is th a t it m ay  take 48 h  o r longer to 
com plete.
T h e  p eritoneal exudate  in acu te  pan crea titis  w as first 
stud ied  in 1950.21 T h e  am ylase co n cen tra tio n  o f  asp irated  
fluid was m easured  b u t no t re la ted  to  the severity  o f  the 
attack. T h e  pred ic tive  value o f  peritoneal lavage was 
described  by P ickford  et a l18—the g rea ter the vo lum e and 
darker the co lou r o f  any free p e rito n ea l flu id , the  w orse the 
prognosis. I f  there  was no  free flu id , one litre  o f  saline was 
in tro d u ced  in to  the abd o m in a l cav ity  and  the co lou r o f  the 
re tu rn  flu id  was assessed. T h is  sim p le  p ro ced u re  proved 
m ore accurate  than  clinical ju d g m en t and  m uch  q u icker than  
m ultip le criteria in the diagnosis o f  severe acute pancreatitis.4,6
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W e rep o rt here the relative success o f  clinical assessm ent, 
m u ltip le  labo ra to ry  crite ria , and analysis o f  p eritoneal flu id  in 
d e te rm in in g  the severity  o f  acu te  pancrea titis  a t the ou tse t o f  
an attack  in a p rospective m u lticen tre  s tu d y  o f  418 patien ts.
Patients and Methods
Between September, 1981, and February, 1984, 436 attacks o f  
acute pancreatitis were studied in 418 padenLSJefcrre'd'by clinicians 
at twenty-four participating hospitals to the study coordinators at 
each o f  three centres, Bristol (A. P. C.), Leeds (A. D . M .), and 
Glasgow (A. P. D . and M. G. S.). 3 patients were admitted to the 
study with laparotomy evidence o f  pancreatic and peripancreatic 
inflammation. In the other 433 attacks the diagnosis o f  acute 
pancreatitis was based on a consistent clinical picture and a plasma 
amylase level o f  >1200 IU/1 (‘Phadebas’).22 Ethical committee 
approval was given by the relevant health authorities and informed 
consent was 'obtained from patients i f  their clinical condition 
allowed at the time o f  hospital admission.
P rognostic  Indices
Each patient was seen by the local coordinator as soon as possible 
after admission and a clinical assessment o f  the severity o f  the attack 
was made. Appropriate blood samples were taken on admission and 
on the 2 subsequent mornings for determination o f  eight laboratory 
criteria o f  severity:17 arterial oxygen tension (< 8 -0  kPa), plasma 
levels o f  calcium (< 2 -0  mmol/1), albumin (<32 g/1), glucose 
(>10 mmol/1, no previous diabetes), urea (>16 mmol/1 with no fall 
within 6 h), lactate dehydrogenase (>600 IU/1), and aspartate amino­
transferase (>200 IU/1) and the leucocyte count (> 1 5 x  109/1).
Peritoneal lavage was carried out after urethral catheterisation in 
253 attacks. T he site chosen was 2 cm below the umbilicus in the 
midline in 249 attacks. Adjacent scarring precluded this approach in 
the other 4 attacks, and a point midway between um bilicus and right 
or left anterior superior iliac spine was chosen. Under aseptic 
conditions the skin and extraperitoneal tissues were infiltrated with 
2% lignocaine and adrenaline 1/200 000. A 5 mm incision was made 
and a standard peritoneal dialysis catheter (‘Trocath’, McGaw, 
G lendale, California, USA) was introduced into the peritoneal 
cavity. T he trocar was withdrawn and the cannula tip advanced into 
the pelvis. The volume and colour o f  any aspirated intraperitoneal 
fluid was noted. A litre o f warmed isotonic saline solution was run 
into the peritoneal cavity, and the patient was rolled gently from 
side to side. T he lavage fluid was then allowed to drain out freely, 
and its colour was recorded. The intensity o f  the colour o f  both free 
and lavage fluid was determined by comparison with a standard 
colour chart.6
T he criteria for prediction o f a severe attack were as follows.
Clinical assessment.—T he coordinator’s initial judgment o f  the 
severity o f  the patient’s illness, based on the presence o f  shock, 
general peritonitis, and respiratory distress.
Peritoneal lavage.—One or more o f  > 20  ml free intraperitoneal 
fluid, dark-coloured free intraperitoneal fluid,6 and lavage fluid 
darker than a pale straw colour.6
' M ultiple laboratory criteria.—Three or more positive criteria 
within 48 h o f  admission to the study.
Patients meeting the criteria for peritoneal lavage or laboratory 
assessments were entered into a prospective, randomised, 
controlled trial o f therapeutic lavage.23
T reatm ent
Patients considered to have a mild attack received analgesia, 
intravenous fluid replacement, and initial restriction o f oral intake. 
The standard conservative treatment for predicted severe cases 
included nasogastric suction, monitoring o f urine output and 
central venous pressure (CVP), with administration o f  colloid and 
crvstalloid solutions to maintain a positive CVP, and the 
administration of oxygen via a face mask or assisted ventilation 
when hypoxaemia was detected.
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T A B L E  I—A E T IO L O G JC A L  A S SO C IA T IO N S  O F  A C U T E  P A N C R E A T IT IS  
A T T A C K S
- M F Total %
Gallstones 1 00 134 2 3 4 54
Alcohol 7 8 ( 1 2 ) 9(2) 8 7 2 0
Idiopathic 51 65 1 16 2 7
Miscellaneous 4
Pancreatic cancer 3 2 5
T  r a u m a 1 I
Postoperative 1 2 3
Post E R C P 1 4(4) 5
H y p erparathyroidism 1 1
D r u g - i n d u c e d 2 2
Figures in parentheses* n u m b e r s  of patients w i t h  c o n c o m i t a n t  gallstones. 
E R C P *  endoscopic retrograde cholangiopancreatography.
Patients randomised to receive therapeutic peritoneal lavage also 
received the standard conservative treatment. In addition lavage 
was carried out through the original dialysis cannula by means o f  
hourly cycles o f  2 litres o f  a warmed dialvsate (‘D ialaflex 61 ’, Boots 
Ltd, Nottingham) with added potassium  (4 mmol/1) continuing for 
72 h. Neither aprotinin (‘T rasvlol’) nor glucagon was given, and 
antibiotics were reserved fox__concurrent infections. Intensive 
biochemical, cardiorespiratory, and renal m onitoring was carried 
out. Survivors were kept under review as outpatients for at least 6 
weeks.
O utcom e
The clinical outcom e was classified as either mild or severe and 
severe attacks as fatal or com plicated (pseudocvst, necrosis and 
abscess o f  the pancreas, other intra-abdominal abscess, septicaemia, 
cholangitis, renal failure, gastrointestinal haemorrhage, venous 
thromboembolism, developm ent o f  diabetes requiring insulin, 
myocardial infarction, and pulmonary' com plications associated 
with hypoxaemia and/or radiological signs). Chest infection without 
respiratory impairment, urinary tract infection, and transient 
alcohol-withdrawal psychosis were classified as minor 
complications and did not constitute a severe outcom e.
S ta t is tic a l A n a ly s is
The chi-square test with Yates’ correction for continuity and 
Fisher’s exact probability test were used to test statistical 
significance.
Results
T h ere  w ere 22 5  attacks in m en  (52% ) and  211 in w o m en . 16 
patien ts had 2 attack s and 1 w as a d m itted  3 tim es. T h e  
m edian  age w as 61 years (ran ge , 1 3 - 9 2  years). T h e  m ain  
aetio log ica l a sso c ia tio n s  w ere  ga lls to n es  (54% ) and alcohol 
(20% ); 14 attacks w ere  a ssoc ia ted  w ith  b o th  g a lls to n e s  and  
alcoh o l. In 116 cases (27% ) no o b v io u s  a e tio lo g ica l factors  
cou ld  be d e term in ed  (tab le  I).
C om plica tions o f  P er ito n ea l L a va g e
3 patien ts w ere in jured  d u rin g  in tro d u c tio n  o f  the 
peritoneal d ia ly sis  cath eter. In 1 a sm all ab d om in a l wall 
haem atom a d ev e lo p ed  but d id not require active  treatm ent. 
In another the b lad der w as in a d v erten tly  catheterised  
suprapub ica lly ; the can n u la  w as w ith d ra w n  and rep laced  in 
the peritoneal cav ity  after urethral ca th eter isa tion  (th is  step  
had been  om itted  in itia lly ) and there w ere n o  su b seq u en t ill- 
effects. T h e  th ird  p a tien t had a low er m id lin e  scar. T he  
catheter was inserted  in the right iliac fossa  and entered  the 
caecum . T h is  accid en t w as im m ed ia te ly  r e c o g n i s e d .  
L aparotom y was carried  ou t and a c lean  caecal p u n ctu re  was 
oversew n . T h e  patient m ade an u n ev en tfu l recoverv  but w as
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T A B L E  II -C O M P L IC A T IO N S  O F  A C U T E  P A N C R E A T IT IS  A T T A C K S
- S urvived D i e d Total
Severe
Pancreatic abscess ■ 6 11 17
Pancreatic pseudocyst 31 6 37
O t h e r  intra-abdominal abscess 2 7 9
Septicaemia 13 11 24
Cholangitis* 7 3 10
Ren a l  failure 3 1 3 16
Gastrointestinal h a e m o r r h a g e 5 7 12
V e n o u s  t h r o m b o e m b o l i s m 5 2 7
Diabetes 4 7 . 11
My o c a r d i a l  infarction 4 4
Severe p u l m o n a r y  complication 36 . 29 65
Not severe
M i l d  chest infection 7 7
Uri n a r y  tract infection 3 0 * 5 35
T o x i c  psychosis 12 4 16
•Clinical features d e v e loped 2 - 8  days after admission. L a p a r o t o m y  or 
necropsy findings c o n f i r m e d  the c o m b i n a t i o n  o f  cholangitis a n d  o e d e m a t o u  s 
pancreatitis in 6 patients.
ex cluded  from  fu rth e r  analysis. T h e  overall v isceral p u n c tu re  
rate  w as 2 in 253 ca th e te r  p lacem en ts (0 -8% ).
F in a l O utcom e
O f  the  435 attacks analysed , 111 (26% ) resu lted  in death  
(41) or se rious co m p lica tio n s (70) (table 11). M o re  th an  h a lf  the 
attacks co m p lica ted  by  ab d o m in a l abscess, renal failure, 
g as tro in te s tin a l h aem o rrh a g e , and  acute d iabetes w ere 
u ltim ate ly  fatal. T h e  o u tco m e w as uncom p lica ted  (m ild) in 
324 attacks (74% ).
C lin ic a l A ssessm en t
70 o f  the  435 attacks w ere classed as severe on  adm ission  
(16% ). 19 o f  these p a tien ts  d ied , 19 had  a serious 
com p lica tio n , and  32 (46% ) a b en ign  course. O f  the 365 
attacks assessed as m ild , 292 had a m ild  ou tcom e, 51 a serious 
co m p lica tio n , and  12 w ere fatal. T h e  sensitiv ity  and 
specific ity  o f  clin ical assessm ent, an d  the o th er p rognostic  
ind ices, are sho w n  in fig 1.
M u ltip le  L a b o r a to r y  C rite r ia
O n ly  attacks in  w h ich  the  n u m b er o f  crite ria  m easured  
allow ed an  u nequ iv o ca l p rognosis w ere assessed (ie, 3 or m ore
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Fig 1— S en s itiv ity  a n d  spec ific ity  o f  p ro g n o s tic  ind ices in acu te  
p a n c re a ti t is .
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Fig 2—R elation between positive m ultip le  labo ra to ry  c rite ria  score
and  outcom e of acute p ancrea titis  a ttacks.
crite ria  positive, all 8 c r ite ria  m easu red , 7 c rite ria  m easu red  
and  on ly  1 positive, or 6 c r ite ria  m easu red  and  0 positive). In  
38 attacks the  data  w ere in ad eq u a te . O f  th e  397 attacks 
assessed 104 w ere severe , in c lu d in g  39 dea th s . 27 o f  the 
deaths w ere inc luded  in th e  107 a ttacks g rad ed  severe by  a 
m u ltip le  c r ite ria  score o f  3 o r m o re  w ith in  48 h  o f  adm ission . 
T h e  n u m b er o f  positive c r ite ria  in re la tio n  to  d isease ou tcom e 
is show n  in fig 2.
T h e  m edian  delay betw een  th e  on se t o f  sy m p to m s and  a 
severe p red ic tio n  by  m u ltip le  c rite ria  score w as 54 h (range, 
5 -> 9 8 ) . T h e  m edian  delay betw een  d iagnosis o f  acute 
pan crea titis  and  severe p red ic tio n  w as 24 h (range 0 -> 9 8 ) .
P eriton ea l L a va g e
155 attacks w ere n o t assessed by  p erito n ea l lavage because 
o f  the  p a tie n t’s or c lin ic ian ’s re lu c tan ce  to allow  an invasive 
p ro ced u re  in an overtly  m ild  a ttack  o f  acu te  pancrea titis . O f  
these 155 attacks 130 co n firm ed  the  clin ical ju d g m en t and 
p u rsu e d  a m ild  course , b u t  25 (16% ) had  com plica tions and  8 
p atien ts w ith  co m plica tions d ied . 20 o th e r  pa tien ts  w ere 
excluded because o f  ex tensive ab d o m in a l scarrin g  and  a 
fu rth e r  5 because o f  dem en tia , d ifficu lty  in  ca the te risa tio n , 
gross congestive card iac  fa ilu re , and  w arfa rin  
an ticoagula tion .
P eritoneal lavage w as successfu lly  accom plished  in 252 ' 
attacks, o f  w h ich  80 w ere co m p lica ted  a n d  30 w ere fatal. 21 o f  
the  30 d eaths w ere co rrec tly  p red ic ted  as severe by  th is 
approach .
O f  the 69 attacks p red ic ted  as severe by  lavage, 22 had 
> 2 0  m l free in tra p erito n ea l flu id  w h ich  w as pale (< n u m b e r 6 
on the co lou r chart); am ong  th is  g ro u p  th ere  w ere 11 
com plicated  attacks, in c lu d in g  7 deaths . 46 attacks w ere 
p red ic ted  as severe on  the basis o f  dark  in tra p erito n ea l flu id  
(> 6  on the co lour chart); am ong  th is g ro u p  there  w ere 41 
com plicated  attacks, in c lu d in g  14 deaths. T h u s , 68 o f  the 
p red ic ted  severe attacks w ere classified  on  assessm ent o f  free 
fluid (vo lum e or co lour). In  the  one rem ain in g  attack , < 2 0  m l 
o f  pale free fluid w as recovered , b u t lavage flu id  was darker 
than  n u m b er 3 on  the  co lour ch art; th e  attack  was clin ically  
m ild. A m ong the 183 attacks p red ic ted  as m ild  27 had som e 
pale free flu id  (< 2 0  m l); only  4 o f  these w ere com plica ted  and 
there w ere no  deaths.
T h e  m edian  delay betw een  onset o f  sym ptom s and 
p red ic tion  was 26 h (range 5 -9 6 ) , and  th a t betw een  d iagnosis 
and p red ic tio n  was 4 h (range 0 -4 8 ) .
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Fig 3—Sensitivity of prognostic indices in gallstone-related and
alcohol-related  acute pancrea titis.
A fu rth e r  5 patien ts  w ere in itia lly  a d m itte d  to the  study , bu t 
the  find ings on  peritoneal lavage led to revision o f  the 
d iagnosis o f  acu te  p ancreatitis . 2 p a tien ts ' had  perfo ra ted  
gallb ladder, 1 perfo ra ted  du o d en a l u lcer, 1 extensive 
m esen teric  th ro m b o sis , an d  1 ru p tu re d  th o racoabdom inal 
ao rtic  aneu rysm .
Gallstones and Alcoholism
Each  o f  the  p rognostic  ind ices was m ore  accurate  in 
d iagnosing  the  severity  o f  a lcoho lic  th an  gallstone 
pan crea titis  (fig 3).
Sum m ation of Prognostic Indices
A m ong the 271 attacks p red ic ted  as m ild  there w ere 6 
d ea th s (2 • 2% , tab le  111) and am ong  the 164 p red ic ted  as severe 
th e re  w ere 35 deaths (21 -3% ; p < 0 -0 0 1 ). T h e  sensitiv ity  o f  
each p rognostic  index for fatal acute p ancreatitis  is show n in 
fig 4. O verall 85%  o f  p a tien ts w ho died  w ere p red ic ted  to have 
severe disease by  one or m ore indices, as w ere all b u t 1 o f  the 
p a tien ts  (95% ) w ho died w ith in  the first 10 days.
F o r com plicated  b u t non-fatal attacks the p rognostic  
ind ices w ere less successful; 71%  wrere co rrec tly  p red ic ted  by 
one o r m ore m ethod . T h e  overall sensitiv ity  for b o th  fatal and 
com plicated  attacks was 77% .
C l i n i c a l  M u l t i p l e  P e r i t o n e a l  An y o n e  All 3 
a s s e s s m e n t  c r i t e r i a  l a v a g e  i n d e x  i n d i c e s
6 0
p r e d i c t i o n s
20
22 1916 14 16 1422 1722 19
N o . o f  p a t i e n t s  
O  l a t e  d e a t h s  (10 d a y s  a f t e r  a d m i s s i o n )
[ 3  e a r l y  d e a t h s  ( w i t h i n  10 d a y s  o l  a d m i s s i o n )
Fig 4— S ensitiv ity  o f p ro g n o s tic  in d ices  fo r la te  an d  ea rly  d e a th s  in 
ac u te  p a n c re a titis .
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T A B I.E  II!—D E T A IL S  O F  F A T A L  A C L 'T E  P A N C R E A T IT IS  A T T A C K S  
P R E D IC T E D  AS M IL D
C a s e Sex A g e  (yr) Aetiology D e a t h C a u s e
1 At 57 Idiopathic L ate R e n a l  failure
2 Al 63 Idiopathic Late Pseudocvst
3 At 73 Gallstones/alcohol Late A/ivocardial infarction
4 • F 7 0 Gallstones Late Septicaemia
5 F 81 Gallstones Late Septicaemia
6 F 6 7 Carcinomatosis Early Cardiorespiratory
failure
All w e r e  predicted as m ild b y  clinical assessment a n d  multiple criteria. C a s e s  2 
a n d  5 we r e  predicted as mild b y  peritoneal lavage a n d  case 6 b y  laparotomy.
In  77 (70% ) o f  the  111 fatal and  co m p lica ted  a ttack s all 
th ree  p rognostic  ind ices w'ere used . S en sitiv ity  for fatal 
attacks was 93%  (28 o f  30), for early  d ea th s 100%  (14), an d  for 
com plicated  b u t non-fatal a ttacks 74%  (35 o f  47)—an overall 
sensitiv ity  o f  82% .
Discussion
T h e  good resu lts  w-hen all th ree  p ro g n o stic  ind ices w ere 
used suffer from  the  in h e re n t d raw b ack  o f  m u ltip le  
laborato ry  crite ria , a delay  o f  up  to 48 h. 2 p a tien ts  d ied  o f  
fu lm inating  p an crea titis  b efo re  a m u ltip le  c rite ria  score was 
available. N ev erth e less, lab o ra to ry  c rite ria  w ere th e  m ost 
sensitive (61% ) in d iv id u a l p re d ic to r  o f  severe disease. 
Peritoneal lavage p ro v id ed  an answ er m u ch  m o re  q u ick ly  
(m ean 4 ti 24 h) b u t w as less sensitive (53% ). C lin ica l 
assessm ent on ad m ission  w as m u ch  less sensitive , b u t a 
p rev ious s tudy  has suggested  th a t by  48 h after adm iss ion  
clinical assessm ent m ay be as good as lavage or lab o ra to ry  
crite ria  in detec ting  severe acute  p a n c re a titis .6
In  previous s tu d ies4,6 perito n ea l lavage gave a co rrec t 
prognosis in 5 8 -7 2 %  o f  severe cases co m p ared  w ith  53%  in 
th is study. A n add itional benefit o f  lavage, c o rre c tin g  an 
erroneous d iagnosis o f  p an crea titis , was seen  in 5 o f 253 cases 
in th is s tudy  and  2 o f  98 cases in a n o th e r  re p o rt .24 W e have 
p rev iously4 suggested  th a t dark  co lo u ra tio n  o f  the  free flu id  
ob tained  by peritoneal lavage is m ore  im p o rta n t th a n  its 
vo lum e in p red ic tin g  severe disease. O u r  re su lts  su p p o rt th is 
hypothesis , a lth o u g h  d ifferences in sen sitiv ity  d id  n o t reach 
statistical significance. P eritoneal lavage is p a rticu la rly  
accurate  in id en tify ing  fu lm in a tin g  acu te p a n c re a titis ,2’ b u t 
on ly  8 o f the 14 early d ea th s (57% ) w ere p red ic ted  by  co lou r, 
the  rem ainder by  vo lum e.
In  over 40%  o f  attacks, p a tien t refusal or clin ical re lu c tan ce  
d id  not perm it peritoneal lavage, p re d o m in a n tly  because  o f  
an overtly  m ild attack w ith  little  or no  pain . T h is  re lu c tan ce  to 
accept an invasive p ro ced u re  is u n d e rs ta n d a b le  an d  is 
p robab ly  related  to cu rre n t th e rap eu tic  op tio n s. Is a 0 -8 %  
risk o f  visceral p u n c tu re  w o rth  the gain o f  an early  d iagnosis 
w hen no particu la r trea tm en t schedule  has yet been  sh o w n  to 
benefit severe cases? U n til  a specific th e rap y  becom es 
available, in tensive m o n ito rin g  and re su sc ita tio n  is all th a t 
can be offered for p a tien ts  w ith  severe disease. T h o se  w ith  
fu lm inating  attacks w ou ld  have m ost to gain  from  early  
p red ic tion , and  fo rtu n a te ly  in th is g ro u p  lavage p ro v id es the 
m ost reliable resu lts.
M u ltip le  labo ra to ry  c rite ria  scores have been used as 
p rognostic  indices in acute  pan crea titis  for m ore  th an  10 
years. O u r resu lts  show  sim ilar specific ity  to  p rev ious rep o rts  
(85%  v  9 2 % l6,l/) bu t low er sensitiv ity  for severe cases (61%  v 
9 6 % 16, 100% 17). T w o  factors can in flu en ce  th e  resu lts—the 
defin ition  o f  severity  and the aetio logical cause o f 
pancreatitis . Fatal a ttacks are u n ifo rm ly  co nsidered  to be
2 2 1
TH E L A N C E T .A U G U S T 24 ,1985
severe, bu t am ong su rv ivo rs severity  m ay be defined  as m ore 
than  7 days in an in tensive-care u n i t ,16 m ore than  14 days in 
hosp ita l, or fa ilu re  to se ttle  on  conservative trea tm en t because 
o f  specified  co m p lica tio n s.6 W e based ou r defin ition  o f  
severity  on  the  dev e lo p m en t o f  local and  system ic 
com p lica tio n s o f  the disease.
T h e  orig inal sets o f  labo ra to ry  crite ria  d ifferen tiate  severe 
and  m ild attacks less accu ra te ly  in gallstone pancreatitis  than  
in alcoholic p an c rea titis .17,26,27 P rev ious rep o rts4,6 show  a 
'o w er p ro p o rtio n  o f  alcohol-related  cases in E ng land  (3% ) 
than  in S co tland  (3 2 % )3 or N ew  Y ork (6 9 % ).16 In  th is  three- 
cen tre  s tu d y  w e elected  to use the crite ria  app licab le to 
g a llstone-related  d isease .17 In  the event there  w as no 
sign ifican t d ifference betw een  alcohol and  gallstone disease 
in the  sensitiv ity  o f  the  m u ltip le  labo ra to ry  criteria . H ow ever, 
peritoneal lavage w as m ore accurate  th an  m u ltip le  labo ra to ry  
crite ria  in  p red ic tin g  severe alcoholic pancreatitis , 
p resu m ab ly  because o f  the  early  developm en t o f  
h aem o rrh ag ic  ascites.
T h e  co m b in ed  resu lts show  that it is now  possib le to 
iden tify  m ost p a tien ts  w ith  severe acu te  pancreatitis  w ith in  a 
few h o u rs o f  adm ission , and  th is ab ility  shou ld  be usefu l in 
netting u p  prospective  th e rap eu tic  tr ia ls .27 A consisten tly  
h igh  specific ity  m inim ises the w aste o f  resources on m ild 
attacks. S im ila rly , a h igh  sensitiv ity  allows the m axim um  
n u m b er o f  severe cases to be stud ied .
Som e type o f  p red ictive assessm ent sh o u ld  be possible in 
any hosp ita l, th o u g h  local c ircum stances w ill d ic ta te  w h ich  is 
the  m ost p rac ticab le  m ethod . I f  an early  answ er is desired , 
peritoneal lavage is the m ethod  o f  choice, desp ite  the  sm all 
a tten d an t risk  o f  visceral p u n c tu re .
W e th an k  co n su ltan t surgeons at the follow ing hospita ls for p a rticipa ting : 
B radford  R oyal In firm ary ; B ristol Royal In firm ary; D ew sbury  G eneral 
H osp ita l; F ren ch ay  H osp ita l, Bristol; G lasgow  Royal Infirm ary; H airm yres 
H osp ita l, G lasgow ; H alifax Royal Infirm ary; H uddersfie ld  Royal Infirm ary; 
L eeds G en era l In firm ary ; P rincess M argare t H osp ita l, Sw indon; Royal 
U n ited  H o sp ita l, Bath; Scarborough  H ospital; S o u th e rn  G enera l H ospita l, 
G lasgow ; S o u th m ead  H osp ita l, Bristol; S tobhill H osp ita l, G lasgow; 
M usgrove  P ark  H osp ita l, T a u n to n ; V ictoria In firm ary , G lasgow ; W eston- 
su p er-M are  G en era l H ospita l; W harfedale  G enera l H ospital; York D istrict 
H osp ita l.
T h is  s tu d v  was su p p o rted  by gran ts from  the A m elie W aring  Fo u n d atio n , 
Baver (U K ) L td , Boots Pharm aceu ticals  pic, Glasgow Royal In firm ary  
E nd o w m en t F u n d , Sco ttish  H om e and H ealth  D ep artm en t, S ou th  W estern  
' gional H ea lth  A u th o rity , Special T ru s tees  o f  the  G eneral In firm ary  at 
.ted s , and  W est R id ing  M edical R esearch T ru s t.
C o rresp o n d en ce  shou ld  be addressed to R . C. N . W ., U n iversity  
D ep artm en t o f  S urgery , Bristol Royal In firm ary , B ristol BS2 8H W .
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APPENDIX 2
COMPUTER DATA FOR 100 PATIENTS 
FROM GLASGOW ROYAL INFIRMARY
223
A P P E N D I X  2 and A P P E N D I X  4 are the print outs of the 
c omp uter files used for the patients studied in this 
thes i s .
B E C AUSE THE D A T A  HAS B E E N  S T O R E D  O N  C O M P U T E R  A N D  IS 
T H E R E F O R E  SUBJECT T O  T HE REGU L A T I O N S  O F  T H E  D A T A  
P R O T E C T I O N  ACT, PATIENT IDENTIFICATION H AS B E E N  
O B L I T E R A T E D  F R O M  THE PRINT OUTS.
All the n ume rical data presented in the thesis has 
been cross checked between these files and the separate 
proformata used to record patient details relating to 
their pseudocyst.
In this appendix and appendix 4 m u l t i p l e  
abbreviations have been used. A  glossary is given on the 
next 2 p a g e s .
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A B B R E V IA T IO N
A BSC
AET / A E T IO L  
ALC  
GS 
PCA  
TRA 
UK
AMYL
ON AD  
ON D IA G
ANOR
AP
AXR
BM
OG / CYSTOGAST
CJJ
COMP
CP
C R IT
CT / CAT 
CYSTODUO  
D I S T  PANC  
ERCP I ERP
EXTN D R A IN  
GB
GI BLEED
GT S IG N
H ID A
HLP
I VC
JAUN
LAP
LAP A SP
LAV
N /V
OCG
PC
PE
PERCUT A SP  / D R A IN
PL EFF
PYREX
REN F A IL
R E SP F A IL
ROUX I ROUX EN Y
TIME
TPN
SPABS
US
MEANING
A B SC E SS
AETIOLOGY
ALCOHOL
GALLSTONES
PANCREATIC CARCINOMA
TRAUMA
UNKNOWN
SERUM AMYLASE
ON A D M ISSIO N
ON D IA G N O S IS  OF PSEUDOCYST  
ANOREXIA
ACUTE P A N C R E A T IT IS
ABDOMINAL X RAY
BARIUM  MEAL
CY S TOGAS TROS TQMY
C Y STO JE JUNOSTCMY
COM PLICATIONS
CHRONIC P A N C R E A T IT IS
M ULTIPLE C R IT E R IA  A SSESSM EN T
COM PUTERISED TOMOGRAPHY
CYS TODUODENOS TQMY
D IS T A L  PANCREATECTOMY
ENDO SCO PIC RETROGRADE
PANCREATOGRAM
EXTERNAL DRAINAGE
GALLBLADDER
G A ST R O IN T E ST IN A L  HAEMORRHAGE 
GREY-TURNER S IG N  
H ID A  SCAN
H Y PERLIPO PRO TEINAEM IA  
INTRAVENOUS CHOLANGIOGRAM 
JAUNDICE  
LAPAROTOMY
A S P IR A T IO N  AT LAPAROTOMY 
D IA G N O ST IC  PERITO NEAL LAVAGE 
NAUSEA AN D /O R  VOM ITING  
ORAL CHOL ECYSTOGRAM 
PSEUDOCYST  
PULMONARY EMBOLISM  
PERCUTANEOUS A S P IR A T IO N  
PLEURAL E F F U SIO N  
PY R EX IA  
RENAL FAILURE  
RESPIR A TO R Y  FA ILU R E  
ROUX EN Y CYS TO J E J UNOS TQMY 
TIME FROM AP TO PC D IA G N O S IS  
TOTAL PARENTERAL N U T R IT IO N  
SUBPH RENIC A B SC E SS  
ULTRASOUND SCAN
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HO S P I T A L  ABBREVIATIONS
BALL
BOUR
DU N D/NINE
D UNF
FALK
GRI
G N K
H A I R
K I L M A R N O C K
L A W
N A D G
O B A N
SGH
STOB
BALLOCHMYLE, AYRSHIRE 
B O U R N E M O U T H  G E NERAL INFIRMARY 
NINEWELLS HOSPITAL, D U NDEE 
VICTORIA INFIRMARY, 
D UNFERMLINE
FA L KIRK ROYAL INFIRMARY 
G L A S G O W  ROYAL INFIRMARY 
INVERCLYDE HOSPITAL, G R E E N O C K  
HAIRMYRES HOSPITAL, G L A S G O W  
K I L M A R N O C K  ROYAL INFIRMARY 
L A W  HOSPITAL, CARLUKE 
N O R T H  AYRSHIRE D I S TRICT 
GENERAL HOSPITAL 
O B A N  INFIRMARY 
SOUTHERN GENERAL HO S P I T A L  
G L A S G O W
STOBHILL HOSPITAL, G L A S G O W
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PSEUDQCYST ERI STUDY: l
NAME SEX A6E HOSP DATE OF PC TIME AETIOL SIZE INVESTIEATIONS OPERATIONS
ALE M 43 KIL 05.08.76 ALC 8 US/BM 5.8.76 ROUX EN Y 16.11.76
AND F 36 DUND 16.03.75 054 ES 16 US:BM CYSTEAST:GB OUT 19.03.75
ARB F 50 ERI ES 20 CYSTEAST
BAL M 33 ERI 05.08.75 022 ALC 8X3 IJSX3:0CG:BM LAP ASP OF CYST 5ml : EASTROENT
BAR M 29 ERI 11.06.76 005 ALC 8X12 US/BM CYSTEAST 16.06.76
BEN M 37 HAIR ALC 12 US.*BM:QPN CYSTEAST 14.12.77
BLA H 52 FALK ES SMALL ROUX EN Y
BLA M 25 ERI 16.05.72 ALC TR 15 BM CYSTEAST 6.6.72:CYSTEAST 28.8.72
BON M 26 ERI 20.12.63 059 ALC BM 20.12.68 CYSTEAST 3.2.69
BRA M 70 ERI 24.05.77 028 ES 12 US/BM CYSTEAST: 27.05.77
BRO M 25 STOB 10.09.83 232 ALC 5X6 USX2: ERCP DISTAL PANC 06.12.83
CAM M 46 ERI 27.04.79 017 ES LAREE US CYSTEAST 12.05.79
CHA M 31 ERI 10.12.78 229 ALC 7 US/OOS EXT DRAIN 29.12.78
CHR F 44 PERT 15.11.76 152 ES 5 US/BM/OPN ROUX EN Y 24.11.76
CLE M 57 ERI 14.05.73 015 ES 10x5 US: BM CYSTEAST 21.8.73:1200®!
CLO M 84 ERI 06.09.78 014 ALC LARiSE US/OOS
CRI F 43 ERI 25.03.80 006 UK 5.2 US
CUT F 43 LAW 06.07.31 as 7.5 IS CYSTEAST 06.07.82
DEV F 69 SRI 22.03.82 018 ES 10X6. USX3:BM CYSTEAST: EB OUT 1.12.82
DOU M 33 ERI 03.08.82 ALC 8.2X1 BM: IJSX9:ERCP 5 PERCUT DRAIN 9.2.83:350ML
DUF M 23 ERI 17.10.77 Oi)4 ALC 10 US
DUN F 33 ERI 05.03.70 215 ES+ALC BM 20.04.70 •CYSTEAST 29.05.70: 1000ml
DUN K 66 BALL 25.04.67 009 ES EXTN DRAIN %. EE 25.04.67
ERS F 50 ERI 16.12.78 ALC 4.3 US/CT LAP ASP TDS 0*9.03.83
EVA F 21 ERI 07.02.79 Oil ALC 15x12 US 10.08.78:7.2 CYSTSAST 13.03.79: 2500®!
FER M 25 S6H 24.05.75 ALC SMALL US/BM DIST PANC 24.05.75
FIT M 54 ERI 14.02.84 004 ALC 7.5X2 USX5
FIT F 33 ERI 30.08.78 150 ALC 7 US/BM/QCG CYSTDOUD 21.11.78
FRE F 74 ERI 14.11.62 ES LAP CYSTEAST 1.12.62
FRE M 43 ERI 16.02.81 022 ALC 8x6 ICS
EAR M 43 ERI 10.04,74 031 ALC 20 LAP CYSTJEJUN 30.04.74
GIL M 35 ERI 27.10.76 375 ALC 10 US/BM CYSTEAST 02.11.76
HAL M 27 ERI 12.02.80 204 ALC 20 US CYSTEAST ROUX EN Y 20.02.80
HEN F ERI ALC
HER M 36 ERI 27.06.77 ALC 12 us CYSTEAST 11,07.77
HIE M 19 ERI 19.0*9.74 027 TRAUMA 18x20 BM 16.9.74/ US CYSTEAST 12 17.10/29.10
HOD M 36 ERI 05.06.79 107 ES/ALC LAREE US/OPN CYSTEAST 06.06.79:EB OUT EXPLOR CBD
HOG M 34 MADE 29.06.84 100 ALC 5 us
HUE M ERI ALC CYSTEAST
KEL M 45 ERI 24.12.73 109 ES 8.5 US/BM
KEL M 77 ERI 16.03.82 008 ES 9X11 CAT:lJSX4:HIDA:I PERCUT DRAIN:
KEN M 68 LAW 11.04.78 038 UK LARGE US/LAP DIST PAW: 11.04.78
KES M 31 ENK 29.01.81 082 ALC 7X3 ERCP/IJS CYSTDUOD 30.01.81
KIN M 37 ERI 08.03.85 479 ALC 11X14 US:OCG:BM CYSTEAST 11.03.85
LAI M 34 ERI 03.12.79 400 ALC 4.5 CT:ERP:US
LAN M 33 ERI 02.06.73 ALC 9 CYSTEAST 27.06,73
LAU M 55 LAW 26.10.79 250 ALC LARGE AXR DISTORT STO CYSTEAST 26.10.79
MAE F 30 HAIR TRAUMA 16 CYSTEAST
MAR F 46 ERI 12.06.79 019 ES 7 US
MCC M 74 ERI 23.10.73 024 ES US/BM
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PSEUDOCYST GRI STUDY: 1
NAME SEX AGE Hasp DATE OF PC TIME AETIOL
MCC M 54 KILM 01.04.78 ALC
MCD M 37 GRI 20.10.75 069 6S+ALC
MCD F GRI UK
MCE M 31 KILM 28.02.80 021 ALC
MCG M GRI 6S
MCC M 31 S6H 30.10.73 ALC
MCK F 53 BALL 6S
MCK M 55 GRI 2.2.68 029 GS
MCK M 36 GRI 14.06.77 005 ALC
MCL M 35 DUNF 02.10.81 030 ALC
MCM M 56 GRI 20.03.73 021 ALC
MCN F 56 BALL ALC
MCP M 49 HAIR 18.02.75 015 ALC
MCR M 38 GRI 15.09.83 ALC
MEE F 60 GRI 15.12.80 034 GS
MIL M 45 GRI 11.04.78 ALC
MIL M 44 GRI 08.09.78 009 ALC
MOP F 30 GRI 24.7.32 ALC HE
MOR F 30 GRI 25.02.81 022 GS
NEI M GRI TRAUMA
PAT M 47 NINE 25.04.78 UK
PRE M 60 GRI 21.05.84 012 UK
RAD M 30 GRI 05.12.79 7 ALC
RAE F 54 GRI 7.9.66 090 GS
RAM M 62 BOUR 24.04.80 012 UK
RAY M GRI ALC
REI M 70•j'j GRI 14.11.75 055 ALC
REI M 36 GRI 05.11.72 114 GS
REI M 38 GRI ALC
ROB F 73 GRI 15.01.74 016 UK
ROS M 50 GRI 10.09.72 ALC
s e l F 56 LAW 17.01.78 100 ALC
SEM F 58 GRI 01.05.84 028 ALC
SHA M 54 GRI 06.09.77 067 ALC
SIM F 49 GRI 04.05.83 018 GS/ERC
SME M 45 OBAN 1.3.84 046 ALC
SMI M 21 GRI 13.03.74 074 ALC
SMI F 24 GRI 29.07.77 100 ALC
STE M 62 STOB 12.04.77 041 ALC
STE M 71 BALL UK
ST I F 78 GRI 15.12.81 008 POST 0
SUL F 30 GRI 01.07.82 109 GS
SWE M 58 GRI 19.07.78 414 ALC
TEM F 49 GRI 17.03.78 ALC
WAL M 52 GRI 25.02.82 ALC
WAT M 37 GRI 03.08.78 024 UK
WEI M 57 GRI 20.04.77 023 GS
WIG M 54 GRI 22.7.70 010 GS
WIL M 39 HAIR ALC
WIL F 48 GRI 14.01.65 019 TRAUMA
SIZE INVESTIGATIONS OPERATIONS
14 US CYST6AST 02.05.78
6 as RQUX/DIST PANC/6B OUT 18.11.75
15 BM/US CYST6AST 28.02.80 
CYSTGAST
9 IJS/AXR CYSTGAST 29.11.78 
CYSTGAST
LAP DRAIN ABSC 12.1.68:CG 02.02.63
5 US
5X6 US/CT CYSTGAST 04.12.81
BM/BE (LP DIAGN EXTN DRAIN 20.03.73 300ML
c EXTN DRAIN
8110 US:OPN ROUX EN Y 26.02.75
ERCP DIST PANDSPLEN 07.10.83
3X7 US:CAT CYSTGAST 10.04.81:6B OUT
4 CYSTGAST 18.04.78
SMALL US
8X5 US:HYP DUODG CG 30.8.82:TDS ROUX LOOP 2.9.83:WHIPPLES
8X5.5 CAT: IJSX3
EXTN DRAIN
SMALL ERCP DIST PANC ROUX EN Y25.04.78:
12X7 US:B N :CAT CYSTGAST 01.06.84
10 US CYSTGAST 09.09.79
LAP EXTN DRAIN 7.9.66:GB OUT
7 US ]
5 aS/BM +
10 OPN:GASTG MASS EXTN DRAIN 
LAP ASP
10 as
17 BM 10.09.72: EX CYSTGAST 20.09.72:1500(81 BILE DUCT DECOM
8 US: ERCP CYSTGAST 23.01.78:
C•J USX3: IVC CYSTDU0D/CYST6AST 04.05.84
9 US CYSTGAST 11.11.77
5 USX4iBM
10 US CYSTGAST 6.3.84
LARGE us CYSTGAST 14.08.74
10 US LAP ASP 31.3.78:CYSTGAST 31.10.78
8 USX2:IVC EXT DRAIN 26.04.77
12 US/OCG e x™  DRAIN
8X9 IJSX4 ASP NEED X2 23/12:30/12: CG 12.1.82
8 US PERCUT ASP:C6 15.08.82:CG 16.01.85
9 US
SMALL US DIST PANC 28.3.78
LAP/ERCP DIST PANCT
SMALL US/BM
LARGE US/BM CYSTGAST 13.05.77
LAP CYSTGAST/GB OUT 
EXTN DRAIN 29.07.74
LARGE LAP EXTN DRAIN 14.01.65
2 2 8
PSEUDOCYST GRI STUDY: 2 CLINICAL DATA
NAME AMYL ON DIAS WBC PYREX PAIN TEND MASS N/V M O R  DIST
ALE 510: IJ 500 6.8 Y
AND 310 7 Y Y Y
ARB
BAL 710: IJ 4200 5.3 Y Y Y Y
BAR 150 6.4 Y Y Y Y Y
BEN 700 10.7 Y Y Y Y Y
BLA
BLA 2950:U 7400 5.2 Y Y Y
BON 400W 13.8 Y Y Y Y
BRA 4600:U 22200 5.5 Y Y
BRO 1250 11 Y Y
CAM 121:U 185
cm 2930 17.4 Y Y Y Y
CHR 215 9.7
c l e 4500:1J 2300 15.1 Y Y Y Y Y Y
CLO 435 9 Y
CRI 192 20 Y Y Y
CUT 190: IJ 2950 7.4 Y Y
DEV 1942 6.4 Y Y Y Y
DOU 350:IJ 3470 11.2 Y Y Y Y Y
DUF 380: IJ 8000 7.4 Y
DUN ION 7.2 Y Y Y Y
DUN Y Y Y Y Y
ERS 2180:U 21050 6.8 Y Y
EVA 781 7.5 Y Y Y
FER 1075 7.5 Y Y
FIT 300 4.7 Y Y Y Y
FIT 2380:U 29700 7.7 Y Y Y Y Y
FRE Y Y
FRE 860:U 3600 12.9 Y
6AR 710: IJ 2550 37.6 Y Y Y Y
6IL 4800 10.6 Y Y Y Y Y Y Y
HAL 519:U 2125 6.8 Y Y Y
HEN
HER 620: IJ 3750
HI6 5000 10.2 Y Y Y Y Y Y
HOD 900 6 Y Y Y Y
HOO 1290 7.8 Y Y Y Y
HUG
KEL 260: IJ 327 5.9 Y Y
KEL 1240 12 Y Y Y
KEN 160 10.7 Y Y Y Y Y
KES 900: IJ 4225 13.9 Y Y Y Y
KIN 1515 10.2 Y Y Y Y Y
LAI 1120:U 22050 Y Y
LAN 610:U 7900
LAU 550 10.4 Y Y
MAS
MAR 1620:U 560 5.6 Y \/! Y Y
MCC 389 18.9 Y Y Y Y
ILEUS JAUNB CHEST DEATH/PH COMPLICATIONS
PL EFF
Y
Y
Y
Y Y Y Y PL EFF/JAUND/6I BLEED/DIAB/DVT
Y ABS:6T SI6N:CYST RUPT:CP
Y 61 BLEED
Y PL EFF
Y
Y
Y REN FAIL/JAUND/SEPTIC/PE
FISTULA: WOUND INF:RECURR ABSCE 
UTI
Y 61 BLEED: CHEST
Y
6AST OUT OB
Y
CHEST/WOUND DEHIS
Y Y
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PSEUDOCYST GRI STUDY: 2 CLINICAL DATA
NAME AMYL ON DIAG WBC PYREX PAIN TEND MASS N/V ANOR DIST ILEUS JAUND CHEST DEATH/PM COMPLICATIONS
MCC 145 10.2 Y Y Y Y SB FIST/WOUND INFN
MCD 2000: IJ 6000 10.5 Y Y
MCD
MCE 740 11.1 Y Y Y Y Y Y BOU QBST:INF CVP
MCG
MCG 1840: IJ 18960 Y Y Y
MCK
MCK 33W 23 Y Y Y Y Y Y Y Y WOUND DEHIS:DVT
MCK 250:U 1550 22.1 Y
MCL 557 9 Y Y Y Y Y Y Y Y PL EFF/JAUND
MCM 250: IJ 450 15.3 Y Y Y Y Y Y CHEST/AX V THRQMB
MCN
MCP 3000: IJ 12790 7.2 Y Y Y Y
MCR 5.1 IJTI
MEE 1609: IJ 10420 9.9 Y Y Y PL EFF:?6T
MIL 240: IJ 2050 12.9
MIL 420 7.4 Y Y Y ASCITES
MOR 720: IJ 3500 5.3 Y Y Y
MOR 2700 20.1 Y Y Y Y Y Y PL EFF
NEI
PAT 330:U 1661 4.9 Y
PRE 1890 8.6 Y Y Y Y Y Y Y
RAD 15800 6 Y Y Y Y
RAE Y Y Y DDUD QBSTN
RAM 1420: IJ 5130 6.5 Y Y Y Y JAUND
RAY
REI 1150:U 900 12.1 Y Y Y PL EFF
REI 140 Y Y. Y Y BLEED
REI
ROB 290 10.6 Y Y CHEST:ANAEMIA
ROS 410: IJ 700 9.2 Y Y Y Y WOUND DEHIS: REDJRR
SEL 6200 10 Y Y Y Y Y
SEM 6100 21.5 Y Y Y Y Y ASCITES/SKIN NODULE
SNA 910
SIM 350 9.4 Y PL EFF
SME 3000 6.4 Y Y
SMI 140: IJ 16.80 7.6 Y Y Y Y Y Y Y
SMI 266: IJ 1070 8.1 Y Y Y Y Y
STE 690 5.6 Y Y Y Y Y
STE Y
ST I 5000 17.8 Y Y SKIN NODULES
SUL 5000 7.4 Y Y Y Y
S!€ 175: IJ 500 8.2 Y Y Y
TEM 660:U 2325
UAL DIABETES
WAT 1445 10.2 Y Y Y Y Y Y Y UTI
WEI 1480 13.2 Y Y Y Y Y CARDIAC ARREST
WIG 5W 16 Y Y Y Y SPABS
WIL Y Y Y RESP FAIL/UTI
WIL 13.2W 24.9 Y Y Y Y DVT/SEPSIS
2 3 0
PSEUDOCYST GRI STUDY: 3
NAME COMMENT
ALE CP:RECURR AP 1968 ON:PANC CALC:EXO INSUFF
AND REF NINE AP’74-'75 RECURR PAIN, WGT LOSS, VOMIT:RE
ARB
BAL AP771:AP 10.7.75 READM 30.7 PAIN,VOMIT,WGT LOSS PC
BAR COLLECTION ? 24.12.75 US
BEN MANY APS OVER 18M:REF GRI
BLA DIED SEPSIS
BLA RECURR CYST:TRAUMA 41 DAYS PRIOR
BON DISCH WITH PYR/TACHY: 3LT FLUID IN CYST
BRA 61 BLEED/OPN /VESSEL STRETCHED/ STONE IN GB
BRO RESOLV: REFILL-DATA
CAM
CHA HLPtCYST BLEED:ABSC POST OP:DRAINED 14.1.79:FAEC F
CHR REF PERTH ABSC DRAINED 6.7.76:DEV FISTULA:PC PROB
CLE 4.7.73 GB OUT MASS IN HEAD:READM PAIN VOMIT WGT L
CLO RESOLVED/US
CRI CULLENS:RESOLVED
CUT CP: AP1980: RECURR PC:DIAG 196*0: PA IN 1932
DEV AMYL 1942 PREOP 218 POST
DOU REF TO MOPD WITH PAIN BM PC:AP DATE UNKNOWN
DUF RESOLVED NO US
DUN AP 768—769:GB OUT 1.12.69:MASS 3.70:ICTERIC CG
DUN QPN AT BALLQ:PC DIAG AT OPN:DIED SEPSIS
ERS AP PC 1978:REC PC BY US/CT TO 83
EVA 3cm CYST: RECURR 29.12.73
FER CYST AT NECK OF PANC:SMALL
FIT RESOLVED
FIT CD 65ml FLUID:
FRE NO AP NOTE:REF CLINIC MASS:CYST ANAST TO ANT WALL
FRE PC FOUND AT CLINIC:US SHOW RESOLVE
GAR PAIN/MASS/W LOSS: 5LT IN PC: 61 BLEED
GIL ABSC 23.10.76*-READM X5 PAIN k ?PC:PC PROB FRiDM BLO
HAL 1000ml IN CYST
HEN RESOLVED
HER CP
HIG TAILBOARD TO ABDN: LAP TEAR ON PANC PC NOTED LATER
HOD READM BLEED DU FOUND TO HAVE PC 800ml
HOQ AP80-PC-C6:GAST QB-GB OUT 4.6.84
HUG
KEL RESOLVED 28.02.74
KEL PYREXIA AND AAMYL POST DRAINAGE
KEN REF LAW INVEST PC NOT FOUND UNTIL LAP
KES CP RECURR PAIN
KIN PC CLINICALLY it ON AXR
LAI RESOLVED
LAN
LAIJ
MAG
MAR RESOLVED PC AFTER AP:SB OUT:PC AGAIN RESOLV:6T SIG
MCC DUBIOUS PC RESOLVED ON LS
FOLLOW UP
WELL LS 24.07.79
WELL
US CYST GONE: DISCH 02.06.76
AP 1974 LAP:DISCH 4.11.76: READM THEN DIED SEPSIS
RECURR PAIN 5.78 & 7.79
WELL3.73
61 BLEED AGAIN:SEPSIS:DIED 
VERY WELL
DEV CP:DIABETIC 4.3.S1:CDJJ FOR JAUND 15.6.83
BILQCULAR CYST: WELL ON FU
RECURR CYST DIED 61 BLEED 8 DAYS POST CG
IJS 6.12 RESQLV/FU 23.3,79:READM 19.10.78 7QBST
OCG ONLY DISH 09.07.81
ENDG it EXO INSUFF: WELL
READM 31.12 VOMIT BIOCFOI UPSET US 7NECR0SIS: FU 2 
WELL DISCH 14.03.84 
NO US BiJT DISCH 4.1.78 
WELL-* ’73 CIRRHOSIS
E ttll GROWN FROM WOUND DRAIN:PH GRAVEL IN 6B:PPEV 
PROB CP:NQ FU 83:3 PC ?2 RESOLVED 
GB OUT 12.09.78:PANC HEAD HARD: CYST REFORM:PJ AT 
ABSC x3 9.75-4.77
US 3.3 4X7.5: us 6.4 2.8: 13.3.85 WELL DISCH 
READM 8.9.79 PAIN VOM:ALCOHOLIC 6E CLIN TO 10.86 N 
COLON CA 1963:POOR DATA 
US RESOLVED:WELL 15.04.81
READMX2 6.1.76 PAIN US/BM SWELL PANC: 24.12.75 PAI
2.12.76 DISCH
RECURR PAIN:CP TOTAL PANC
WELL 11.3.75
READMx3 TO 1981 NO A SA:RECURR DU OPN’84 
WELL
HB FELL:6B OUT 10.06.82:N0 CYST:NO RJ
WELL 9.1.80
NO CYST ERCP 1986
6.85 WELL: RECURR CYST 11.86 CG
2ND CYST 31.1.80 2CMS
GB OUT 12.07.79: MASS IN HEAD 
TO 11.9.74 WELL SURGERY DEFERRED
2 3 1
PSEUDOCYST GRI STUDY: 3
NAME COMMENT
MCC REF KILM 18MNTH H/G PAIN PC ON US: 700ML: GB RUPTU
MCD AP HAIR X4 73-74 EXT DRAIN PC 7.74 REF GRI BETTER
MCD RESOLVED
MCE LAP DIAS: PAIN/VOMIT/PYREX [all QBST
MCG
MCG CP/ APX5 76-78 PANC CALC
MCK
MCK AP 19.12.67 READM 4.1.68: ABSC 4 GB OUT: PC AFTER
MCK RESOLVED:READM 3.8.77 SA 3900 US PC 3CM:US PC NOT
MCL ABSC/REN RESP FAIL/SEPTIC POST OP/7 OPNS OPEN HOUN
MCM PROB CP: DIED 10.74
MCN 7ABSC/7BLEED FROM SPLENIC
MCP V46E DUOD OBST 12.74:A SA HAIRM REF FOR INVEST:MUL
MCR CP:AP 1975 X6:PC FOUND BY ERCP
MEE RECURR PC 80-87:NO GS ON PATH
MIL
MIL RESOLVED:US DIAG ??:IJS 22.2tj.78 RESOLV
MOR CP:ANNULAR PANC: RECURR PAIN
MOR RESOLVED:CULLENS
NEI
PAT CP:AP 9.7448.76 PC CG:REC PAIN:ERCP SHOWED SMALL C
PRE 2 CYST DRAINED: DUOD OBST: FALLING HB
RAD 2PCJCG THEN EXT D 7.12 7CM
RAE DIED: AT OPN CYST IN P HEAD UNEXPECTED
RAM RESOLVED:TRANS BOURNM:IMPROVED AFTER DISCH BUT PC
RAY RESOLVED
REI RESOLVED ON US:BEVEL CP
REI READM WITH BLEED INTO PC
REI
ROB RESOLVED CLINICAL ONLY
ROS REF CLINIC NO AP NOTED
SEL REF LAW APX2 sBILOCULAR
SEM ASCITES: SKIN NODULES
SHA LAP 19.07.77 GB OUT 7N0 CYST
SIM 6T SIGN:POST SPHINCT: US PC RESOLVED
SME RECURR AP 1980-84
SMI CYST WENT AND REFILLED:BILOC 1LT FLUID:
SMI RECURR CYST 1ST 7.77:WENT 2ND 3.78:LAP ASP:3RD 9.7
STE PREV AP ABSC 1972:ALCOHOL
STE REACUM AFTER PdJT DRAIN:DIED SEPSIS 4 BLEED
STI CYST REFILL: AMY FELL POST OP: SKIN NODULES
SUL PERCUT ASP 6.82:500ml:RECURR PAIN: CG 8.82:RECURR
SWE CP:MANY AP:PC 19.7.78 AND 10.07.79:RESOLVED:ANAEMI
TEM 7 TRUE CYST
WAL CP:AP 1979: RAIN 1981: ERCP 1982 DIST PANC 1.3.82
WAT IJS DIAG:PROLONGED N/V:RESQLVED DUBIOUS
WEI DIED DAY 1 POST ELECT OPN ?MI
WIG 500ML IN CYST:NECR PANC
WIL DEID 4D POST OP:PM EF7IJTI / AP / CIRRH / RES ID PC 4CM
WIL NO SA PRE OP/13.2 POST/DRAIN FLUID BECAME INFECTED
FOLLOW UP 
WELL TO 5.7.78 
HAIRM
BUGS IN PC
WELL TO 15.08.79
DIAB 1981
US CONFIRM RESOLVED:READM 18.4.34 DIED 21.6.84 SEV
BROUGHT FOR PC DRAIN:BLEED:SEPSIS
READM 17.06.74 SP ABSC DRAINED X2 REN FAIL DIED 24
LONG FU WELL
AP 7.84/ 3.36: DISCH 1,37 
86 STILL PAIN SMALL CYST
AP775:'78:2.84:ERCP 4.86 PD ABN CP
RECURR PAIN FURTHER SUR6:CP:LAST SEEN 9.11.84
USX2 PC STILL THERE: GB OUT 12.03.84: NO COMMENT 0
WELL
DIED 61 HAEM ? SPLENIC ARTERY 
WELL
READM + 27 VOMIT OPN DUOD FISTULA DIE 15.11.66 
US AND SA RESOLVED: BETTER BEFORE RESOLV
7CYST 23.02.77 ERP FAILED: 1981 PAMS CALC NO PC GE 
ANAEMIC:GB 0UT17.06.73
NO LIS:CCS 24.9.74 NORMAL:WELL
1981 UNWELL:? MALAB:ERCP PD FILL TO NECK QN_Y:??CP 
READ 8.6.84 1 DAY: WELL FU XI 
CP:CYST RECURRED
ERCP 7.7.83 STONE: 29.11.84 2ND SPHINCTPLAST 
WELL 14.11.84
FU DIAB PANC INSUFF:FU DIAB GE CLIN TO 11.85 
DIED OD:NQ RECURR CYSTsSA WAS HIGH WITH CYST.
WELL 13.6.77
NIL
22.10.84 PERCUT DRAIN:OPN 16.01.85
WELL: OCC PAIN: DEV TIA
WELL
AP DATA NOT RECORDED 
NO IJS:QCGX3 N: IVC N: LAST 18.3.82 
LESSER SAC PC GREEN FLUID
E COLI EVENTU/NO GROWTH IN CYST FLUID/CLINIC UPS 4
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APPENDIX 3
LIST OF PARTICIPATING CONSULTANTS 
HOSPITAL
Bradford Royal Infirmary &
St Luke's Hospital, Bradford
Bristol Royal Infirmary
Dewsbury General Hospital & 
Staincliffe General Hospital
Frenchay Hospital, Bristol
Glasgow Royal Infirmary
Hairmyres Hospital, Glasgow
Halifax Royal Infirmary
Huddersfield Royal Infirmary
Leeds General Infirmary &
Chapel Allerton Hospital, Leeds
A N D  HOSPITALS.
C O N S U L T A N T
B Gadsby Peet 
J J Pr i ce 
M  Wh i 11 ake r
R N  Baird 
MJ Co o p e r 
W K  E l t r i n g h a m  
HJ Espiner 
DJ Leaper 
M  Ho r r o c k s 
JH Peacock 
AJ Webb
R C N  W illiamson
PJ Lyndon
LR C e 1e s t i n
C M Dav i dson
RE May
D C Ca r t e r
D G Gi lmour
JSF Hutchiso
C W Imr i e
CS Me a r d 1 e
T Menzies
JK Todd
JR Go 1d r i n g
JR Ri chards
W O Thomson
VK Modg ill
D  London
K W Wi 1 son
G A Bunch
NG Gr aham
W G Ha r r i s
EA Benson
RL Do i g
D  Johnston
MJ Mcmahon
JH Shoesmi th
FG Smi ddy
NS W i 11i ams
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Pr incess Ma r g a r e t Ho s p i t a 1, Sw i n d o n 
Royal United Hospital, Bath
St Martin's Hospital, Bath 
Scarborough Hospital
Southern General Hospital, G l a sgow
Southmead Hospital, Bristol 
Stobhill Hospital, Gl a s g o w
Taunton and Somerset Hospital
Victoria Infirmary, Glasgow
Weston Super Mare Genera 1 Hospi ta 1
Wh arfedale Ge n e r a 1 Ho s p i t a 1 
York District Hospital
PH Powley
D C  Brit ton 
K  L I o y d - W i 1 1 i ams 
W F W  Southwood 
A R  T u r n b u 11 
RB Smi th
AV P o 11ock 
G M R  Smi t h
JC Ferguson
A  Lit ton
G C McBa i n
HI T a n k e 1
BD Pen 1 1ow
M H Thompson
H J O  Wh i t e
M H C a 1v e r t
FT C rossling
R  Da 11i n g
JA Ga r r e 11
CD Co 11i n s
G N Lumb
PJ O ' boy 1e
AJ Mack
IS Smi t h
TJ F 1 ew
A  Hi n c h 1i f f e
DJ Adams
JL Craven
R  Hall 
DS Hopton 
TS Matheson
APPENDIX 4
COMPUTER DATA FOR 29 PATIENTS 
FROM LEEDS, BRISTOL AND GLASGOW
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PSEUDOCYST DATA: PROSPECTIVE STUDY (3 CITY) 1
NAME SEX AGE TYPE AET LAV CRIT DIA6 DAY OPN TYPE DIED COMP COMPLICATIONS
ADA F 76 PC 6S S 5S US 21 1 CG L UTI/PL EFF
AUS F 70 PC 6S 0 3S US 6 25 5 CHEST PL EFF:DIAB:MIIREN FAIL:
BIR F 34 PC 6S M 3S CAT 6B OUT 1 CHEST
BRA M 45 PC GS M 1M US 4 1 6B OUT 0
CAM F 61 PC GS n■j LQ•J'J US 12 1 CJJ:GB AL CHEST: DIAB
COO M 43 PC UK C•j 3S CAT 13 1 CJ.J 2 PL EFF:F*SM COLITIS
DEV F ' 69 PC 6S 4S US 18 1 C6 2 CHEST: PSYCHOSIS
FLU M 21 PC ALC c•J 1M US 28 1 SB OBST 3 CHEST:61 BLEED:SB OBST
600 M 52 PC 6S M 2M US 23 4 CHEST: 61 BLEED:UTI: PSYCH
600 F 30 PC U( 0 2M US 10 1 IJTI
HIR M 32 PC ALC • j 2M US 49 1 BYPASS O CHEST: DIAB
LAR F 63 PC UK s 2M US 10 1 UTI
LEW F 73 PC UK M OM us 19 1 CG 0
LYT F 53 PC GS 3S IJS 7*,J 6B OUT 0
MCC M 2? PC ALC 3S US 18 1 CG 1 CHEST •
MIT F 62 PC hS M 2M us 8 6B OUT PL EFF: UTI
MUD F 71 PC bS M ltl us •*v*» 1 CG 0
O’L M 33 PC ALC - OM us -
PAT M 56 PC CAR <2 OMtLl { us 33 1 EXT DRA 3 CHEST:REN FAIL:FISTULA
PHI M 60 PC GS M 4S us 20 6B OUT 0
PHI M 63 PC UK M OM IJS 16 1 LAP 36 3 CHEST PL EFF:61 BLEED:CVS
RAN M 42 PC ALC e OM CAT 21 0
SMI M P i•.“j PC GS s 1M us 22 1 CG:GB 0 1 WOUND INF
STA F ■j ! PC UK M OM £.11 us 33 L PE:PSYCH
TAT M 11 PC GS C 2M us 28 1 PSYCH
VEN F 61 PC UK 2M us 15 1 CJ.J 0
WAL M 74 PC ALC s 2M us 12 0
WAR M 44 PC ALC M 1M us 24 2 CHEST:DIAB
WIC F 50 PC 6S M 3S us 23 1 6B OUT 0
PSEUDOCYST DATA: PROSPECTIVE STUDY (3 CITY; 2
OPERATION POST MORTEM XRAY CYST AT DIAGNOSIS Rx
NAME STAY LAV(T) OP DAY TYPE FINDINGS PM PM FINDINGS US CT SIZE TEMP WBC AMYL ANTIBS TPN
ADA 39 Y 28 06 PCJSOOal Y+ 5 A 22 95 CEPH/F
AUS 25 N Y NECROTIC PANC:CYSTIC Y+ LARGE A 14. 83 GENT/A Y7
BIR 16 N 139 6B 0 PANC HEAD SWOLL Y+ Y+ 3.5 N 5.5 166 TETRA
BRA 13 N 23 6B 0 NO PC Y+ NO SIZ N 10 413
CAM 95 N 266 CJJ: PSEUDO Y+ N NO SIZ A 12. 2146 Y Y
COO 23 Y 43 CJ.J PC 200ml Y+ Y+ NO SIZ A 23. 400 AMP:FL
DEV 28 N 117 C6 PC 800MLS: 6B OUT C6 Y+ 9X5.5 9.9 1110 CEPH/A
FLU 39 N 11 SB 0 SB OBST Y+ N LARGE A 1900 AMP/GE
600 25 N Y+ 6 A 10 253 GENT/C Y3
600 61 N Y+ N 4 A 11 748 -'SEPT Y37
HIR 13 Y 59 BYPA DUO OBST Y+ N LARGE A A A YES Y44
LAR 24 N Y+ N 5X7.5 16. 1015 MOX/AM N
LEW *j£T N 67 C6 10CM PC Y+ N 10 N 20 360 Y Y7
LYT 15 N 120 GB 0 PANC SWELL: NO PC Y+ Y+ 6x4 N 17. 573
MCC 23 N 62 C6 PC 1200fni Y3 N 9 16. 1362 NET Y.E
MIT 68 N 131 SB 0 PANC HARD Y4 Y+ 4x9 13 100 Y Y6
MUD 63 N 41 C6 PC 60ti I: NEC PANC Y+ Y+ 8 14 1782 CEPH Y30
O’L 8 N Y+ N 3.5 N 7.3 4900
PAT 12 Y 39 EXT RUPTURED CYST 61 BLE Y+ N 6 A 13 1350 AMP Y
PHI 20 N 07 SB 0 CYST L SAC & HEAD Y5 N 4.5 17. 135
PHI 36 N 21 LAP 2 CAVITIES WASHED QU N Y+ NO SIZ N 13 1670 SEPT: Y
RAN 37 Y N Y+ 5 6.9 132 GENT VO f V
SMI 7 N 48 CS:6 PC 600ffil:SS Y+ 8 A 15. 3097 Y
STA 39 N Y4 N NO SIZ 17. 1120 SEPT:
TAT 35 N V '. M O li H 'J 11. 2170 Y
VEN 12 N 56 CJJ LESS SAC 60ml DUCT C Y+ N 3x10 N 12. 1333 MULT
WAL 27 Y Y+ N LARGE N 10. 490
WAR 16 N Y+ Y+ LARGE 5.6 1298 CEPH Y
WIC 27 N 57 6B 0 MUC OF 6B MASS INV D Y+ N 5 A 5.5 113
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PSEUDOCYST DATA: PROSPECTIVE STUDY (3 CITY) 3
NAME CONFIRM COMMENT FOLLOW UP
ADA US:OPN HYPOCALC: OB NOT OUT: DEVELOPED DYSPHAOIA:CAND OESPH
A1JS US: PM PC NOTED US6,11,18: NECR PANC
BIR CAT:OPN SEVERAL CYSTS IN PANCREAS: 3.5 MAX IN NECK OB OUT 23.8.82
BRA US:CLIN SPGNT RES OF CYST: NO SIZE OB OUT 9.2.83: NO PC
CAM US:OPN CULLENS ITU: READM X3 3RD ADM PC 25.08.33:REF UCL
030 CAT: Btl:US: READM 10.12:PC 200ffll AT OPN
DEV US: OPN PC SEEN DAY 18: DISCH DAY23: READM +66:PC 4.5X7.5: AFTER CYST DRAINED READM WITH VOMITING SETTLED
FLU US:CLIN LAP DAY 15 FOR ADHESIONS TO FAT NECR:PANC NEC NO P READM AFTER 1 WEEK. SETTLED: DISCH AFTER 6 MONTHS
600 US:CLIN NOTED TO HAVE CA IN R KIDNEY NEPHRECT:PC 1.5.86 PERCUT ASP
600 US:CLIN PC DAY 10:PAIN DAY 15 PC 4CM ATEMP AND AMYL PC RESOLVED: DISCH AFTER 6 MONTHS
HIR US:OPN READM +23:PC ON IJS DUOD OBSTRC BYPASS GJJ 10.3:DIS
LAR US:CLIN ?PC DAY 4:TEMP WBC UP:US DIA6 NO CLINIC PJ
LEW US:OPN PROLONS ILEUS:MASS:USPC:READM +40:DRAIN 67 VENTRAL HERNIA REP 4.82 DIED
LYT US:CAT OB OUT 2ND ADM PANC OED NO PS AT OPN
MCC IJS: OPN READM +29: COf-P BY SPABS ST AUR
MIT US:CLIN PC RESOLVED DAY 45 ON US OB OUT •
MUD US:CAT:OPN ? OS IN FAECES ERCP/SPHINC NO CBD GS:PD QBSTN: WELL 1.86
O’L US IJS PC PRIOR TO ADM SMALL PS 15.09.83 DISCH
PAT US:OPN READM +17:EXT DRAIN:DISCH 34 CA AMPULLA: CDJJ: DIED 7.10.84
PHI US:OPN CT OP CYST STILL THEBE DISCH 12.11.84
PHI IJS: OPN SUDDEN COLLAPSE 7RUPT CYST:LAVAOE ONLY DIED CARDIAC ARREST:CHEST
RAN CT CAT RESOLVED LAST SEEN 6.2.86
SMI US:OPN fEADM 17.07.&3 PAIN PS WELL
STA IJS: CLIN IJS PC RESOLVED 1 MONTH OCO/IVC NEO RESOLVED
TAT IJS US NOT SPECIFIC PROBABLE
VEN US:CT:OPN CAEC PERF:READM +14 WITH PS RJ CYST A READM 7.6: PAIN AFTER OP
WAL US:CLIN US PC STILL THERE: REFUSE OPN
WAR US:CT READM +3: CT PC EZ 8.11.85 k 3.1.86 PAIN:DIST PANCT 15.10.86
WIC IJS: CLIN: OP CYST RESOLVED ON IJS 16.07
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PSEUDOCYST DATA: PROSPECTIVE STUDY (3 CITY) 4
NAME PYREX PAIN TEND MASS N/V ANQR DIST ILEUS JAUN CHEST
ADA Y Y Y N Y Y Y
AUS Y Y Y Y Y Y
BIR N Y Y N Y Y
BRA N Y Y N
CAM Y Y Y Y Y Y Y
COO Y Y Y Y Y Y
DEV N Y Y Y Y Y
FLU Y Y Y Y Y Y
600 Y Y Y Y
600 Y Y Y Y
HIR Y Y Y
LAR Y Y Y Y Y
LEW N Y Y Y Y Y Y
LYT N Y
MCC Y Y Y Y Y Y
MIT Y Y Y Y Y
MUD N Y Y
O’L N Y Y Y N
PAT Y Y Y Y Y Y Y
PHI Y Y Y Y
PHI N Y Y Y Y Y Y
RAN Y Y Y Y
SMI Y Y Y Y N N N
STA Y Y Y Y V
TAT N Y Y Y
VEN N Y Y Y Y
WAL N Y Y Y
WAR Y Y Y Y
WIC Y Y Y Y
APPENDIX 5
COPY OF TRIAL PROFORMA
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TRIAL OF PERI T ONEAL L A V A G E  I N SEVERE ACUTE PANCREAT I T I S
INSTRUCTIONS 
Write numerate answers in the boxes provided
e . g .  for pulse rate of 72
Where alternative answers are given, ring the 
correct answer to the question
e . g .  for male patient
pulse rate I 0 I 7
Patient's name 
Address
(male
““‘(female
Trial number 
(from coordinator)
Date of birth
day month year
10 II 12 13
imale female
Age
Hospital Do not 
write in 
these boxes
Hospital number
20 21 22 23
15
16 17
Da*e of 
odrriission 
to hocpital
day month year
24 25 26 27
Consultant
Presenting symptoms
Do not 
write in 
these boxes
28
30
29
abdominal painr no
vomiting/retching 
col I opse/coma 
bock pain
yes
no
yes
no
Previous History
( None
Episodes of similar pain ( Undiagnosed pain 
( Proven pancreatitis
Number of episodes
Alcohol intake
Previous
Previous surgery
Months since 
first episode
Pints of beer 
per week
Glasses of wine 
per week
Measures of spirits 
per week
Jaundice
Dyspepsia
Proven gall stones
Ischaemic heart or 
vascular disease
Dicbetes
Cholecystectomy
Common bile duct 
exploration
Sphincterotomy/
sphincteroplasty
Peptic ulcer 
operation
1
2
_3_
39
40 41
42 43 44
45
47
49
yes
no
yes
no
yes
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
46
48
50
2
51
1
2
[52"
n
53 !rn
1 :
2 . 
FIT;
I !
_2 _'
56_
I
_2_
57_
I
_2_
5 8 j
I
_2_
59
Write in other significant symptoms Write in other relevant operations
36
Do not 
write in 
these boxes
37
Do not 
write in 
these boxes
60
~6\~
62~
38
242
Trial Number Serum amylase 
IU/L
Physical Examination
Height in cms 
Weight in kg 
Body mass index 
Temperature °C 
Pulse rate 
Systolic BP mmHg
Abdominal pain
Peritonism 
Clinical assessment of severity
12
15
18
24
27
10
13
16
19
22
25
28
absent 1
mild 2
moderate 3
severe 4
30
absent 1
localised 2
generalised 3
31
mild 1
severe 2
20
23
26
29
32
Diagnostic Lavage
performed satisfactorily 
failed attempt 
not done
Volume of free fiuid(ml) 
Colour of free fluid
34 35
pale fluid 
dark fluid
Free fluid colour number 
(from colour chart)
Colour of lavoge return fluid
pale straw colour 
darker than pale straw
Return fluid colour number
pain improvedResponse to lavage
no change
36
38
40
Multiple Criteria
pO < 8.0KPo(600tnmHg) y** 
2 no
WBC > 15,000  
Glucose>l0mmol/L  
Urea> l6mmol/L and no foil after 6 hr 
LDH>600 IUA
GOT>200 IUA  
C a++< 2 . OQmmol A  
Albumin< 32gA
Multiple Criteria score 
Assessment of severity by trial critaria
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
n ila
severe
1
2
42
1
2
43
1
2
44
1
2
45
1
2
46
1
2
47_
1
2
48_
1
2 
49
diagnostic lavage 
hypoxia alone 
multiple criteria 
laparotomy(necrosis or hoemorrhagic pancreatitis) 4
clinical assessment alone
Hours from onset of symptoms 
to diognosis of severe 
pancreatitis
Hours from diagnosis of 
pancreatitis to diagnosis 
of severe pancreatitis
53
55
Supplementary oxygen y*! 1
Amylase content of free fluid
IUA 58
Comments on diagnostic difficulties 
Do not 
write in 
these boxes
59
63
67
60
64
68
57
65
69
54
56
62
66
70
243
3
Triol
Number
Randomised for ov*JS®
no lavage
Therapy
Therapeutic lavage performed 
Duration of lavage (days)
y«*
no
10
ADDITIONAL TREATMENT DAY + COMMENTS
leave
blank
Antibiotics yesno
Antispa smodics
yes
no
Dextran yesno
Diuretics yesno
Fresh frozen yes
plasma no
Ciucagon
ves
no
Mechanical yes
ventilation no
Parenteral yes
nutrition no
Pressor yes
agents no
Steroids yesno
Trasylol. yesno
Write other relevant treatment 
(see separate sheet for operations)
Do not 
write in 
these 
boxes
12
15
18
21
24
27
30
33
36
39
42
44
46
48
50
13
16
19
22
25
28
34
37
40
43
45
47
49
Progress
Uncomplicated recovery 
Complication but survived 
Died
Day of discharge from ocute bed 
or death
Oxygen required until day :
Temperature normal from day:
Flatus first passed on day.
Parenteral analgesia required 
until day
Any other comments on progress:
53
55
57
59
61
54
56
58
60
62
63 64 65 66 67 66 69 70 71 72 73 74 75 76 77 78 79 80
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Triol Number
Number of operations 
following ocute admission
Operation findings Day of (first) operation 
(or autopsy findings)
Peritoneal fluid
Fat necrosis
Bruising
Pancreatitis
Pancreatic
none
straw coloured 
dark coloured 
cloudy 
bile stained 
frank blood
absent
localised
generalised
(±>sent 
localised to pancreas 
more remote
( oedematous
•< . i . focal) noemorrnagic 
L. extensive
yes
n o
pseudocyst
cbscess
Other intra abdominal abscess
Liver
Gall blodder
normal
cirrhosis
normal
dilated
stones
y«
no
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
inflamed no
Operative cholangiogram 
Pancreatic duct filling on OTC 
normal 
dilated
yes
n o
yes
yes
n o
yes
n o
Common bile duct
stones
ryes
J probcbly 
| possibly
P ro c e d u re
:ho!angitis ^
no procedure
yes
no
yes
drainage
P a ic r c a s  ■< d e b r id e m e n t
pancreatectomy
Cholecystectomy
Exploration CBD 
(supraduodenal)
yes
no
yes
no
yes
no
yes
no
yes
no
Sphincterotomy/plasty no
23
24
25
1
2 
26
27
28
29
30
32
33
34
35
Comments and other procedures leave blank
36
37
38
39
245
Trial number
Aetiology
Gall stones 
Alcohol 
C a. pancreas 
Trauma
Post-operative 
Post-ERCP
Hyperparathyroid
Drug induced 
(specify)
Viral (specify) 
Other (specify) 
Unknown
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
Write in drugs prior to admission
leave
blank
18 19
20 21
22 23
24 25
26 27
28 29
Investigations
Proven gall stones yesno
1
2
30
Abdominal x-ray
yes
no
Oral cholecystogram
I .V , chol angiogram yes
no
P. T. chol ang iogram yesno
U . S. scan
yes
no
C .T . scan yesno
Laparotomy yesno
I
2_
.41
G all stones shown yesno
I
_2
32
Gall stones shown yesno
I
2_
34
Gall stones shown yesno 2
"361
Gall stones shown yesno
1
2 
38~
Gall stones shown yesno
1
2 
40
Gall stones shown yesno _2_
42
Gal l  stones shown ye*no
I
_2_
44
Autopsy Report ond Cause of Death
leave
blank
45
46"
47~
48~
49~
l o ~
J L
IT
~53~
IT
Trial number
Bacteriology (write organisms and date) 
Sputum
Urine
Blood
Bile
Pancreatic dbscess
Other introcbdominal cbscess
Diagnostic lavage fluid/peritoneal fluid
Therapeutic lavage fluid
Other
Complications of lavage (state)
leave
blank
15
19
23
10
16
18
20
22
24
25 26
27 28
29 30
31 32
33 34
35 36
Complications
Chest
Cholangitis 
DVT/PE 
Diabetes 
G . I. bleed
Myocardial infarct
Pancreatic abscess 
(or fistul a)
Other intra 
abdominal abscess
Pseudocyst 
Renal failure 
Septicaemia 
Toxic psychosis 
Urinary troct infection
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
yes
no
37
40
43
46
49
52
55
64
67
70
73
day
day
day
day
day
day
day
day
day
day
day
day
day
38
41
39
42
44
47
45
48
50
53
56
54
57
>9 60
62
65
68
63
66
69
71 72
74 75
Write other complications
76
78
77
79
80
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